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ABSTRACT 
The aim of this project was to investigate how the cell-cycle of both nuclear-
donor and recipient donor affects the development of embryos reconstituted by nuclear 
transfer. 
Two methods of synchronising embryos were established. Embryos could be 
held in mitosis by culture for nine hours in 101iM nocodazole or culture for four hours 
in 0.1 pg/mi colcemid. Secondly, treatment with 1 pg/mI of aphidicolin of embryos 
previously synchronized in mitosis was able to synchronize the blastomeres at the 
GuS border without any apparent effect upon development to blastocyst. 
A method of parthenogenetic activation of recently ovulated and preovulatoiy 
oocytes was established, involving the culture of the oocytes for 60 minutes in 25 mM 
strontium in a calcium magnesium free M16 medium. Spontaneous activation was 
almost non existent in oocytes recovered from the ovary or in those recovered very 
early after ovulation (14 hours after hCG). It was possible now to conduct 
experiments on nuclear transfer in which the timing of activation was strictly 
controlled. 
To study the effect of variations in the time of fusion in relation to activation, 
late 2-cell stage nuclei were fused six hours before, at the same time or 12 h after 
activation. After activation of enucleated oocytes, the cytoplast fragmented. This 
phenomenon appears to be mediated by microtubules, since culture of activated 
cytoplast with inhibitors of microtubules polymerisation (nocodazole) inhibited 
fragmentation. A "nuclear transfer" induced activation was observed, although the 
cytoplast donor oocytes were not activated by the procedures involved in the recovery 
or the enucleation methods. A greater proportion of reconstituted embryos developed 
to blastocyst when nuclei were transferred to preactivated cytoplasts. 
After mapping cell-cycle events in activated oocytes, and 4-cell and 8-cell stage 
mouse embryos, nuclear donor cell-cycle effect and its interaction with cytoplast cell-
cycle were studied. Mouse 4-cell stage were used as donors of nuclei in Gi-phase, 
early S-phase and late S-G2 phase. The recipients were enucleated cytoplast either 
non-activated (meiosis II) or preactivated 6-8hr (early S) or 12-16 hr (late S) before 
II 
fusion. Development after nuclear transfer was influenced by donor and recipient cell 
cycle stage and by the interaction between them. There was an advantage of using 
nuclei in Gi as donors. Nuclei in early-S or late S-G2 only developed in synchronous 
recipients, whereas Gi nuclei developed in oocytes in both meiosis II and early S. 
Mouse 4-cell nuclei in Gi were able to support development to term when 
transferred to an oocyte in meiosis II; this ability was lost if the nuclei have started 
DNA synthesis, and that loss could not be prevented by aphidicolin. Development to 
blastocyst was also achieved by using 8-cell nuclei in Gi as nuclear donors. Use of 
older oocytes increased development to blastocyst when nuclei in S-phase were 
transferred to preactivated recipients. No development was obtained when early or late 
zygotes were used as cytoplast donors, which suggest the existence of a 
"reprogramming factor" in the cytoplast from oocytes. 
These results confirm the importance of controlling cell cycle during nuclear 
transfer and emphasise the advantage of transferring nuclei in Gi-phase. In addition, 
they suggest that development may be achieved from later stages, provided that the 
nuclei are transferred into appropriate recipients. 
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CLONING BY NUCLEAR TRANSFER 
1.1 INTRODUCTION. 
Nuclear transfer experiments were first proposed by Spemann in 1938 
(cited by DiBenardino, 1979) as a tool to investigate the potential of the 
genome of differentiated cell nuclei. The idea was to transfer nuclei from 
embryos at progressively more advanced stages in development, into 
enucleated 1-cell embryos to study their ability to direct development. This 
idea was tested first in nuclear experiments in amphibia (Briggs and King, 
1952, 1960) in which nuclei were injected into the cytoplast of enucleated 
parthenogenones of Rana pip iens. In the successive years extensive 
experiments were conducted using mainly two amphibian species Xenopus 
laevis and Rana pipiens (see Gurdon et al., 1979; DiBenardino, 1979; 
DiBenardino, 1987; DiBenardino, 1988; DiBenardino and Hoffner Orr, 1992). 
Early nuclear transfer experiments in mammals encountered severe 
difficulties due principally to the size (approximately 1000 times smaller than 
the frog egg) of the oocyte and zygote and their sensitivity to microsurgical 
manipulations. Two approaches were investigated in search of an efficient 
method of nuclear transfer in mammals. The approach in which the plasma 
membrane of the recipient cytoplast is penetrated has been defined as 
"surgical" nuclear transfer.(Modlinski, 1975), whereas "non-surgical" nuclear 
transfer is conducted when cell membrane surrounded nuclei (karyoplasts) are 
transferred into the cytoplast using cell fusion. A technique of virus-induced 
cell-membrane fusion was adapted to nuclear transfer experiments in mouse 
(Graham, 1969; Baranska and Koprowski, 1970; Bernstein and Mukherjee, 
1972; Lin and Florence, 1973) and rabbit (Bromhall, 1975). The last 
experiment provided inconclusive evidence for development to morula after 
nuclear transfer into enucleated cytoplast. Modlinski (1978, 1981), using a 
surgical nuclear transfer method (microinjection) conducted nuclear transfer 
experiments in mouse in which the different ability of nuclei from 8-cell stage 
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embryos, trophectoderm and inner cell mass cells to contribute to the 
development of a tetraploid blastocyst after their introduction into zygotes was 
reported. Later, fertile mice derived from inner cell mass nuclei transferred into 
enucleated zygotes were reported by ilimensee and Hoppe (1981). However, 
others failed to confirm the latter results. 
It was only after the establishment of a non-surgical nuclear transfer 
method that facilitated the enucleation of the recipient cell (McGrath and 
Solter, 1983a), that nuclear transfer experiments with mammalian embryos 
became routine and were undertaken on a similar scale to those in amphibia 
(see Howlett et al., 1989; Prather and First, 1990; Bondioli et al., 1990; First 
and Prather, 1991; Wilmut and Campbell, 1992; Campbell et al., 1995). 
Once methods for the manipulation of mammalian embryos were 
established, nuclear transfer experiments that started as an investigation of cell 
differentiation soon also became a quest for methods of producing large 
numbers of embryos from livestock of high genetic merit. The aim was to use 
embryos from high quality parents as donors of nuclei that would be 
transferred into cytoplasts from lower quality individuals. The embryos 
produced by those manipulations were considered genetically identical copies 
(clones) of the nuclear donor embryo. Clones are defined as individuals that 
are genetically identical copies of another individual which have been 
produced by means of asexual reproduction (Seidel, 1983). However, it should 
be noted that offspring resulting from a nuclear transfer procedure could not 
automatically be assumed to be phenotypically identical, since the 
mitochondrial DNA and cytoplasmic environment will differ for each cytoplast 
into which nuclei from the same embryo are transferred. Also other factors 
such as epigenetic phenomena and uterine, neonatal and later environment 
would influence its phenotype (see Seidel, 1983). However, the ability to 
produce such clones from cultured cells or from cells of an adult individual 
would have an enormous potential for the dissemination of genetic 
improvement, for rapid genetic manipulations (lransgenics) and for studies of 
the hereditary contribution to commercial traits. 
In order to accomplish this goal three conditions are necessary. First, 
all the genetic information present in the zygote must also be present in the cell 
used as nuclear donor (i.e. no DNA losses during development). Second, this 
information must be retrievable once the nucleus is transferred into the 
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cytoplast (i.e. the genes must be accessible to the transcription factors) 
allowing the gene expression of the transferred nucleus to be transformed into 
one equivalent to that of the pronuclei (reprogramming, see definition in next 
paragraph). If either of these two conditions can not be achieved, that would 
constitute a biological barrier to cloning by nuclear transfer. Third, nuclear 
transfer itself must not introduce any harmful changes. Investigating any such. 
harmful changes and developing new nuclear transfer procedures that take care 
to avoid them would facilitate the improvement of cloning by nuclear transfer. 
One factor which has been shown to have important implications for 
development after nuclear transfer is abnormal DNA replication caused by use 
of donor and recipient cells at inappropriate cell cycle stages. These three 
conditions will be considered in this review. 
In this thesis, any change in the gene expression of a nucleus 
transferred into a different cytoplasmic environment is defined as 
reprogramming of gene expression. Theoretically, this reprogramming can be 
complete or incomplete. Complete reprogramming would occur when all the 
genes characteristic of the nuclear donor cell, but which are not expressed in 
the recipient cell, are switched off, and all the genes normally expressed in the 
recipient cell are maintained or switched on. A partial or incomplete 
reprogramming would occur when, although gene expression is modified after 
nuclear transfer, this modification is not complete either because some genes 
are not switched off or there is an inability to switch on all the necessary genes. 
When the recipient, as in most of the nuclear transfer experiments referred to 
in this thesis, is either an oocyte or a zygote, reprogramming of the transferred 
nucleus is understood as the modification of its gene expression in such a way 
that it becomes equal (when complete) or similar (when incomplete) to the 
gene expression of the recipient's original genome. As a result, the 
differentiation process of the transferred nucleus would be "rewound" back to 
the starting point of the developmental programme. In this thesis, this process 
will be referred to as reprogramming after nuclear transfer. 
The term reprogramming refers only to changes in gene expression. 
Observed morphological changes of the nucleus after nuclear transfer, which 
may be related to the changes in gene expression, are referred to in this thesis 
as "remodelling" (e.g. nuclear swelling). 
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1.2 GENETIC INFORMATION IN THE DONOR CELL 
NUCLEUS. 
One of the main questions in development is how the cells progress 
towards somatic cell specialisation. Two opposed models have been proposed. 
One involves losses and rearrangement of DNA sequences, in the other the 
specialised state would be achieved through epigenetic control of gene 
expression (e.g. chromatin structure, trans-acting factor-DNA interactions, 
DNA methylation-hypomethylation). 
Regular DNA losses have been reported in only few animal species in 
ciliated protozoans, nematodes, crustaceans and insects (Klobutcher et al.., 
1984; Hennig, 1986; Tobler, 1986). Among vertebrates, DNA losses occur in 
the genetic rearrangement of the immunoglobulin genes in chicken (Weill and 
Reynaud, 1987) and mammalian B lymphocytes (Alt et al., 1987) and in T-cell 
receptor genes in mammalian T lymphocytes (Hood et al., 1985; Marrack and 
Kappler, 1987). 
With the exceptions quoted above the evidence available today 
indicates that the whole genome is retained during development even in 
specialised somatic cells. This evidence includes biochemical analysis showing 
that the genome size remains quantitatively equivalent during development and 
differentiation, and functional studies as, for example, in the activation of 
dormant genes in specialised cells. This activation is a relatively common 
phenomenon, consistently demonstrated in several experimental systems 
including cell cultures (see Harris, 1986), transdifferentiation (Eguchi, 1988), 
heterokaryons (Harris, 1974; Blau et al., 1983; Blau et al., 1985; Baron and 
Maniatis, 1986; Blau and Baltimore, 1991), cell hybrids (Harris, 1985), cancer 
(Pierce, 1985; Sachs, 1987) and nuclear transfer (DiBenardino and Hoffner Orr 
1992; see also next section). In these cases, the activation of dormant genes is 
accompanied by changes in the cell phenotype of specialized cells. This 
evidence indicates that many silent genes can be maintained in the genome in 
the absence of expression, and that under favourable conditions they can be 
stimulated to function and remain functional. 
It has not yet been demonstrated that animal genomes of differentiated 
somatic cells retain totipotency (see definition later) and therefore it is not 
possible to exclude the possibility of subtle, irreversible changes in the DNA 
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of certain genes and/or in their cis-controlling regions. But the most tenable 
hypothesis appears to be that most of the somatic cells retain the same genetic 
information (or amount of DNA) as the zygote and that the specialized state is 
achieved by a continuous regulation of their gene expression by trans-acting 
factors that either activate or repress genes without an irreversible change in 
the nuclear DNA (DiBenardino and Hoffner, 1970; Dibenardino et al., 1984; 
Blau etal., 1985; DiBenardino, 1987; DiBenardino, 1988; Blau and Baltimore, 
1991). 
1.3 TOTIPOTENCY OF THE DONOR CELL NUCLEUS; 
REPROGRAMMING OF GENE EXPRESSION AFTER 
NUCLEAR TRANSFER. 
In this thesis, a totipotent cell is defined as one that is able to contribute 
to all cell lineages and, given the right environment, to develop into a fertile 
adult individual (i.e. the zygote, one 2-cell stage blastomere in mouse 
(Tarkowski, 1959; Tarkowski and Wroblewska, 1967), one 8-cell stage 
blastomere in sheep (Willadsen, 1981)). By contrast, pluripotent or multipotent 
cells would be those which are able to contribute to several cell lineages, but 
are not able to develop into an adult individual. (Note- According to this 
definition single blastomeres from mouse 4-cell, 8-cell (Kelly, 1975) and 16-
cell (Ziomek et al., 1982) that, when combined with other genetically marked 
cells, are able to contribute to all tissues of the conceptus, but by themselves 
are unable to form viable offspring (Tarkowski and Wroblewska, 1967) are 
considered as pluripotent and not as totipotent cells). Similarly, in this thesis, a 
totipotent nucleus is defined as one that is capable of directing development 
into a fertile adult individual, given the right conditions (i.e. transfer into a 
cytoplast which would provide the necessary cytoplasm). 
Nuclear totipotency requires that whatever genetic mechanisms operate 
to direct differentiation, they are completely reversible. In other words, the 
nucleus transferred into the cytoplast (oocyte or zygote) must become 
pronucleus-like in developmental terms. Expression of genes characteristic of 
its former stage or tissue must be switched off and at the due time, the 
expression of genes required for the early development have to be activated. 
Therefore, the real test of the totipotency of a nucleus remains its ability to 
direct development to a fertile adult after nuclear transfer. As will become 
apparent from the following discussion, this measurement varies with the 
method of nuclear transfer. 
Nuclear transfer experiments conducted with amphibian embryos 
suggested that, at least in the early stages of development, differentiation is 
achieved by means that do not involve loss of nuclear totipotency. Thus, 
Briggs and King (1952, 1960) obtained metamorphosed frogs following 
transplantation of nuclei from blastula and early gastrula stage embryos into 
enucleated parthenogenones. Later, development to fertile adults after transfer 
of nuclei from blastula stage embryos was achieved in both Xenopus laevis and 
Rana pipiens (Gurdon, 1962) thus demonstrating, for the first time, genomic 
totipotency of amphibian blastula stage nuclei. In some cases even nuclei from 
early stage larvae of Xenopus directed development to adulthood, showing 
thus their totipotency (Gurdon, 1962; Gurdon and Uehlinger, 1966; Kobel et 
al., 1973; Gurdon, 1986). Experiments with early embryonic nuclei in 
Drosophila (Ilimensee, 1973; Zalokar, 1973) and the teleost fish (Yan et al., 
1984) revealed these nuclei to be totipotent also. 
However, no nucleus of a documented differentiated somatic cell nor of 
any adult cell has yet been shpwn to be totipotent, although evidence for 
genetic multipotentiality of nuclei from specialized somatic cells of the 
advanced embryo, juvenile and adult frog is available. Development to feeding 
tadpoles (5.9 %) was achieved when erythrocytes of juvenile Rana pipiens 
frogs were used as nuclear donors (DiBenardino et al., 1986). Pre-feeding 
tadpoles were obtained, in Xenopus laevis, after nuclear transfer of nuclei 
from embryonic myotomes (2 %)(Gurdon et al., 1984), adult erythroblast (2 
%) (Brun, 1978), adult skin cells in culture (3 %) (Gurdon et al., 1975) and 
adult spleen (6 %) (Wabi et al., 1975) and, in Rana, from adult erythroblast (2 
%) (DiBenardino and Hoffner, 1983). 
More interestingly, in those experiments it was found that the ability of 
the transferred nucleus to direct development after nuclear transfer could be 
enhanced by using oocytes in metaphase I instead of parthenogenones as 
recipients and by subsequently conducting serial nuclear transfers 
(DiBenardino and Hoffner, 1983; Orr et al., 1986; DiBenardino et al., 1986; 
DiBenardino and Hoffner Orr, 1992). 
These were very important findings. They showed that the 
developmental potential of the transferred nucleus was not something 
maintained by irreversible changes, as the differentiation process could be 
reversed, at least partially. Secondly, that the reversal could be influenced by 
the choice of cytoplast used as recipient. 
After the technical difficulties of enucleating the recipient cell were 
overcome (McGrath and Solter, 1983a) nuclear transfer experiments with 
mammalian embryos became routine. The first series of experiments were 
conducted using as nuclear donors, cells from early cleavage stages and 
enucleated zygotes as recipients. As in amphibians, the advantage of using 
oocytes in metaphase II instead of zygotes or parthenogenones was suggested 
by several publications (Czolowska et al., 1984; McGrath and Solter, 1986; 
Willadsen, 1986; Robl et al., 1987). Enucleation of metaphase II oocytes was 
achieved with the aid of a DNA-specific fluorochrome, Hoechst 33342, to 
visualise the chromosomes (Ebert et al., 1985; Tsunoda et al., 1988). When 
enucleated pronuclear stage embryos were used as recipients, no development 
was observed in nuclear transfer experiments conducted with cow (Robl et a!, 
1987), mouse (McGrath and Solter, 1984) and rat (Kono and Tsunoda, 1988) 
embryos. However, when oocytes in metaphase II were used as cytoplast 
donors development to term was achieved in several mammalian species 
(sheep, Willadsen, 1986; cattle, Prather et al., 1987; pig, Prather et al., 1989; 
rabbits, Stice and Robl, 1988). 
Although the mouse was the mammalian species in which most of the 
early work was conducted, it appeared to be rather difficult to clone by nuclear 
transfer, development of fertile mice was reported after 8-cell stage nuclei 
were transferred into enucleated 2-cell blastomeres (Tsunoda et al., 1987). It 
was suggested that, since patterns of gene expression were relatively similar in 
2-cell and 8-cell stage embryos little reprogramming was required in this case 
(Smith and Wilmut, 1993). However, more recently, development to term has 
been also been reported when an enucleated oocyte in metaphase II was used 
as a recipient for late 2-cell stage nuclei (Kono et al., 1991b) and early 8-cell 
stage nuclei (Cheong et al., 1993). 
In comparison to amphibians, very little is known about the most 
advanced embryonic stage from which development after nuclear transfer will 
occur in mammals. Development to term has been reported from inner cell 
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mass nuclei in sheep (Smith and Wilmut, 1989), rabbit (Collas and Robi, 1991) 
and cow (Collas and Barnes, 1994). Also, development to term has been 
reported after cultured cells from primary explants of inner cell mass were 
transferred into enucleated oocytes in sheep (Campbell et al., 1995). 
Development to the blastocyst stage after nuclear transfer has been 
reported from thymocyte nuclei (Kono et al., 1991a) and stem cells (Kato and 
Tsunoda, 1993) in mouse; male primordial germ cells (Moens et al., 1995), 
stem cell-like (Giles et al., 1995), cumulus granulosa cells and foetal 
fibroblasts in rabbit (Collas and Robi, unpublished, cited by Collas and Barnes, 
1994); and cumulus granulosa cells in cow (Collas and Barnes, 1994). Mouse 
donor primordial germ cells lead to implantation sites although no 
development to term (Tsunoda et al., 1989). In this last report enhanced 
development after serial transfer was described. Also, development to 
blastocyst of embryos produced after inter-specific nuclear transfer has been 
reported (Wolfe and Kraemer, 1992). 
In summary, the results from nuclear transfer experiments suggest a 
progressively restricted development after transfer of nuclei from more and 
more developmentally advanced cells. A relationship between the latest stage 
from which development to term has been obtained in different species and the 
stage of development at which the major onset of zygotic transcription occurs 
in those species has been suggested (McGrath and Solter, 1984; Howlett et al., 
1987; Prather and First, 1990; Wilmut and Campbell, 1992). Development to 
term has been achieved from later stages in those species in which the onset of 
transcription occurs also later (see table 1.1). However, it is not clear if this 
relationship is due to a loss of totipotency of the transferred nucleus or to a 
longer period prior to the onset of the zygotic transcription during which the 
transferred nucleus can recover after nuclear transfer. 
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Table 1.1 - A comparison between the stage of development at which 
transcription from the embryonic genome begins and the most advanced 
stage of development from which nuclei transferred to enucleated 
oocytes have been able to support development to adulthood. (From 
Wilmut and Campbell, 1992; with modifications) 
Species 	Mouse 	Rabbit 	Cow 	Sheep 	Xenopus 
Start of 	Two-cell 	Four-cell 	8- 16 cell 	8- 16 cell 	4000 cell 
transcription 
Nuclear 	Eight-cell 	32-cell 	32-cell 	64-cell 	Tadpole 
totipotency intestinal 
epithelium 
- Data on nuclear transfer from Cheong etal., 1993; Collas and Rob!, 1991; Bondioli 
et al., 1990; Smith and Wilmut, 1989; Gurdon, 1986. Data on transcription from 
Bolton et al., 1984; Van Blerkom and Manes, 1974; King et al., 1985, 1988; Camous 
et al., 1986; Calarco and McLaren, 1976; Newport and Kirschner, 1982. 
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A loss of totipotency would happen if genes that had been switched off, 
but are necessary for the progress at the earlier stages, cannot be switched on 
again after nuclear transfer. Alternatively it may reflect harmful effects of the 
products of genes not normally active early in development, but which are not 
switched off by nuclear transfer. It may be that those changes appear step by 
step. If, for instance, an inhibitory factor attaches to the DNA before 
triggering changes in methylation patterns or histone binding that finally result 
in conformations that render the DNA unable to bind transcription activating 
factors. These changes may be progressively more difficult to reverse by the 
present nuclear transfer methods which may only be capable of reversing the 
early changes. 
In the species where maternal-zygotic transcription occurs later it may 
be that fewer changes occur during the early cleavage stages so that less 
reprogramming is needed. Alternatively, the nuclei have extra rounds of 
division and DNA replication before the transferred nucleus is asked to direct 
development and therefore has a better chance to prepare itself for that 
moment. 
Reprogramming of gene expression can be monitored by direct 
observations of changes in RNA and peptide production as has been reported 
in nuclear transfer experiments in amphibians (Etldn, 1976; DeRobertis and 
Gurdon, 1977; Korn and Gurdon, 1981; Wakefield and Gurdon, 1983; Gurdon 
et al., 1984) and mammals (mouse: Howlett et al., 1987; Latham et al., 1991; 
Latham et al., 1994; cow: Yang et al., 1995). However, in two experiments 
where parthenogenones (Howlett et al., 1987) and enucleated zygotes (Latham 
et al., 1994) were used as recipient-cytoplast donors, it was found that 
although inactivation of the gene expression characteristic of the nuclear donor 
stage (8-cell) happened after nuclear transfer, the reactivation of the genes 
needed at the earlier stages of development was not complete. As a 
consequence, the failure in reprogramming of the donor nucleus in those 
experiments was related to the poor development of the resulting embryos. 
Also, indirect evidence for changes in gene expression has been obtained by 
observations of nucleolar organizing regions in mouse (Dyban et al., 1988) 
and in developmentally regulated membrane antigen (TEC-03) in cow (Van 
Stekelenburg-Hamers et al., 1994) after nuclear transfer. It can be concluded 
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that reprogramming of the transferred nucleus, although it may be incomplete 
or partial, is a common phenomenon after nuclear transfer. 
The main evidence supporting that reprogramming is achieved in some 
degree is the recapitulation of preimplantation development observed after 
transfer of nuclei from more advanced stages, 8-cell to blastocyst (inner cell 
mass), into enucleated oocytes (Willadsen, 1986; Prather et al., 1987; Slice and 
Rob!, 1988; Prather Cr al., 1989; Smith and Wilmut, 1989; Collas and Robi, 
1991; Cheong et al., 1993). Another way of studying reprogramming is to 
consider the timing of morphological events during this recapitulation (i.e.-
compaction and blastocyst formation). It seems that an incomplete 
reprogramming happens in mouse embryos after transfer of 8-cell into 
enucleated 2-cell blastomeres (Tsunoda et al., 1987; Howlett et al., 1987) since 
both compaction and blastocyst formation occur earlier than in controls. 
However, blastocyst formation at the same time as in controls has been 
reported in mouse embryos produced by nuclear transfer (Barnes et al., 1987). 
This information has not been mentioned in others experiments (Tsunoda and 
Shioda, 1988; Kono and Tsunoda, 1988; Smith etal., 1988; Kono eta!, 199 lb. 
1992; Cheong etal., 1993). 
It is not clear what causes reprogramming of gene expression. Nuclear-
cytoplasmic protein exchanges after nuclear transfer had been described in 
amphibia (reviewed by Gurdon et al., 1979; DiBenardino, 1979; DiBenardino, 
1987). Swelling of the transferred nucleus up to pronuclear-size, thought to be 
the consequence of a protein exchange between the transferred nucleus and the 
recipient (Prather and First, 1990), had been described both in mammals 
(rabbit, Stice and Rob!, 1988; pig, Prather et al., 1990; mouse, Czolowska et 
al., 1984 and cow, Slice et al., 1994) and in amphibia (Graham et al., 1966; 
Gurdon, 1968). 
It seems likely that remodelling of nuclear structure and 
reprogramming of gene expression are interdependent. The available evidence 
suggests that they are produced by "factor(s)" present in the oocyte cytoplasm 
after germinal vesicle break down that are removed, or otherwise inactivated 
during pronuclear formation. For convenience in this discussion those factors 
will be referred to as remodelling factors. 
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One of the candidates that has been proposed as responsible for 
reprogramming is the process or group of factors involved in the intense 
morphological changes that happen to the oocyte and sperm nuclei after 
fertilization and result in the remodelling of the oocyte chromosomes and 
sperm nucleus into functional pronuclei capable of DNA synthesis (for reviews 
see Longo, 1985; Poccia, 1986; Zirkin et a!, 1989; Perreault, 1992). Those 
morphological changes include meiotic spindle rotation, sister chromatid 
separation as anaphase H and telophase II progress, extrusion of the second 
polar body and remodelling of the oocyte chromosomes into the female 
pronucleus (see chapter 4). At the same time the sperm nucleus undergoes 
nuclear envelope breakdown (Borsuk and Tarkowski, 1989; Borsuk 1991, see 
reviews by Longo, 1985; Zirkin et a!, 1989), chromatin decondensation (see 
reviews by Longo, 1985; Zirkin et a!, 1989; Perreault, 1992) and replacement 
of protamines by histones (Eckland and Levine 1975; Kopecny and Paviok, 
1975, 1984; Nonchev and Tsanev, 1990; Rodman et al, 1981). Sperm nuclear 
decondensation, meiotic progress and formation of male and female pronuclei 
occur in a coordinated way (Wright and Longo, 1988; Lassalle and Testart, 
1991). Decondensation is followed by partial recondensation of the sperm 
chromatin just before it expands again during pronuclear formation (Wright 
and Longo, 1988; Lassalle and Testart, 1991). The condensed oocyte 
chromatin remains in telophase while the sperm chromatin decondenses and 
then undergoes also a transient recondensation (Adenot et a!, 1991). It is 
important to note that the timing -of those events appears to be controlled by the 
oocyte rather than by the sperm (Naish et a!, 1987; Perreault et a!, 1988; 
Perreault, 1990; Zirkin et a!, 1989). It would be possible that some factor(s) 
that acts during those changes after fertilization could interact with the 
transferred nucleus inducing its reprogramming. 
The ability of the oocyte to initiate decondensation of the sperm 
nucleus depends of the stage of the oocyte (see Zirkin et a!, 1989). Sperm 
decondensing activity is highest in the metaphase state when maturation / 
mitosis / meiosis promoting factor (MPF) activity is also maximal (Cran and 
Moor, 1990). In contrast germinal vesicle intact oocytes and both pronuclear 
stage parthenogenones and zygotes fail to induce sperm decondensation (Usui 
and Yanagimachi, 1976; Thadani, 1979; Balakier and Tarkowski, 1980; 
Komar, 1982; Perreault et al., 1984; Borsuk and Tarkowski, 1989; 
Maleszewski, 1992). These observations suggested that extra chromosomal 
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constituents of the karyoplast of the germinal vesicle (most probably nuclear-
specific proteins) responsible for sperm decondensation are liberated to the 
oocyte cytoplasm after the germinal vesicle breaks down (Usui and 
Yanagimachi, 1976; Balalder and Tarkowski, 1980), and are not present after 
pronuclear formation. Nevertheless, sperm nuclei incorporated into pronuclear 
stage mouse parthenogenones were remodelled during the first mitosis 
(Maleszewski, 1992), which suggests that either MPF also has a role in 
remodelling or remodelling factors, others than MPF, removed from the 
interphase cytoplasm are released again during mitosis. 
The metaphase II oocyte is also capable of remodelling heterologous 
sperm and somatic cell nuclei into functional pronuclei (Tarkowski and 
Balalder, 1980; Czollwska et al, 1984; Szollösi et al., 1986; Naish et a!, 1987). 
Remodelling, or morphological changes, observed in thymocyte nuclei 
transferred into metaphase II oocytes went along the following sequence of 
events. Nuclear envelope break down and premature chromatin condensation 
occurred first. This was followed, after activation of the recipient oocyte, by 
nuclear envelope reformation, nuclear swelling and formation of nucleoli 
(Czolowska et al., 1984; Szollosi et a!, 1986). When thymocyte nuclei were 
transferred into non-activated oocytes, they underwent nuclear envelope break 
down and premature chromatin condensation. After which the thymocyte 
chromosomes acquired a metaphase configuration. They stayed in this 
situation for several hours before dispersing into the cytoplast. However, when 
the thymocyte nuclei were transferred into oocytes in metaphase IT that had 
been activated prior to fusion those changes varied (Szöllösi et al., 1986). It 
was observed that the removal of nuclear envelope in activated oocytes was 
slightly slower than in the non-activated oocytes (Szöllosi et al., 1986). 
Moreover, nuclear envelopes of thymocyte nuclei transferred 5 hours after 
activation remained intact (Szöllösi et al., 1986). 
In this thesis it was decided to distinguish the whole process that 
happens when nuclei are transferred into oocytes in metaphase H that are 
subsequently activated; from the shorter remodelling that happens when nuclei 
are transferred into oocytes already activated. Therefore it will be distinguished 
between nuclear envelope break down, premature chromosome condensation 
and proper remodelling. In this thesis remodelling of the transferred nucleus, 
when not otherwise stated, will be considered as the series of morphological 
changes associated with decondensation of chromatin, swelling of the nucleus 
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and formation of peripherally located nucleoli which fused into a single, 
centrally placed nucleolus as is the case in pronuclei following fertilization 
(SzöllOsi et al., 1986). 
Studies of remodelling of thymocyte nuclei after nuclear transfer into 
metaphase II oocytes suggested also that factors essential for nuclear swelling 
are limited in quantity and available only during a limited period of time after 
activation. These studies suggested that the synchrony between fusion of the 
donor nucleus and activation of the recipient oocyte is a critical factor affecting 
nuclear remodelling, and presumably reprogramming of the transferred nucleus 
(Tarkowski and Balalder, 1980; Czollwska et al, 1984; Szollösi et al., 1986). 
However, the effect of the presence of the female pronucleus in the oocytes 
used in these experiments needs to be considered when those results are 
extrapolated to nuclear transfer experiments. In these experiments it was found 
that for optimal remodelling of the nuclei these had to be introduced into the 
oocyte cytoplasm within a period from 30 minutes before activation until 60 
minutes after activation of the oocyte (Czollwska et al, 1984; Szöllösi et al., 
1986). This window corresponds with the period between metaphase II and 
telophase II (Szollösi et al., 1986). The remodelling activity of the oocyte 
cytoplasm was influenced by the number of nuclei introduced into the oocyte, 
the presence of the female pronucleus and the activation-fusion interval 
(Czollwska et al, 1984). A similar degree of remodelling was achieved when 
nuclei entered the oocyte cytoplasm at the same time (Czollwska et al, 1984). 
Therefore, it was hypothesised that during remodelling, factors (may be 
nuclear proteins) that exist in a limited quantity are gradually absorbed by the 
decondensing and swelling nuclei until the pool becomes exhausted 
(Czollwska et a!, 1984). Any nucleus that starts decondensation and swelling 
beyond a certain time limit in relation to any other interphase nucleus already 
present in the oocyte, as for example the female pronucleus, is handicapped in 
the competition for remodelling factors (Czollwska et a!, 1984). Thus when the 
thymocyte nuclei were transferred outside the window mentioned before, those 
compounds were no longer present and complete remodelling could not been 
achieved (Czollwska et a!, 1984; Szöllösi et al., 1986). This idea that 
remodelling factors are limited is supported by observations in polyspermic 
eggs of competition between the growing nuclei for the uptake of nuclear-
specific proteins from the cytoplasmic pool (Hirao and Yanagimachi, 1979; 
Witkowska, 1981, 1982; Naish eta!, 1987). 
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Replacement of protamine in sperm chromatin could be considered as 
analagous. The metaphase arrested cytoplasm appears to be ideal for inducing 
sperm decondensation and protamine replacement. This protamine replacement 
process may be crucial for reprogramming after nuclear transfer. Recent 
studies have shown that somatic histone Hi is not detectable in oocytes, 
zygotes and 2-cell stage embryos, but it becomes associated with chromatin 
during the 4-cell stage and remains present throughout subsequent 
preimplantational development (Clarke et a!, 1992). This observation 
correlates well with the reported inability of cytoplasts from enucleated 
zygotes to support development of embryos reconstituted by nuclear transfer of 
nuclei from 4-cell stage embryos; although they supported development of 
embryos reconstituted by nuclear transfer of nuclei from 2-cell stage embryos 
(Smith et al., 1988; Cheong and Kanagawa, 1993). It has been suggested that 
changes in histone composition of chromatin during early mouse 
embryogenesis could underlay the changes in nuclear totipotency reported by 
nuclear transfer studies (Clarke et al, 1992). Therefore it would be 
hypothetized that the protamine replacement process could be used as a way of 
replacing somatic histone Hi with a histone Hi subtype more appropriate for 
the early stages of development. 
1.4 IMPACT OF CELL CYCLE ON NUCLEAR TRANSFER. 
The high incidence of development reported when nuclei are 
transferred between mouse embryos at the same stage of development 
(McGrath and Solter, 1983a, 1983b, 1984) has suggested that the techniques 
involved in nuclear transfer in mammals, per Se, do not have a significant 
effect on subsequent development. Therefore, when the totipotency of nuclei 
from differentiated or more advanced embryonic cells has been tested by 
nuclear transfer experiments, failure of the reconstituted embryos to develop 
has been interpreted as a loss of totipotency of the transferred nucleus and as 
the impossibility of reprogramming it by the eñucleated zygote (McGrath and 
Solter, 1984; Howlet et al., 1987). 
However, evidence from experiments conducted in both, amphibian 
and, later, mammalian embryos has shown that the ability to direct 
development after nuclear transfer can be enhanced using as recipients non- 
15 
activated oocytes (see before) suggesting that nuclear-cytoplasmic interactions 
after nuclear transfer rather that nuclear totipotency could be responsible for 
the failure to develop of the embryos produced by nuclear transfer. In this 
section evidence suggesting that asynchrony in the cell-cycle stage of nuclear 
donor and recipient cytoplast may be responsible for a large part of this failure 
will be examined. 
The cell cycle in eukaryotic cells consists of a period of DNA 
replication (S-phase), a period in which the chromatids are separated (mitosis) 
and the gaps between them: GI from mitosis to S-phase and G2 from S-phase 
to mitosis. Progression through the cell cycle is regulated primarily at two 
points: the Gi to S transition or restriction point, before which a decision is 
made to replicate DNA, and the G2 to mitosis transition, where cells commit to 
enter mitosis and undergo cell division. There are two resting or cell-cycle 
leaving points: GO in Gi but before the restriction point and another in G2 that 
has not a specific name. The transition along the cell-cycle is tightly controlled 
by a series of enzymatic complexes consisting of a cyclin-dependent kinase 
(CDK, the catalytic subunit) and a cyclin (the regulatory unit). (For reviews 
see: Murray and Kirschner, 1989; Pardee, 1989; Kirschner 1992; Norbury and 
Nurse, 1992; Jacobs, 1992; Murray 1992; Murray and Hunt, 1993; Reddy, 
1994; Peter and Herskowitz, 1994). Nuclear transfer procedures may easily 
disturb those cell-cycle controls and have lethal results for the produced 
embryos. Early embryonic cell cycles in mammals are longer (10-15 hours in 
mouse embryos, Smith and Johnson, 1986) than in amphibian (35 minutes, 
Newport and Kirschner, 1982). This characteristic could be useful to further 
investigate how the nuclear-cytoplasmic asynchrony affects output of nuclear 
transfer experiments. 
In amphibia, the first cell cycle after fertilisation last 75 minutes and is 
followed by 11 synchronous cell cycles, each 30 minutes long. These early cell 
cycles consist of a regular alternation of periods of mitosis and DNA 
replication, with Gi and G2 phases largely suppressed. At the time the egg has 
become a blastula there is a progressive change to a longer cell cycle with 
clear Gi and G2 phases (Graham and Morgan, 1966). Among the mechanisms 
driving the extremely short S-phase is an unusually high frequency of 
replication initiation sites in the genomic DNA. Thus the distance between 
initiation sites is much shorter in embryonic amphibian cells than in cultured 
somatic amphibian cells (Callan, 1974). It appears that in early embryonic 
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cell cycles, all origins of DNA replication are activated early in the S-phase, 
whereas in slowly replicating somatic cells, clusters of DNA replication 
origins are activated at different times throughout the S-phase (reviewed by 
Davidson 1986; Diffley and Stillman, 1990). It has been suggested that 
nuclear structure (Diffley and Stillman, 1990) and transcription factors 
(reviewed by DePamphilis, 1993) play a critical role in the regulation of DNA 
replication. Also, at the early stages in frog development the cell cycle is 
controlled by purely cytoplasmic reactions, which without any feedback 
mechanism from the nucleus, activate and inactivate mitosis promoting factor 
(MPF) and drive the nucleus, whether ready or not, into and out of mitosis 
(Gerhart et al., 1984). 
Nuclear transfer experiments conducted with amphibian embryos 
showed that the transferred nucleus undergoes morphological changes and as 
a consequence takes the appearance of the original nucleus in the recipient 
cytoplast. Thus, nuclei from adult cells transferred into cytoplast of 
parthenogenones seem pronuclei-like; they enlarge over 100 times within an 
hour as the chromatin decondenses (Graham et al., 1966). However this 
decondensation is uneven as a condensed mass of chromatin, from which 
threads of chromatin become dispersed, can be seen in one part of the 
enlarging nucleus (Graham etal., 1966). Another important observation is that 
nuclei from more specialized cells swell more slowly than nuclei from 
embryonic cells (Graham et al., 1966; Gurdon, 1968). These morphological 
changes (remodelling) appear to be mediated by protein exchanges between 
nuclei and cytoplast (reviewed by Gurdon et al., 1979; DiBenardino, 1979; 
DiBenardino, 1987) and may be important for the acquisition of early 
embryonic DNA replication patterns for nuclei from developmentally more 
advanced cells. 
In experiments conducted in amphibia, chromosomal abnormalities 
were present in the majority of abnormal embryos resulting from nuclear 
transfer (Briggs and King, 1960; Briggs et al., 1964; Gurdon, 1964; 
DiBenardino, 1979) and most of these abnormalities occurred in the first cell 
cycle (DiBenardino and Hoffer, 1970). Also, there was a positive correlation 
between the degree of chromosomal abnormalities and stage of development 
from which the nucleus was obtained (DiBenardino and Hoffner, 1970), and a 
relationship between the ability of a nucleus to replicate and the stage of 
development achieved (von Beroldingen, 1981). When nuclei from an egg 
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were transferred into Xenopus enucleated oocytes, DNA synthesis began 20 
minutes after nuclear transfer and was completed 20 min later. However 
gastrula and brain nuclei started DNA synthesis later and continued it for over 
90 min after nuclear transfer in the case of brain nuclei (Graham et al., 1966). 
Together, these experiments suggested that the major failure of differentiated 
cell nuclei to fulfil a complete developmental program after nuclear transfer is 
a consequence of chromosomal damage that appears to be due to the inability 
of nuclei from developmentally more advanced cells to acquire the quicker 
early embryonic DNA replication patterns. As a result, chromosomes still 
engaged in DNA replication enter mitosis and suffer mechanical damage 
during abnormal chromatid separation at anaphase (DiBenardino and Hoffner, 
1970). 
There is also evidence of important effects of cell cycle following 
nuclear transfer in mammals. There are effects upon DNA replication of the 
cell cycle stage of both the recipient cytoplast and donor cell. These effects 
have been observed by direct measurement of DNA replication and 
microscopic studies of the transferred nucleus. 
DNA replication happens only once during the cell cycle and although 
there are exceptions (e.g. meiosis, endoreduplication) in the normal mitotic 
cell-cycle there are controls which prevent re-replication of the DNA (for a 
review see, Kelly et al., 1993). This appears to be achieved by a licensing 
factor that binds to mitotic chromosomes during mitosis and induces 
replication during interphase. Somehow this licensing factor is either 
consumed or inactivated once around of DNA replication has occurred. The 
integrity of the nuclear envelope during interphase seems crucial to preventing 
new licensing factor from entering the nucleus and inducing re-replication of 
DNA before separation of sister chromatids has occurred (Blow and Laskey, 
1988; Cox, 1992; Leno et al., 1992). 
DNA synthesis in the transferred nucleus has been investigated in cow 
embryos produced by nuclear transfer (Barnes et al., 1993; Campbell et al., 
1993). The result depended upon whether the nucleus was transferred into an 
oocyte in metaphase II or in S phase. 
When a metaphase II oocyte was used as recipient, the nuclear 
envelope of the transferred nucleus broke-down and DNA replication occurred, 
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regardless of the cell cycle stage of the transferred nucleus (Barnes et al., 1993; 
Campbell et al., 1993). Nuclear envelope breakdown is induced by the activity 
of MPF. MPF phosphorylates nuclear lamins, leading to nuclear envelope 
breakdown (Heald and McKeon, 1990; Peter et a!, 1990a), histone Hi which 
results in chromosome condensation (Arion et al., 1988) and nucleolin and 
other nucleolar proteins, inducing nucleolar disassembly (Peter et a!, 1990b). 
MPF activity varies during oocyte maturation. These changes in the 
biological MPF activity are paralleled by biochemical changes in histone Hi 
kinase activity (Choi et a!, 1991; Hashimoto and Kishimoto 1988; Kubiak et 
al, 1991; Fulka et a!, 1992). Mouse oocytes start meiotic maturation 
spontaneously when they are removed from follicles and completion of 
metaphase I requires 8 to 10 hours after isolation from the follicles (Calarco et 
al, 1972). During this period, activity of histone Hi kinase gradually increases 
and oocyte chromatin condenses (Calarco et a!, 1972; Choi et a!, 1991). 
Histone Hi kinase activity decreases between 8 to 10 hours, during the passage 
from metaphase I to metaphase II and first polar body emission (Choi et al, 
1991; Fulka et al, 1992). Histone Hi kinase activity increases again by 14 
hours, remaining at high levels for the rest of metaphase H (Choi et al, 1991; 
Fulka et a!, 1992). MPF, although dispersed also in the rest of the oocyte 
cytoplasm, appears associated preferentially to the metaphase chromosomes of 
the oocyte (Czolowska et a!, 1986). It has been reported that MPF 
chromosome condensation activity in the cytoplasm of metaphase II mouse 
oocytes decreased slowly with post ovulatory age (Czolowska et a!, 1986). By 
comparison, following fertilization or parthenogenetic activation (see section 
4.5) and MPF activity falls precipitously from high metaphase II levels to 
background levels to permit nuclear membrane-chromatin association, 
pronuclear envelope formation and subsequent DNA replication. In mouse 
oocytes histone Hi kinase activity was at background levels by 3 hours after 
fertilization (Choi et a!, 1991). Nuclear envelope breakdown activity was not 
detected 5 hours after activation (Czolowska et a!, 1986). 
If nuclei are transferred into recipient cytoplasts which have a high 
level of MPF activity re-replication of already replicated DNA, that may result 
in aneuploidy, will be induced unless the donor nucleus is in Gi phase at the 
time of transfer. In that case, DNA replication is required and will occur. 
However, if the nucleus is in S phase then attempted re-replication of the DNA 
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will lead to errors and tetraploid daughter cells are expected if the transferred 
nucleus is in G2 phase at the time of transfer. 
By contrast, if the oocyte was activated and cultured to allow decay of 
MPF activity, the stage of the cell cycle of the nucleus determined whether or 
not there was replication of the DNA (Barnes et al., 1993; Campbell et al., 
1993). In this case replication was observed in nuclei transferred in Gi or S 
phases, but not those in 02 phase. It was assumed, but was not measured 
directly, that completion of replication in S phase nuclei was normal. 
These observations extend those made by direct microscopic 
observation following fusion of cells to oocytes in metaphase II. There is 
premature condensation of the chromosomes when cells or blastomeres from 
early embryos are fused with oocytes in metaphase II (Tarkowski and Balalder, 
1980; Czolowska et al., 1984; Czolowska et al., 1986; Szollösi et al., 1986). 
This phenomenon was first observed following the fusion of an interphase 
nucleus with a mitotic cell (Johnson and Rao, 1970; Rao and Johnson, 1970). 
In experiments conducted with rabbit (Collas et al., 1992ab) and mouse (Kono 
et al., 1992; Cheong et al., 1993) embryos, premature chromosome 
condensation of nuclei in S-phase has been related to poor development after 
nuclear transfer due to impaired chromosomal segregation. Cheong (1993), 
using mouse embryos, reported one clump of chromatin during premature 
chromatin condensation of 01-phase nuclei after nuclear transfer, but several 
were observed when nuclei in S-phase and 02-phase were used. Collas 
(1992b), using rabbit embryos, reported formation of intact metaphase plates 
during premature chromosome condensation only when 01-phase or early S-
phase nuclei were used. 
It has been suggested that premature chromosome condensation results 
in chromosome damage, the degree of which depends upon the morphology of 
the prematurely condensed chromosomes. This morphology varies according 
to the cell-cycle phase of the nucleus at the time of fusion. Thus, prematurely 
condensed chromosomes from nuclei in Gi-phase appeared as very long, 
single chromatids; those from 02-phase nuclei are elongated and slender 
double chromatids; and those from S-phase nuclei are characterised by their 
fragmented appearance. The S-phase chromatin appears as clumps of 
differentially condensed chromatin fragments resembling either 01 (single 
chromatids) or 02 (double chromatids) chromosomes with "gaps" between 
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them. It seems that those gaps are regions were DNA replication is happening 
at the time of fusion and premature condensation and, as a consequence, are 
not able to condense as completely as the rest of the chromosome (for a review 
see Rao, 1982). 
These results suggested that there may be two different approaches to 
nuclear transfer. If a nucleus is to be transferred into an oocyte at metaphase II 
then the donor cell should be in Gi phase. By contrast, if the recipient oocyte 
is in S phase then a nucleus may be transferred at any stage of the cell cycle. In 
these circumstances, such a recipient oocyte may be considered a "universal 
recipient" as it is expected that normal ploidy will be maintained following 
transfer of a nucleus at any stage of the cell cycle. However, it is not known 
which stage of the meiotic cell cycle provides the most effective environment 
for reprogramming of gene expression. 
Studies of the effect of cell cycle upon development have been 
hampered by the technical difficulty of obtaining blastomeres at specific stages 
of the cell cycle. In all mammals there is variation in cell cycle stage, both 
between embryos recovered from the same donor and between cells of the 
same embryo. if blastomeres are taken at random the great majority of cells are 
expected to be in S phase, as this is the longest phase of the cell cycle (Sawicki 
et a!, 1978; Luthard and Donahue, 1973; Siracusa et al, 1975; Bolton et a!, 
1984; Streffer et a!, 1980; Molls et a4 1983; Smith and Johnson, 1986). As a 
result, before the experiments described in this thesis were completed, the great 
majority of studies had used cells taken at unknown phases of the cycle. In 
these circumstances, improved development to blastocyst was achieved when 
abnormal DNA replication was avoided, by using recipient-cytoplast that no 
longer induced nuclear envelope break-down, (the universal recipient) in 
nuclear transfer experiments with sheep (Campbell et al., 1994) and cow (Stice 
et al., 1994) embryos 
Taken together, these results stressed the need for careful consideration 
of the effect of nuclear-cytoplasmic interactions after nuclear transfer when 
deciding the totipotency of the nucleus of cells used as nuclear donors. As 
already mentioned in the above examples, one of the more important sources 
of impaired development after nuclear transfer may be the asynchrony between 
nucleus and cytoplast cell-cycle stages. However, it remains to be discovered 
whether or not other factors, such as the ability to reprogramme gene 
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expression, vary at different stages of the meiotic cell cycle, having in mind 
the need to maintain normal ploidy. 
1.5 POSSIBILITY OF CLONING BY NUCLEAR 
TRANSFER. 
After examining the three conditions stated before, it appears that 
major impediments to cloning by nuclear transfer arise from the present 
methodology. A greater understanding of the factors involved in the nuclear 
transfer procedures and their effect upon the nuclear-cytoplasmic interactions 
of the embryos reconstituted by nuclear transfer and, overall, on their 
subsequent development, may contribute to the establishment of effective 
methods for nuclear transfer from advanced embryonic cells and ultimately 
from somatic cells. 
When selecting nuclear donors for further study, it seems that most 
somatic cells retain the same genetic information as the zygote. Therefore it 
appears that, with the due exceptions, there is not a biological limit in terms of 
absence of genes from the transferable nucleus. However, irreversible changes 
(e.g. chromatin structure, DNA methylation) that render genes inaccessible to 
the trans-acting factors may yet constitute such a biological limit. In order to 
avoid events that would impair development after nuclear transfer, it may be 
important to use nuclear donors in a particular cell-cycle phase. If means can 
be developed to obtain groups of blastomeres at specific stages of the cell 
cycle they will provide one source of such nuclei. In addition, the existence of 
embryonic stem cells in mammals may provide a useful source of nuclei in 
limitless numbers. 
The other main factor to be considered is the recipient cytoplast. The 
source of cytoplast is of paramount importance. From the evidence available 
at the moment, it appears that factor(s) present in the cytoplasm are responsible 
for the modulation of the gene expression (Blau et al., 1991). As an 
explanation for this phenomenon, it has been hypothesized that a remodelling 
of the proteins in the chromosomes could lead to changes that eventually 
permit the genome to respond to the appropriate transcription factors and 
synthesize the appropriate RNAs during embryogenesis (Leonard et al., 1982; 
DiBenardino and Hoffner, 1983; DiBenardino, 1987). Theoretically, processes 
22 
such as the one suggested above could be used to completely reprogram the 
developmental programme of the transferred nucleus in such a way that it 
would be able to direct normal development. Although cytoplasts from 
zygotes, 2-cell stage embryos and parthenogenones are able to support 
development after nuclear transfer in some cases, use of cytoplasts from non-
activated oocytes appears to be crucial to reverse nuclear differentiation and 
achieve sufficient degree of reprogrammation of the transferred nucleus. 
1.6 AIMS OF THE PROJECT: 
INTRODUCTION TO THE THESIS. 
The main aim of this project was to investigate the effect of the cell-
cycle phase of both nuclear and recipients and their interaction after nuclear 
transfer on the subsequent development of the reconstituted embryos. The 
starting hypothesis was that by the use of enucleated non-activated oocytes as 
recipient cytoplast, reprogramming of the transferred nucleus would be 
maximised, and by varying nuclear donor and recipient cell cycle the chances 
of impairing development after nuclear transfer would be minimised. 
Therefore, the focus of the investigation was to see if there was any particular 
combination that would enhance the development of the reconstituted embryo. 
At the time when this project was started (May 1991), the ability of 
embryos reconstituted by nuclear transfer of 4-cell stage mouse embryo nuclei 
into enucleated zygotes was considered to be null (McGrath and Solter, 1984; 
Howlett et al., 1987). However, development to term had been reported after 
transfer of nuclei from 8-cell stage embryos into cytoplast from 2-cell stage 
embryos (Tsunoda et al., 1987), which suggested that all the relevant 
information would still be present in the 4-cell stage nucleus and reasons other 
than loss of DNA would be responsible for their inability to direct 
development after nuclear transfer. An effect of the cell-cycle phase of both 
nuclear donor and recipient on the development of the reconstituted embryo, 
when nuclei from 2-cell stage embryos were transferred into cytoplast from 
zygotes, had been reported (Smith et al., 1988). Therefore 4-cell stage embryos 
were chosen as nuclear donors and it was decided to see if, by varying nuclear 
donor and recipient cell cycle, it was possible to obtain development after 
transfer of nuclei from 4-cell stage embryos into cytoplast from oocytes. The 
experiments were conducted using mouse embryos, due to the existence of 
reliable in vitro culture methods that allow the study of methods of cell-cycle 
23 
manipulation. Also the mouse provides a cheap and very sensitive mammalian 
model for nuclear transfer experiments. 
Before the main nuclear transfer experiments were undertaken, it was 
necessary to obtain both nuclei and cytoplasts at specific phases of the cell-
cycle. In chapter 3 are described the experiments conducted to establish 
methods of nuclear donor cell cycle control. To know the recipient cell cycle 
phase at the time of nuclear transfer it was necessary to control strictly the 
timing of activation of those recipients. This was achieved by using recently 
ovulated oocytes since those are not easily activated during manipulation. 
Chapter 4 is dedicated to the experiments conducted to establish a method of 
activation of preovulatory and recently ovulated oocytes. 
The experiments described in chapter 5 were carried out to establish the 
protocols which were required to separate out the effects of MPF activity and 
hypothetical remodelling factors present in the cytoplasm on reprogramming 
after nuclear transfer and to obtain preliminary information about the effects 
upon development of these new protocols. During the course of these 
experiments a number of unexpected technical difficulties were found and over 
come. 
In chapter 6 the effect of nuclear and recipient cell-cycle stage and their 
interaction were explored. Preliminary nuclear transfer experiments with stem-
cells are discussed in appendix 1. 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
The developmental studies reported in this thesis have been conducted 
upon mouse preimplantational embryos and oocytes. In this chapter the general 
facilities, animals, materials and methods utilised during the project are 
described. More detailed accounts are given in each of the experimental 
chapters. Detailed composition of the diverse culture media and the procedures 
followed in their preparation are detailed in appendix 2 (section A2.1 to A2.7). 
Also in this appendix, the details of stock solutions of chemical compounds 
and antibodies used in this project can be found. 
2.1 GENERAL EMBRYO MANIPULATION FACILITIES. 
All experiments on embryo manipulation were conducted at the Roslin 
Institute. The basic equipment in this laboratory included: a humidified, 5 % 
CO2 in air incubator (Flow Laboratories, Rickmansworth, Hertfordshire, UK) 
set a 37 °C; a binocular, dissecting microscope with transmitted illumination 
(magnification: x12-xl00; M8, Wild) and an embryo micromanipulator system 
(see section 2.4.3). 
Room temperature varied from 15°C in winter to 22-24 °C in summer. 
The working area in the bench was washed with detergents regularly and 
sterilised before each experiment with ethanol 96%. The work was always 
done over clean absorbent tissues. 
The culture material used was mostly sterile disposable plastic ware. 
Three types of Petri dishes were utilised through these experiments; 35 mm 
diameter (Costar corporation, Cambridge USA) and 50 mm (Sterilin, Bibby 
Sterilin Ltd., Stone, Staffs, UK) and 60 mm (Costar corporation, Cambridge 
USA). Four sizes of adjustable volume digital pipettes of 0.5 to 10 Al , 2 to 20 
tl, 20 to 200tl and 100 to 1000 p.1 capacity (Jencons scientific Ltd., 
Bedfordshire, UK) and appropriate universal fit tips (Laser, Laboratory 
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systems Ltd., Southampton UK) were used for exact measurements of the 
medium. Also 20 ml universal tubes (Sterilin, Bibby Sterilin Ltd., Stone, 
Staffs, UK) and 1.5 ml Eppendorfs tubes (Sterilin, Bibby Sterilin Ltd., Stone, 
Staffs, UK) were utilized as recipients for drugs and media. Embryological 
watch glasses were thoroughly rinsed with water, dried and keep in dust free 
but non sterile conditions. 
2.2 IN VITRO CULTURE OF MOUSE EMBRYOS. 
2.2.1 - In Vitro Culture Of Embryos. 
A microdrop culture system with M16 medium (Whittingham,1971) in 
a 5% CO2 - 90% air atmosphere at 37°C was utilized for the in vitro culture of 
the embryos. The microdrop cultures were set up by dispensing drops of 
medium on the bottom of the Petri dish and then flooding the dish with 
paraffin oil (Merck Ltd. Poole, Dorset, UK). The volume of medium varied 
from 10 to 100 .tl depending of the kind of culture required. Before the 
embryos were transferred into the drops, the culture dishes were incubated to 
allow temperature and CO2 equilibration. Early in the project, conventional 
M16 was used for the culture of embryos. Soon it was noted that after lowering 
the osmolarity from 280 moms to 260 moms, reducing the amount NaCl and 
glucose and increasing sodium pyruvate the embryos developed more quickly 
(PJ Otaegui, data not presented; see also Ho et al., 1994). This formulation was 
denominated gM16 and was used in most of the experiments reported here. 
Finally another small change was made further reducing the amount of glucose 
and adding 100 j.LM of EDTA (Ethylenediaminetetraacetic acid) (Sigma code 
n°E-5 134; Poole, Dorset, UK). This medium (pM 16) was used for the nuclear 
transfer experiments. For detailed recipes see section A2.1 
To study the effects of various compounds on cell cycle and 
development, a stock solution of the specific compound was made (see section 
A2.7) and the culture medium (gM16) supplemented a few hours before the 
start of the experiment. This compound containing medium was then used to 
set up the microdrop culture. 
One litre of either gMl6 or pMl6 was prepared each time from which 
100 ml aliquots were separated. Then, 0.4 g of bovine serum albumin (BSA) 
was dissolved in each aliquot. The fresh medium was then filtered and 
dispensed into 1.5 ml Eppendorfs tubes. The Eppendorfs were filled in such a 
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way that once closed the air inside would be minimal. They were kept at 4°C 
and used only once to minimize any chance of contamination. A new batch 
was prepared every two weeks. The Eppendorf tubes were removed from the 
refrigerator and allowed to reach room temperature before setting up the 
microdrop culture. 
2.2.2 - Handling of the Embryos 
During embryo recovery and other manipulations which required long 
periods outside the incubator, M2 (Whittingham and Wales, 1969) an HEPES 
buffered medium was used instead of the gM16. The embryos were routinely 
washed by placing them into an embryological watch glass dish containing 1 
ml of M2 at room temperature. The media used inside the manipulation 
chamber (see 2.4.2) was also M2. Microdrop cultures were used to incubate the 
embryos at 4°C in the refrfgerator (air atmosphere). 
Several chemicals had to be used throughout the micromanipulation 
process (eg: hyaluronidase, cytoskeletal inhibitors). As described before, stock 
solutions of them were made (see A2.7), aliquots were stored at -20°C in 
Eppendorfs. A few hours before use the right amount of M2 was added to the 
Eppendorfs and the solution was allowed to reach equilibrium at room 
temperature. 
Medium M2 was prepared from stock solutions (see A2.3) every two 
weeks, sterilized through filtration and kept in aliquots of about 15 ml in 20 ml 
universals at 4 °C. Before use, it was allowed to reach room temperature. Once 
opened each aliquot was consumed or disposed of to minimize risk of 
contamination. 
Medium was sterilised immediately after preparation by utilising a 60 
ml syringe (Plastipak, Becton Dickinson) to push the medium through a 0.22 
1.Lm single use syringe filter unit (Millex-GY, Millipore S.A., 67 Molshein, 
France or Sterile Acrodisc, Gelman Sciences). The first 5 to 10 ml of sterilised 
media were discharged to avoid toxicity effects from the filter (Harrison et al., 
1990). 
In addition to, culture media composition and the procedures followed 
in their preparation, the details of stock solutions of chemical compounds and 
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antibodies used in this project can be found in Appendix 2 (see sections A2.1 
to A2.7). 
2.3 PRODUCTION OF OOCYTES AND EMBRYOS. 
2.3.1 - Animals, Housing and Handling. 
For most of the experiments described in this thesis embryos were 
recovered from Fl females (C57BL/6 x CBA/Ca) mated to Fl (C57BL/6 x 
CBA/Ca) males. When embryos with a different coat colour were needed (as 
"helpers" in embryo transfer experiments) an inbred white colour strain (MF1) 
was used. The three inbred strains, C57BL16, CBA/Ca and MF1, were from 
existing stocks at Roslin Institute, Roslin. 
The animals were housed in a small animal unit (S.A.U.) with a light 
cycle of 14 hours light (03:00 h to 17:00) and 10 hours dark (17:00 h to 03:00) 
until January 1992 and since then of 12 hours light (08:00 h to 20:00) and 12 
hours dark (20:00 h to 08:00). There were 20 air changes per hour. The 
temperature was kept constant at 21 °C ± 2°C and air humidity was kept at 50 
% ± 10%. The health status of the colony is of minimal disease, the animals 
being specific pathogen free (SPF). They are Staphylococcus aureus positive 
(an human comensal bacteria). The animals had "ad libitum" access to food 
and water. 
2.3.2 - Superovulation Regime. 
The hormones used to superovulate the mice were pregnant mare's 
serum gonadotrophin (eCG, Folligon; Intervet) to increase ovulatory follicle 
number and human chorionic gonadotrophin (hCG, Chorulon; Intervet) to 
induce the ovulation. Both eCG and hCG were prepared by dissolving the 
lyophilised powders in sterile 0.9 % NaCl solution to give a final concentration 
of 50 lU/mi. The solutions were then aliquoted, stored at - 20 °C and used 
within two months. 
Virgin females at four to five weeks old were use as oocyte donors 
whereas four to seven week old animals were used as embryo donors. The 
injections were given at different times of day to allow recovery of either 
oocytes or embryos at the different points in development that were required. 
Superovulation was induced by five LU of eCG injected intraperitoneally 
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followed 48 h later by five Hi of hCG injected also intraperitoneally. When 
embryos were required, females were mated with males of the same strain 
immediately after hCG injection and checked for copulation plugs the 
following morning. Ovulation was observed 11 to 12 hours after hCG injection 
(data not presented). 
23.3 - Embryo Recovery. 
Females were killed by cervical dislocation a few minutes prior to 
embryo recovery. They were then laid out on their backs on absorbent tissues. 
The abdominal skin was soaked with 96 % ethanol, pinched up with forceps 
and a transversal cut was made perpendicular to the craneo-caudal axis. 
Grasping both sides of the cut firmly, the skin was pulled in opposing 
directions to expose the abdominal body wall, which was then cut open 
transversally to the linea alba using forceps and fine scissors. The intestines 
were push out of the way to locate the two horns of the uterus, the oviducts and 
the ovaries. 
Ovulated oocytes and early preimplantion embryos were recovered 
from the oviducts. By pulling the upper end of one of the uterine horns gently 
with small forceps away from the abdominal cavity, it was possible to see the 
mesometrium. A hole was made in the mesometrium with the tip of a fine 
scissors and the mesometrium was dissected away from the oviduct, ovary and 
fat pad. A cut was made between ovary and oviduct and the oviducts were 
dissected attached to a segment of uterus that was used to handle them. 
The oviducts were placed in a embryological watch glass containing 
embryo manipulation media (M2) at room temperature. They were transferred 
to the dissecting microscope and under low magnification the eggs were 
harvested. With one fine forceps holding the oviduct close to the utero-tubal 
junction, another forceps was used to tear the oviduct wall near where the eggs 
were located and to push them out by gently squeezing the oviduct. 
If preovulatory oocytes were needed, the ovary was removed attached 
to the oviduct and a portion of uterus as described before, and placed in a 
embryological watch glass containing M2 at room temperature under the 
dissecting microscope. Using low magnification, the ovary was dissected from 
the oviduct tearing the bursa ovarica with fine tweezers and was transferred 
into another embryological watch glass containing clean M2 at room 
temperature. There the oocytes were harvested by holding the ovary on the 
bottom of the dish with a forceps and using the other to tear open the follicles 
and pull out the oocytes. 
To harvest blastocyst stage embryos, the uterus was removed by 
cutting across the base of the cervix and dissecting away the mesometrium 
membrane before cutting between oviducts and ovaries. The uterus was 
removed from the body attached to the oviducts and placed in an 
embryological watch glass containing M2 at room temperature. Both uterine 
horns were cut just below the junction with the oviduct and they were also cut 
from the cervix. A 25 - gauge needle, attached to a syringe containing M2, was 
inserted 2 - 3 mm inside the cervical end of the uterine horn and was grasped 
firmly with forceps. About 1 ml of medium was flushed through each horn and 
collected in a plastic Petri dish. The dish was transferred to the dissecting 
microscope and under low magnification, was searched for embryos. 
Blastocysts were transferred using a mouth pipette into a embryological watch 
glass containing M2 at room temperature. If none was found, the oviduct and 
utero-tubal junctions left were searched for embryos, using a tweezer to hold 
the oviduct and squeezing gently the junction with the other to push out the 
embryos. 
The recovered eggs were placed into an embryological watch glass 
containing embryo manipulation media (M2) and kept in the bench at room 
temperature until further manipulations. 
2.3.4 - Uterine Embryo Transfer. 
To study development to term, embryos at the blastocyst stage were 
transferred to the uteri of day 3 pseudopregnant recipient females (day of plug 
= day 1). Normally between 10 to 15 embryos were transferred into the right 
uterine horn by laparotomy. The surgery was performed in a laboratory within 
the mouse house, to minimise contamination risks. 
Embryo transfer procedures were conducted using standard techniques 
(Hogan et al., 1986). Anaesthesia was induced by intraperitoneal 
administration of 0.20 to 0.30 ml of a mixture of midazolam (Hypnovel, Roche 
Products Ltd., Welwyn Garden City, UK.) and fentanyl-fluanisone (Hypnorm, 
Janssen Pharmaceutica, B.V. Tilburg) (Flecknell, 1983; Hetherington, 1987). 
This anaesthetic was prepared by dissolving separately, 1 ml of Hypnorm 
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(containing 0.3 15 fentanyl citrate and 10 mg fluanisome) and 1 ml of 
Hypnovel (containing 5mg midazolaam hydrochloride) each in 2 ml of 
distilled water, before mixing the two solutions. The anaesthetic was stored at 
room temperature and replaced after four weeks. 
After induction of anaesthesia, the dorsal region of the right abdominal 
wall was soaked with 96% ethanol and a patch of skin about 1.5 x 2 cm was 
shaved with scissors. Paper tissues moistured in ethanol were used to removed 
loose hair. Grasping the skin with blunt forceps a vertical incision was made 
midway between the last rib and the leg. By sliding the incision from side to 
side, the right ovary was located under the abdominal body wall. The muscle 
directly overlying the ovary was grasped with pointed watchmakers forceps 
and a small incision was made using sharp scissors. A toothed forceps was 
now used to keep the incision open by gently pulling up the edge, while a fine 
forceps was introduced inside the cavity to grasp the ovarian fat pad and 
exteriorise the associated ovary, oviduct and the upper end of the uterine horn. 
Once outside they were placed upon the clean skin and normally would stay 
here without slipping back inside the abdomen. At that stage the mouse was 
transferred to the stage of a binocular dissecting microscope (Olympus SZH) 
illuminated with a fibre optic incident light source (Schott, KL1500). 
The embryos to be transferred were kept in a microdrop (50 j.tl) of M2 
under paraffin oil. Using another dissecting microscope (Olympus SZ, 
transmitted illumination) they were aspirated into a mouth-pipette, with a 
internal diameter of around 100 JLm, just wider than the embryos, and a square 
tip. The pipette was pre-loaded with oil, air bubbles, media and more air 
bubbles to allow fine control. Embryos were drawn up into the pipette 
touching one another, as a pearl-chain, to minimize the amount of medium 
introduced into the uterus. 
Going back to the animal, the top of the uterine horn was grasped and 
kept in place with a fine forceps to allow a 25-gauge hypodermic needle to 
puncture the uterine wall and enter the lumen. Without loosing hold of the 
uterus, the embryo-loaded pipette was picked up and the tip was introduced 
about 5 mm inside the uterine horn, through the hole made with the needle. 
After checking that the pipette was in the lumen, the embryos were deposited 
gently into it using the air bubbles along the pipette as markers. At the end the 
pipette was checked to ensure that all of the embryos had been expelled. To 
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minimize contamination and inflammatory reactions a new pipette was use for 
each animal. 
Once the transfer was finished, the viscera were returned into the 
abdominal cavity by lifting the edge of the hole and pushing in the ovarian fat 
pad with blunt forceps. The incision in the body wall was closed with a single 
suture (510 Mersilk; Ethicon), while a Michel clip (Martin Michel clips 12mm; 
Archibald Young & Son Ltd., UK) was used to close the skin. Mice were 
allowed to recover on a heated blanket before they were returned to the cage-
rack. The clip was removed after seven days. If pregnant, they littered 17 days 
later. 
2.4 MICROMANIPULATION OF EMBRYOS 
2.4.1 - Preparation of Micro-Tools 
2.4.1.1 - Mouth pipettes 
Mouth pipettes were mouth-controlled, hand-pulled Pasteur pipettes. 
They were made by rotating a disposable glass Pasteur pipette (D 810, 145 
mm; John Poulten Ltd.,U.K.) over a Bunsen burner to soften the glass. After 
withdrawal from the flame, the pipette was quickly pulled to produce a 
capillary elongation about 15 cm long (see fig. 2.1a). Rubbing both ends of the 
elongation caused clean breaking of the nearest side of the elongation (see fig. 
2.1b) producing a fine square tipped capillary, approximately four cm long and 
of 150 - 200 jtm of internal diameter (see fig. 2. 1c). A modified Pasteur pipette 
bulb was utilised as an adapter to connect the end of the pulled pipette to a 
length of rubber tubing with a fitted mouthpiece made with a disposable 
pipette tip. 
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Figure 2.1 - Preparation of mouth pipettes: 
Mouth pipettes were made by rotating a disposable glass Pasteur pipette over a 
Bunsen burner to soften the glass. After withdrawal from the flame, the pipette was 
quickly pulled to produce a capillary elongation about 15 cm long. 
Rubbing both ends of the elongation caused clean breaking of the nearest side of the 
elongation. 
A fine square tipped capillary, approximately four cm long and of 150 - 200 pm of 
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Figure 2.2 - Microtools used in nuclear transfer procedures: 
a) holding pipette, b) enucleation pipette and c) cutting needle. 
(Drawings not to scale) 
2.4.1.2 - Holding pipettes 
The holding pipettes were prepared by heating a small section of a 10 
mm long capillary tube (external diameter 1.0 mm; GC100-10, Clark 
Electromedical Instruments, Reading, UK) uniformly over a small Bunsen 
burner flame. Once softened, the capillaries were pulled by hand to produce a 
five to ten cm elongation with an external diameter of around 100 gm. The 
pulled capillary was positioned on a microforge (MF1-microforge, Research 
Instruments Ltd.UK) and bent in four positions at angles of 45 O  (see fig 2.2a). 
This was done by placing the capillary near the hot glass drop, but without 
touching it, in such a way that the heat would melt only the nearest side of the 
tube wall causing it to bend 450  downwards. The pipettes were broken close to 
the last bend by partially cutting them with a diamond pen and gently pushing 
the far end to produce a square tip. The square tip was then heat-polished with 
the heated filament causing the glass to melt until the hole on the tip had a 20-
25 gm. diameter. 
2.4.1.3 - Enucleation pipettes. 
The enucleation pipettes were prepared by pulling thin-walled, 1.0 mm 
diameter glass capillary tubes (GC100T-15; Clark Electromedical Instruments, 
Reading, UK) on a horizontal pipette puller (753 Micropipette Puller, 
Campden Instruments Ltd., UK). The settings were adjusted to produce a 
gradual taper over a two cm length of glass, from the shoulder to the needle 
point. The microforge was then utilised to break the capillary at right angles at 
an external diameter of 15 to 25 .Lm, according to the use destined. This was 
achieved by positioning the capillary vertically on the microforge and placing 
the glass at the required diameter (determined by a graticular eyepiece) 
adjacent to the glass bead on the platinum wire heating filament. With the glass 
bead slightly heated, the capillary was brought into contact so that the two just 
fused together. Simultaneously the filament was switched off and the spring-
loaded connecting rod, holding the filament, was depressed causing the 
capillary to break at the point of contact with the glass bead. The tip was then 
heat polished, but care taken not to produce any deformation, finishing with a 
clean, square flat end enucleation pipette (see fig 2.2b). 
The inner surface of the enucleation pipettes was siliconised to reduce 
stickiness to the cellular membranes during manipulation. The pipette was 
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connected to an empty 60 ml syringe and the tip of the pipette was immersed 
into a silicone solution (Sigmacote Sigma cat no SL-2) from where small 
amounts were drawn up and down three times. After siliconisation the pipettes 
were placed overnight in an oven at 80 °C for drying. Sometimes the outer 
surface was polished by immersing the tip in a 20% solution of hydrofluoric 
acid. Contact of the inner surface with the acid was prevented by a stream of 
air flowing throughout the pipette. 
2.4.1.4 - Cutting needle. 
The cutting needles were prepared by pulling thin-walled, 1.0 mm 
diameter glass capillary tubes (GC100TF-15; Clark Electromedical 
Instruments, Reading, UK.) on the same horizontal pipette puller as before. 
The settings were adjusted to produce a short gradual taper of less than one cm 
in length, from the shoulder to the needle point. The microforge was then 
utilised to melt the tip of the pipette and make a needle 5 to 7 pm diameter and 
about 300 gm long (see fig 2.2c). This was achieved by positioning the 
capillary horizontally on the microforge and placing the tip of the pipette 
adjacent to the glass bead on the platinum wire heating filament. With the glass 
bead heated at medium power (the settings were empirically determined for 
each new filament), the capillary was brought into contact so that the two fused 
together and the glass at the tip of the pipette melted into the bead sealing the 
capillary. The glass bead was then slowly moved away from the pipette 
producing a solid glass cylinder 200 to 300im long and about 5 to 10 gm of 
diameter (determined by a graticular eyepiece). Then the heat was first reduced 
a little and within 1-2 seconds the filament was switched off. Due to the 
contraction of the filament the glass bead was suddenly separated from the 
capillary producing a sharp end at the breaking point. 
2.4.2 - Micromanipulation Chamber. 
The micromanipulation chamber was built from a siliconized slide to 
which two rectangular glass supports (20 x 3 x 2 mm) were fixed with a 
mixture of 5% sterile wax in vaseline to avoid leakage. A large drop of 
medium was situated in the centre of the slide in such a way that it was 
touching both glass supports. A coverslip was positioned over and fixed to the 
supports with vaseline. Both sides of the chamber were now filled with 
paraffin oil to minimize medium evaporation (see fig 2.3). 
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2.4.3 - Micromanipulator Assembly. 
The micromanipulator system consist of an inverted microscope 
(magnification up to x400; Diaphot-TMD; Nikon UK Ltd., UK) with 
condenser and objectives for differential interference contrast (Normarski 
optics); two micromanipulators (Micromanipulators M; E. Leitz Ltd., UK) 
with coaxial coarse and fine adjustment, tilting top and control for transverse 
and sagital movement and hydraulic system. 
The micromanipulators were mounted on either side of the microscope 
and raised from the base to the level of the microscope stage. Each 
micromanipulator had double or single unit instrument holders which held 
micro tools-holders for 'the micro pipettes. The hydraulic system was 
controlled by three micrometer syringes (Agla Micrometer Syringe Kit, 
Wellcome Reagents Ltd, UK) which were connected through flexible 
polythene tubing (mod. 21.852-0062; Bel-art Products, UK) to the instrument 
tubes. The whole of the hydraulic system was filled with an inert mineral oil 
(Fluorinert 77, Sigma, cat n° F 4758 UK). 
The holding pipettes were held in the left-hand manipulator, with its 
corresponding micrometer syringes situated on the right-hand side. The reverse 
arrangement was established for the enucleation pipette and its micrometer 
syringe. Before fixing the pipettes into the respective microtool-holders, the 
tubing was purged of air bubbles using a 20 ml syringe filled with Fluorinert, 
which was connected into the hydraulic line via a three-way tap. The pipettes 
were locked into the tool holders and using the reservoir syringes, each pipette 
was filled with Fluorinert. The pipettes were aligned parallel to each other and 
their tips introduced into the manipulation chamber. Medium from the 
chamber was then drawn a short distance into the pipettes using the 
microsyringes. The cutting needle was held in the right-hand side manipulator 














Figure 2.3 - Micromauipulation chamber: 
vie from above showing position of transversal (T) and longitudinal (L) cuts, 
transversal cut view, and c) longitudinal cut view. (Drawings not to scale) 
Figure 2.4 - Cutting the zona pellucida of oocytes: 
The holding pipette and the cutting needle were positioned so that the cutting surface 
of the needle was perfectly parallel to the holding pipette. The oocyte was rotated by 
gently pushing it with the cutting needle and using the holding pipette and the bottom 
of the chamber to provide resistance, until the metaphase cone was recognised and 
situated at 8 o'clock. 
The oocyte was immobilised by a firm suction with the holding pipette and the 
cutting needle was pushed through the zona pellucida inside the perivitelline space 
overlaying the metaphase cone, carefully avoiding the cellular membrane, and outside 
again piercing the zona pellucida once more. 
A small slit was produce in the zona pellucida rubbing the part pierced by the needle 






Figure 2.5 - Oocyte positioning in the enucleation 
procedure: 
I - oocytes to be enucleated. 
2 - enucleated oocytes. 
3 - enucleatjon zone, where UV light was used. 
Figure 2.6 - Oocyte enucleation procedure: 
Note that during enucleation the oocytes were exposed to UV light only at the end of 
the procedure e) to asses the successful enucleation. In this figure microphotographs 
a) and c) are shown to help to locate the metaphase complex in the DIC 
microphotographs. 
a) and b) The oocyte was oriented with the slit in the zona facing the enucleation 
pipette by repeatedly pushing and lifting the oocyte with the holding pipette. By 
increasing the suction it was held firmly in that position. 
c) and d) The enucleation pipette was introduced under the zona pellucida and was 
positioned adjacent to the metaphase complex. It was possible to identify a clearer, 
non granular zone inside the cytoplasm that would reveal a circular structure when 
pushed gently with the enucleation pipette. The metaphase complex was thus identified 
and then gently sucked into the enucleation pipette. 
f) The pipette was then withdrawn from within the zona pellucida. 
e) The enucleation was checked by exposing both the oocyte and the enucleation 
pipette to the ultraviolet (UV) light for one or two seconds. Since the chromosomes 
were stained with Hoechst it was possible now to see them and assess the procedure. 
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Figure 2.7 - Nuclear transfer procedure: 
The nuclear donor embryos were oriented with the slit in the zona facing the 
enucleation pipette and held in position by increasing the suction from the holding 
pipette. 
The enucleation pipette was then introduced under the zona pellucida and positioned 
adjacent to the nucleus to be removed. The nucleus and a small amount of cytoplasm 
surrounded by the cellular membrane (karyoplast) were moved inside the pipette by 
gently increasing the suction on the enucleation pipette. 
By moving the pipette outside the zona a complete separation of the karyoplast was 
achieved. This procedure was repeated until all the nuclei of the embryo were inside 
the enucleation pipette. A space was kept between the karyoplasts to avoid them 
sticking to each other. 
Since Sendai virus mediated fusion was the method used, the enucleation pipette 
was then moved to a 3 p1 drop of the viral solution adjacent to the main drop in the 
chamber. There the karyoplasts were carefully expelled into the viral solution. 
The karyoplasts were sucked back after a 30 seconds exposure to the virus. 
The recipients, by repeating pushing and picking them up with the holding pipette, 
were then oriented so that the slit on the zona faced the enucleation pipette. 
The enucleation pipette was then introduced inside the perivitelline space of the 
recipient and a karyoplast was laid there. 
The pipette was moved outside the zona leaving the karyoplast inside. This 
procedure was repeated with other recipients until all the nuclei inside the pipette were 
used. 
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2.4.4 - The Nuclear Transfer Procedure. 
2.4.4.1 - Preparation of oocytes. 
Prior to any manipulation it was necessary to remove the cumulus cells 
that covered the zona pellucida. When 2-cell stage embryos were used it was 
enough to gently pipetting and changing them through two clean ml of M2 for 
separate the embryos from the cumulus cells. However, additional treatment 
was needed for freeing the oocytes. That was achieved by exposing the 
recently recovered oocytes to media (normally M2) supplemented with 
300tg/ml of hyaluronidase. Post-ovulatory oocytes were incubated for 5 miii 
at 37°C in this media prior to remove them to M2 where the cells were then 
remove by gently pipetting using a 100 .Lm inner diameter mouth-pipette. 
Preovulatory oocytes needed a longer 20 min incubation in M2 media plus 
hyaluronidase. A control group was always used to detect any parthenogenetic 
activation of the oocytes due to this exposure to hyaluronidase. 
2.4.4.2 - Cutting the zona pellucida. 
To micromanipulate the embryos it was necessary to open a slit in the 
zona so that the cellular membrane become accessible. The procedure is shown 
in figure 2.4. The holding pipette and the cutting needle were positioned so 
that the cutting surface of the needle was perfectly parallel to the holding 
pipette (see fig. 2.4a). Ideally, the holding pipette would have around 90 to 100 
gm of external diameter and a central hole of 20.tm (see fig. 2.2a). When 
cutting zona pellucida of oocytes, the media used in the manipulation chamber 
was M2 without cytoskeletal inhibitors, that was done to avoid any disturbance 
of the oocyte morphology. The oocyte was rotated by gently pushing it with 
the cutting needle and using the holding pipette and the bottom of the chamber 
to provide resistance, until the metaphase cone was recognised and situated at 
8 o'clock (see fig. 2.4a). Then, the oocyte was immobilised by a firm suction 
with the holding pipette and the cutting needle was pushed through the zona 
pellucida inside the perivitelline space overlaying the metaphase cone, 
carefully avoiding the cellular membrane, and outside again piercing the zona 
pellucida once more (see fig. 2.4b). Suction was discontinued now and the 
needle was withdrawn with the oocyte hanging from it. A small slit was 
produce in the zona pellucida rubbing the part pierced by the needle against 
the wall of the holding pipette and thus tearing it (see fig. 2.4c). A similar but 
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simpler version of this method was used to cut the zona of embryos, because in 
those there was no need to make the slit over any determined area of the 
embryo. 
2.4.4.3 - Oocyte enucleation. 
Once their zona pellucida was cut, oocytes were incubated for 3 to 5 
min in 0.8 Lg/ml of Hoechst 33342 in M2 at room temperature. After that, they 
were washed once in 1 ml of M2 and put inside the chamber. The medium in 
the manipulation chamber was M2 plus 10 Lg/ml of cytochalasin B, a 
microfliament inhibitor which would give enough elasticity to the cytoskeleton 
to allow micromanipulation. The oocytes in groups of 8 to 10 at a time, were 
positioned in the upper right corner of the medium before and after enucleation 
whereas the enucleation procedure was conducted in the upper left side. For 
this manipulation, the space occupied by the medium inside the chamber was 
increased to maximize the separation between the enucleation zone, where UV 
light was used, from the zone where the oocytes were stored (see fig. 2.5). 
After picking up the oocyte with the holding pipette, it was positioned 
in the enucleation zone by moving the slide towards the right. Under x 200 
magnification, by repeatedly pushing and lifting the oocyte with the holding 
pipette, the oocyte was oriented with the slit in the zona facing the enucleation 
pipette, and by increasing the suction it was held firmly in that position (see 
fig. 2.6b). With the magnification now changed to x 400, the enucleation 
pipette was introduced under the zona pellucida and was positioned adjacent to 
the metaphase complex (see fig. 2.6d). It was possible to identify a clearer, non 
granular zone inside the cytoplasm that would reveal a circular structure when 
pushed gently with the enucleation pipette. It was because of the need to be 
able to see this structure that the use of microtubule polymerisation inhibitors 
(nocodazole) was avoided since they would disrupt the metaphase spindle that 
was used to identified the position of the chromosomes. 
The metaphase complex was thus identified and then gently sucked into 
the enucleation pipette. The pipette was then withdrawn from within the zona 
pellucida (see fig. 2.60. This movement caused the formation, between the 
oocyte and the pipette, of a cytoplasmic bridge that would stretch to a fine 
thread, break off and reseal. At this moment the enucleation was checked by 
exposing both the oocyte and the enucleation pipette to the ultraviolet (UV) 
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light for one or two seconds (see fig. 2.6e). Since the chromosomes were 
stained with Hoechst it was possible now to see them and assess the procedure. 
2.4.4.4 - Nuclear transfer 
For the nuclear transfer procedure, the M2 medium in the chamber was 
supplemented with inhibitors of both microfilament (cytochalasin B 10 pg/ml) 
and microtubule (nocodazole 10pM) polymerization. The nuclear donor 
embryos were placed directly in the chamber without preincubation in 
cytoskeleton inhibitors, since a good enough elasticity of the cytoskeleton was 
achieved after 2 to 5 minutes exposure to the drugs in the chamber. 
The nuclear donor embryos were oriented as explained before and held 
in position by increasing the suction from the holding pipette (see fig. 2.7a). 
The enucleation pipette was then introduced under the zona pellucida and 
positioned adjacent to the nucleus to be removed. The nucleus and a small 
amount of cytoplasm surrounded by the cellular membrane (karyoplast) were 
moved inside the pipette by gently increasing the suction on the enucleation 
pipette (see fig. 2.7b). By moving the pipette outside the zona a complete 
separation of the karyoplast was achieved through the formation, break and 
reseal of a cytoplasmic bridge. This procedure was repeated until all the nuclei 
of the embryo were inside the enucleation pipette (see fig. 2.7c). A space was 
kept between the karyoplasts to avoid them sticking to each other. 
Since Sendai virus mediated fusion was the method used, the 
enucleation pipette was then moved to a 3 jtl drop of the viral solution 
adjacent to the main drop in the chamber. There the karyoplasts were carefully 
expelled into the viral solution (see fig. 2.7d) and sucked back after a 30 
seconds exposure to the virus (see fig. 2.7e). 
Back in the main chamber, slide and microtools were moved to position 
a group of previously enucleated recipients between the holding and 
enucleation pipettes. The recipients, by repeating pushing and picking them up 
with the holding pipette, were then oriented so that the slit on the zona faced 
the enucleation pipette (see fig. 2.71). This pipette was then introduced inside 
the perivitelline space of the recipient and a karyoplast was carefully laid there 
(see fig. 2.7g). The pipette was moved outside the zona leaving the karyoplast 
inside (see fig. 2.7e). This procedure was repeated with other recipients until 
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all the nuclei inside the pipette were used. The reconstituted embryos were 
then washed in 1 ml of clean M2 and put into M16 microdrops at 37°C. 
2.4.4.5 - Fusion procedure 
In the experiments described in this thesis, fusion between the 
transferred karyoplast and the recipient was Sendai virus mediated. The 
karyoplast was exposed to an inactivated viral solution before it was put in 
contact with the membrane of the recipient cytoplast. Typically fusion of the 
two membranes occurred in 15 min at 37°C. 
2.4.4.6 - Activation. 
Details of activation methods used through these experiments are given 
in chapter 4. 
2.5 PREPARATION OF THE INACTIVATED SENDAI 
VIRUS SOLUTION. 
The viral stock which produced growth in embryonated eggs was a 
generous gift from Dr. Bill Christie (MRC, Edinburgh). The results obtained 
are described below together with the methodology, which was based on Giles 
and Ruddle (1973). 
Nine-day embryonated chicken eggs were candled and the air space 
was marked with an arrow indicating the position of the embryo. A horizontal 
line approximately 5 mm long was marked at the level of the inner shell 
membrane, which delimits the bottom of the air space, on the side of the egg 
opposite the embryo. The eggs which appeared infertile were discharged and 
the fertilized ones were grouped in batches of 5 for inoculation into the 
allantoic cavity opposite to the -embryo. The eggs were surface-sterilized by 
two washes with ethanol 70 %, one batch at the time. Each wash was allowed 
to dry completely. Using an injection needle as a punch and a scalpel handle as 
a hammer, two small holes were made, one (vent hole) at the point of the 
arrow over the air space and the other (site of injection) at a point 2 mm above 
the horizontal line. Four groups were injected with 0.2 ml of a 10 -3 dilution of 
the viral allantoic fluid in Hank's Balanced Salt solution (HBSS) (see A2.6). 
The fifth group was used as control and injected with HBSS alone. The site of 
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injection and the vent hole were sealed with drops of sterile melted paraffin. 
Eggs were incubated at 35.5°C in a moist chamber for 72 hours and turned 
three times a day. 
At the end of the incubation period, the eggs were placed in a 
refrigerator at 4°C for at least 2 hours to reduce the bleeding during the 
harvesting procedure. The surface of the eggs was sterilized and aseptically 
opened by cracking the shell with a sterile scalpel handle. The pieces of shell 
were gently removed with sterile forceps to expose the inner shell membrane. 
Any egg which appeared to have a dead embryo or any other abnormality (ie: 
odour, ruptured yolk sac) was discharged. Allantoic fluid (5 to 10 ml per egg) 
was withdrawn using a 10 ml sterile syringe with 1.5 inch 18-gauge needle by 
inserting the needle through the inner shell membrane into the allantois. 
The titre or haemagglutination activity of the fluid was determined by 
an assay based on the Salk pattern method (see Cassals, 1967). A packed cell 
volume of 0.5 ml of chick red blood cells were washed twice in 10 ml aliquots 
of HBSS and resuspended in 100 ml of HBSS which was used throughout as 
the diluent. Serially increasing 2-fold dilutions were made in a tray (96 V 
shape wells; Sterilin, Bibby Sterilin Ltd., Stone, Staffs, UK) from an initial 
1:10 dilution of the allantoic fluid. To 0.1 ml of each dilution, 0.1 ml of red 
blood cells suspension was added and mixed in each well. The tray was 
covered with Saran wrap and incubated at 4°C for 2 hours. A negative 
agglutination reaction was indicated by a "button pattern" of red blood cells 
collected in a tight disk at the bottom of the well, while a positive agglutination 
reaction was indicated by a "shield pattern", a diffuse or continuous sheet of 
red blood cells covering most of the well. The virus titre was determined by 
the highest dilution giving complete agglutination. This dilution was said to 
contain 1 haemagglutinating unit (HAU) in the volume used (Cassals, 1967). 
The harvested allantoic fluid produced an average titre of 8192 HAU/ml while 
the control had no titre. 
The allantoic fluid'from the injected eggs was centrifuged at 2000 x g 
for 20 mm. The supernatant was decanted and saved, and the pellet discharged. 
The supernatant was centrifuged at 16000 x g for 1 hour. The remaining 
supernatant fluid was completely removed and discharged. The pellet at the 
bottom of the tube was broken up with a glass pipette having a rounded fire-
polished end until a paste-like consistency without lumps was achieved. The 
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paste was then resuspended in 1% BSA in HBSS without glucose (HBSSG-), 
in approximately one tenth the original volume taking care not to atomize the 
virus and contaminate the environment. That was achieved by transferring the 
paste to an emptied rubber-stoppered glass bottle using and small amount of 
1% BSA in HBSSG- and a syringe with a 1.5 inch 25-gauge needle. The paste 
was then resuspended in the bottle by expelling the suspension 8 to 10 times 
through the 25-gauge needle. BSA was added at this stage to reduce the loss of 
HAU which may occur during inactivation (Kiebe et a!, 1970) or low 
temperature storage (Neff and Enders, 1967). The virus suspension was 
centrifuged at 2000 x g for 20 minutes and transferred to a sterile container. At 
this stage the average titre of the solution was 131072 HAU/ml. 
A chemical method of inactivation was chosen, using 13-propiolactone 
(BPL; Sigma, cat n°P 5773 UK) which destroys the viral RNA. The procedure 
was carried out at 4°C with all solutions kept on ice and pipettes equilibrated to 
the working temperature. A 0.5% solution of BPL was diluted in a saline 
bicarbonate solution (1.68 g NaHCO3 + 0.85 g NaCl + 0.2 ml of 0.5% phenol 
red + 100 ml double distilled water). One ml of 0.5% BPL in saline 
bicarbonate was added to each 9ml of Sendai virus suspension and agitated for 
10 mm. The solution was incubated at 37 °C for 2 hours with agitation and 
statically at 4°C overnight to inactivate the remaining BPL. A sample was 
removed for HAU assay and for infectivity determination. At this stage the 
titre had fallen to 32768 HAU/ml. The infectivity of the inactivated Sendai 
virus was determined by inoculating 9-day embryonated eggs with 0.2 ml of 
1:4 and 1:20 dilution of the inactivated material for 72 hours for a first egg 
passage. Samples (0.2 ml) of undiluted allantoic fluid harvested for each series 
(1:4 and 1:20) of the first egg passage were used to initiate a second 72 hours 
egg passage. No haemagglutination activity in either egg passage indicated that 
the virus had been completely inactivated. The virus suspension was diluted to 
about 8000 HAU/ml. Aliquots of the viral solution were made and stored in 
liquid nitrogen until use. 
2.6 DETECTION OF BrdU INCORPORATION. 
A modified non radioactive method based on the immunochemical 
detection of bromodeoxyuridine incorporation for the nucleus was chosen to 
determine the DNA synthesis phase on the cell cycle. Bromodeoxyuridine 
(BrdU) is a thymidine analogue and is specifically incorporated into DNA 
during replication. Mouse anti-BrdU monoclonal antibody conjugated to 
fluorescein was used to identify cells which had incorporated BrdU (see 
A2.7.2 and A2.7.3 for details). 
Embryos were incubated in M16 supplemented with 100 pM BrdU. 
After incubation the zona pellucida was removed with acid Tyrode solution 
(Hogan et al., 1986) and zona free embryos were washed in PBS, transferred to 
slides and allowed to air dry. When dried, a drop of 0.5 % agar solution was 
placed over the embryos and they were air dried again. Once dried the embryos 
were fixed in methanol for 10 min, washed in PBS, permeabilised in 2% Triton 
X-100 for 10 min at room temperature, washed in PBS, hydrolysed in 4N HC1 
for 2h at 37°C and washed twice in borate buffer (pH=8.5), and three times in 
PBS. Excess PBS was removed and the embryos were then incubated in an 
humidified chamber with 7p.1 of fluorescein conjugate anti-BrdU monoclonal 
antibody diluted to 50 jig/ml in PBS supplemented with 0.1% BSA. After one 
hour incubation at room temperature, the slides were washed in PBS, excess 
PBS was removed, the embryos were mounted (Dabco Aldrich Ltd, Dorset, 
UK) and examined by epifluorescence using a Nikon microphot..SA. 
2.7 DETECTION OF CORTICAL GRANULE RELEASE 
DURING OOCYTE ACTIVATION. 
A simple staining method based in the detection of fucosil- and sialyl-
glycoconjugates that appear in the oocyte cellular membrane shortly after 
sperm penetration or parthenogenetic activation (Lee et al, 1988), was used to 
detect the cortical granular release and indirectly, parthenogenetic activation of 
cytoplast from enucleated oocytes. These glycoconjugates were identified by 
the binding of lectins conjugated to fluorescein isothyocyanate (FITC). Lectin 
FBP, specific for fucose, was chosen to label the oocytes (see A2.7.10 for 
details). 
Prior labelling, oocytes were washed in PBS plus 0.4% BSA for 15 
minutes. Then the oocytes were incubated in the FITC-lectin solution for 30 
minutes at room temperature. After incubation, they were washed thoroughly 
in PBS plus 0.4% BSA for 15 minutes to remove the unbound FITC-lectins. 
Then the labelled oocytes were mounted in a drop of PBS plus 0.4% BSA and 
examined by epifluorescence using a Nikon microphot SA. 
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2.8 STATISTICAL ANALYSIS OF DATA. 
Details of the methods used for the statistical analysis of the 
experimental data are given in each experiment. Those analysis were 






To study how the cell-cycle phase of the nuclear donor affects 
development of the embryo reconstituted by nuclear transfer, it was necessary 
to set up a system which would allow the synchronization of donor 
blastomeres at specific phases of the cell cycle. Ideally such a system should 
be capable first of synchronizing the blastomeres of a population of nuclear 
donor embryos at the desired specific point of the cell cycle and second of 
holding them there for several hours. This synchronization has to be reversible 
and must be achieved without causing any negative effect upon the 
development of the treated embryos. 
The importance of being able to hold cells during long periods of arrest 
was due mainly to two reasons. Mouse embryonic blastomeres lose their 
synchrony after the first mitotic cleavage and the asynchrony between 
blastomeres of a group of embryos increases as they develop. Thus 
increasingly longer periods of treatment would be needed to ensure that all the 
blastomeres of all the embryos arrive at the synchronization point before the 
end of the treatment. The other question to consider was that the cell-cycle 
length during preimplantation development is approximately 12 hours (Smith 
and Johnson, 1986), as a consequence some experiments would have to be 
done during the night, with an increased risk of human errors. Although this 
may be avoided by storing the mouse embryos at 4°C up to 48 hours without 
any negative effect upon their development to blastocyst (Herr and Wright, 
1988), this treatment would not synchronise the blastomeres. Therefore, a 
synchronization method able to hold the cell-cycle for long periods at 37 °C 
would give enough time for all the blastomeres to arrive at the synchronization 
C) 
point and would make it possible to have a source of nuclear donor 
blastomeres at the most convenient time of the day. 
For the purposes of this project nuclei in 01, S and G2-phases were 
needed. The strategy chosen to achieve this aim was to first synchronise the 
blastomeres in mitosis. Once all of them were in mitosis, the embryos would 
be released from the synchronisation treatment and allowed to continue 
through the cell-cycle. At this stage, a method of keeping them from entering 
S-phase had to be established to obtain nuclei in Gi. To have nuclei in 02, a 
method which would restrain them from going into mitosis had to be found. 
Thus three methods were needed: one to synchronise the blastomeres in 
mitosis, another to keep them in G  and a third to maintain them in G2. 
This chapter is divided into three sections: the experiments conducted 
to establish a method of synchronization of the embryonic blastomeres in 
mitosis are described in the first; the methods of synchronization on 01-phase 
based on the inhibition of DNA synthesis in the second and synchronization in 
02-phase is discussed in the third. 
Several compounds that have shown cell-cycle control potential in 
mammalian cell cultures were used to study their ability to inhibit cell-cycle 
progression in embryonic blastomeres (see table 3.1). Two observations were 
made for each compound. First the ability of each substance to provide the 
synchronization effect was assessed, then the reversibility of its action was 
checked. 
3.2 EMBRYOS 
Fl mice (C57BL/6 x CBA/Ca) aged 4 - 6 weeks, superovulated and 
mated with Fl males of the same genotype, were used as P2 embryo donors. 
The mice were killed by cervical dislocation 44 to 48 h after hCG injection (p-
hCG) and the 2-cell stage embryos recovered from the oviducts in M2 
medium. Until required for manipulation the embryos were cultured in gM16. 
The general procedures for superovulation and recovery of embryos are 
described in Chapter 2. 
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Table 3.1 - Compounds whose ability to inhibit cell-cycle progression in embryonic blastomeres was studied. 
Compound 	 Inhibition of cell-cycle 	Mechanism 
progression 
Nocodazole 	 Mitosis 	 Inhibition of microtubule 
polymerisation 
Colcemid (demecolcine) 	Mitosis 	 Inhibition of microtubule 
polymerisation 
Trichostatin A 	 01 and 02 phases 	Inhibition of histone 
deacetylase 
Mimosine 	 01 phase 	 unknown 
Aphidicolin 	 DNA replication 	 Blocks DNA a polymerase 
activity 
Hydroxyurea 	 DNA replication 	 Inhibition of ribonucleotide 
reductase 
Hoechst 33342 	 02 phase 	 Inhibition of DNA topoisomerase 
II activity  
References 
Hoebeke et al., 1976 
Johnson et al, 1988 
Taylor, 1965 
Rieder and Pacazzo, 1992 
Yoshida and Beppu, 1988 
Yoshida et al., 1990 
Lalande, 1990 
Oguro et al, 1978 
Huberman, 1981 
Engstrom et al., 1979 
Thelander et al., 1990 
Tobey et al., 1990 
Woynarowski et al., 1989 
Cycloheximide 	 01-phase, DNA replication, 	Inhibition of protein synthesis in 	Obrig et al., 1971 
G2 phase 	 ribosomes 
3.3 SYNCHRONIZATION IN MITOSIS 
Cytoskeletal inhibitors are one group of compounds that have the 
potential to arrest the cell cycle at specific stages. Some of them have been 
used to study the effect of inhibition of microtubule or microfilament function 
upon mouse preimplantation development (Siracusa et al., 1980; Siirani et al., 
1980), but few studies have examined their use in controlling the cell cycle. 
Recently, colcemid has been shown to arrest 16-cell rabbit embryos reversibly 
(Collas et al., 1992) and a comparative study of the use of nocodazole and 
colcemid to induce synchronous cell division in mouse 2-cell embryos 
concluded that nocodazole was less detrimental to subsequent pre- and post 
implantation development (Kato and Tsunoda, 1992). 
Exposure to nocodazole or colcemid, both inhibitors of microtubule 
polymerisation was the method chosen to synchronize the nuclei in mitosis. 
The anti-mitotic activity of these compounds is due to their interference with 
the microtubule assembly process by binding to tubulin monomers (Hoebeke et 
al., 1976). By doing so, they prevent the assembly of the spindle and arrest 
cells in the metaphase-anaphase boundary, prior to chromosomal separation 
(Johnson et al., 1988). 
3.3.1 - Experimental Design 
3.3.1.1 - Exposure to nocodazole 
Three sets of experiments were conducted to: i) determine the 
minimum concentration of nocodazole required to arrest and maintain the cell 
cycle in mitosis, ii) determine the maximum period of culture in that 
concentration that was compatible with normal development to blastocyst, and 
iii) study the ability of nocodazole treated embryos to develop to term. 
The effects of nocodazole were investigated using embryos at 2-, 4-, 8-
and 16-cell (morula) stages of development. Embryos were transferred into 
medium supplemented with nocodazole when they were expected to be 
approaching the end of S-phase (Pratt, 1987) so that the exposure to 
nocodazole before the blastomeres entered mitosis would be minimised. Thus, 
2-cell embryos were transferred into nocodazole supplemented media at 48 h 
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after hCG injection (p-hCG); 4-cell at 58 h p-hCG; 8-cell at 72 h p-hCG and 
16-cell at 84 h p-hCG. 
The ability of each concentration of nocodazole to arrest the cell cycle 
was assessed either by counting the number of cells in live embryos, to 
determine the proportion in which cell division had occurred, or by staining 
the embryos with aceto-orcein to determine the proportion of cells in mitosis at 
the end of the exposure. After overnight fixation in a solution of 25% glacial 
acetic acid in methanol, embryos were washed with absolute methanol 
followed by a solution of 45% glacial acetic acid in distilled water. They were 
stained with 1% orcein in 45% acetic acid. 
When the developmental potential of embryos was to be determined, 
they were washed several times in M2 and gM16 and cultured at 37 °C in 
microdrops of gM16 under liquid paraffin in an atmosphere of 5 % CO2 in 
air. Only those embryos that developed to expanded blastocyst stage with a 
visible inner cell mass were recorded as blastocysts. 
Experiments were conducted to study the effect of nocodazole upon 
development to term. In the first, 2, 4, 8 and 16-cell embryos were exposed to 
51iM of nocodazole in modified M16 for 12 h. In the second, 4-cell embryos 
were exposed to lOjtM of nocodazole in modified M16 for 9 h. After treatment 
embryos were washed several times in M2 and M16 and cultured. Embryos 
that formed fully expanded blastocysts were transferred to the uteri of day 3 
pseudopregnant recipient females (day of plug = day 1). The recipient females 
were allowed to give birth and the number of offspring was recorded. Control 
transfers were made with blastocysts that had developed from the 2-cell stage 
in culture. In this experiment, the embryos were transferred by Dr. O'Neill. 
3.3.1.2 - Exposure to Colcemid 
The effect of the length of the exposure to 0.1 9g/ml of colcemid upon 
development to blastocyst was studied with 2 -cell and 4-cell stage embryos. 
As stated before, groups of embryos were exposed to colcemid around the time 
they were expected to enter mitosis, that is 48 h post hCG injection for 2-cell 
embryos and 58 h post hCG for 4-cell embryos. They were incubated for 4, 9 
and 12 hours in gMl6 plus 0.1 p.g/ml of colcemid. At the end of the exposure 
period, the embryos were washed for one minute in lOOp.l of M16 and then 
through five 70 p.1 drops before introducing them into a 30 p.1 culture drop. 
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Short exposure times have the disadvantage that some of the embryos may not 
arrive at the synchronization point during the treatment. To minimise the effect 
of these embryos upon the interpretation of results, a post-treatment selection 
was used; any embryo that had not cleaved two and a half hours after the end 
of the exposure period was assumed not to have reached mitosis during the 
treatment and was removed from the experiment. Development to blastocyst 
was recorded. 
3.3.1.3 - Comparison between colcemid and nocodazole; completion 
of mitosis after treatment. 
Differences in the time necessary to complete mitosis once the 
embryos were released from the synchronization treatment were detected 
between 2-cell embryos exposed to colcemid for four hours and 4-cell 
embryos exposed to nocodazole for nine hours. It was not clear if the 
difference was due to the stage of the embryo, the length of the treatment or 
the compound used during the synchronization. A direct comparison was set 
up between colcemid and nocodazole to determine what caused that 
difference. Groups of 2-cell embryos were exposed either to lOj.iM nocodazole 
or 0.1 .tg/m1 of colcemid in gMl6 for three hours. After that they were washed 
and transferred to drops of gM16 without the drug. Every fifteen minutes some 
embryos were stained with Hoechst 33342 and their progress through mitosis 
until nuclear membrane reformation was monitored by UV microscopy. 
3.3.1.4 - Statistical analysis of the data. 
In the experiments conducted with nocodazole, the effects of embryo 
stage, duration of exposure and their interaction, and the effect of nocodazole 
concentration, allowing for differences between days, on the proportion of 
treated embryos developing to the blastocyst stage were examined by a logistic 
linear model. Differences between means were assessed by a Student's t test. 
Extra-binomial variation was accommodated by the method of McCullagh and 
Nelder (1989). A similar logistic linear model was utilized to look at the effect 
of stage on the rate of development to term of transferred embryos after 
exposure to nocodazole. 
In the first experiment conducted with colcemid, the lack of variation 
in the results of the control group, 2-cell and 4-cell stage embryos exposed to 
colcemid for 4 hours made difficult an adequate statistical analysis of those 
M. 
results. Therefore, only data from the rest of treatments were considered in the 
statistical analysis. The data consisted of a randomized block design with days 
as blocks and embryo stage and length of exposure to colcemid as treatment. 
Their effect on the proportion of treated embryos developing to the blastocyst 
stage was analysed by unbalanced analysis of variance. Differences between 
means were assessed by a Student's t test. 
In the comparison between colcemid and nocodazole, the data 
consisted of a randomized block design with days as blocks and the compound 
used and time after release from the mitotic block as treatment. Their effect on 
the proportion of nuclei remaining in mitosis was analysed by unbalanced 
analysis of variance. Differences between means were assessed by a Student's 
t test. 
3.3.2 - Results 
3.3.2.1 - Use of Nocodazole 
3.3.2.1.1 - Effect of concentration, length of exposure and embryo stage upon 
ability of nocodazole to hold the cell-cycle in mitosis. 
The ability of nocodazole to arrest the cell cycle was dependent upon 
both the concentration of nocodazole and the developmental stage of the 
embryo, although different estimates of the minimum effective concentration 
of nocodazole were provided by the two procedures of assessment: cell counts 
and direct observation of nuclear morphology. As determined by counts of cell 
number, even the lowest concentrations (0.25 and 0.62 pM) used in this 
experiment were able to prevent the cleavage of 95 % of exposed 2-cell 
embryos when 100 % of embryos in the control group had divided (Table 3.2). 
However, embryos at 4-cell and 8-cell stages exposed to 0.25 and 0.62 PM of 
nocodazole for 12 h divided before the end of the treatment and to achieve 
mitotic arrest of those embryos a concentration of 2.5pM was required. 
When the stage of the cell cycle was determined by staining, in a 
comparison of 2.51LM and 5pM nocodazole the effect depended upon the 
concentration of the drug and the stage of embryo development (Table 3.3). 
More than 94% of the cells were arrested in mitosis when embryos at the 2, 4, 
8 or 16-cell stages were cultured in the presence of 5pM nocodazole for 12 h 
(Table 3.3). The chromosomes were condensed and grouped in the centre of 
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the blastomere, with no indication of chromosome dispersal (Fig. 3.1 a-d). By 
contrast, 2.5iM nocodazole inhibited mitosis in a lower proportion of cells in 
the 4, 8 and 16-cell stage embryos (Fig 3.10. The effect of nocodazole 
persisted over long periods, as even after 20h exposure to 5 p.M nocodazole, 
most of the nuclei had condensed chromosomes (Table 3.4). 
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Table 3.2 - Effect of concentration of nocodazole and embryo stage on the proportion 
of mouse embryo cells prevented from cleaving. 
	
0.25 j.tM 	0.62 p.M 	2.5 p.M 	5 p.M 	7.5 p.M 	10 p.M 
2-cell 	87/88 (99) 	82/82(100) 	27/27 (100) 	197/197 (100) 	27/27(100) 	133/133 (100) 
4-cell 	0/30 (0) 	7/27 (26) 	72173 (98) 	26/26(100) 	26/26(100) 	27/27(100) 
8-cell 	0/37 (0) 	4/17 (26) 	67/67(100) 	28/28(100) 	26/26(100) 	24/24(100) 
a Number (%) of embryos with the same number of cells at the end of exposure for 12 h. Assessed by counting the number of blastomeres 
in the live embryo. At least three replicates in each group. 
Table 3.3 - Effect-of concentration of nocodazole and embryo stage on the proportion of mouse embryo cells arrested 
in mitosis. 
2-cell 4-cell 8-cell Morula (16-18) 
5 	V 38/38(100) 40/40(100) 144/152(94) 337/358(94) 
2.5 xM 	14/14(100) 24/36 (68) 89/112 (79) 59/90 (65) 
a Number (%) of nuclei in mitosis at the end of exposure for 12 h. Recorded after staining with aceto-orcein. 
Figure 3.1 - Mouse embryos synchronized in mitosis with nocodazole. 
Embryos were stained with aceto-orcein to determine the proportion of cells in mitosis 
at the end of the exposure (see 3.4.1.1). 
More than 94% of the cells were arrested in mitosis when embryos were cultured in 
the presence of 5 j.LM nocodazole for 12 h. The chromosomes were condensed and 
grouped in the center of the blastomere, with no indication of chromosome dispersal: 
a) 2-cell stage embryo, b) 4-cell stage embryo, c) 8-cell stage embryo, d) 16-cell 
stage embryo (morula) and e) 32-cell stage embryo (morula). 
By contrast, 2.5MM nocodazole inhibited mitosis in a lower proportion of cells in the 
4, 8 and 16-cell stage embryos. 1) A 16-cell stage embryo cultured in the presence of 

















Table 3.4 - Effect of length of exposure to nocodazole and embryo stage on the proportion of mouse embryo cells 
arrested in mitosis. 
Stage Oh. 12h. 16h. 20h. 24h. 
2-cell No data 38 / 38 	(1()0) 10 / 10 (100) 39/40 	(98) No data 
4-cell 	No data 	48/50 (96) 	40/40 (100) 	26/33 (78) 	18/24 (75) 
8-cell 6/119 	(5) 144/153 (94) 78/78 (100) 109/127 (86) Nodata 
Morula 17/344 (5) 337/358 (94) 72/91 (91) 35/ 37 (94) 73/82 (89) 
a Number (%) of nuclei in mitosis at the end of exposure to 5p.M Nocodazole. Recorded after staining with aceto-orcein. 
3.3.2.1.2-. Effect of concentration, length of exposure and embryo stage upon 
development to blastocyst after exposure to nocodazole. 
Overall 97% ± 0.92 of untreated control embryos reached the 
blastocyst stage. Exposure to the amount of DMSO used as solvent for 
nocodazole had no detrimental effect on development (untreated control 
327/336; DMSO control 49/51; X 2=0.248, df=1, p0.5). Among treated 
embryos, only data from higher concentrations of nocodazole have been 
considered because embryos at 4-cell, 8-cell and 16-cell stages exposed to 0.25 
and 0.62 j.tM nocodazole for 12 h divided before the end of treatment and, 
after release from the drug, most of the embryos from these groups developed 
to normal blastocyst. 
Exposure to any concentration of nocodazole within the range 2.5 to 
10.tM for 12h caused a reduction in the proportion of embryos that formed 
blastocysts (Table 3.5). Most of the embryos which failed to reach the 
blastocyst stage showed a disorganized morphology with blastomeres of 
irregular size, small fragments of cytoplasm, or large intracellular vacuoles. 
Within this range of concentrations, no effect of concentration upon 
development to blastocyst was found (2=3.5,  df=3, p>0.3. Table 3.5). As the 
period of exposure to 5p.M nocodazole increased from 12 to 24h, the 
proportion of embryos developing to the blastocyst stage decreased in a linear 
manner on the logistic scale (x2= 160.55, df=3, p<zO.00l. Table 3.5). 
A significant effect of embryo stage upon development to blastocyst 
after exposure to nocodazole was found (X 2=36.52, df=3, p<0.001. Table 3.5). 
When considering all stages exposed to 2.5 to lOp.M nocodazole for 12 to 24h 
it was possible to divide the embryos into three groups: i) the control group; ii) 
2-, 4- and 8-cell stage embryos and iii) the morula (16-cell) stage. There was a 
significant difference between these three groups in the proportion of embryos 
forming blastocysts (p <0.001) (Table 3.5). 
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Table 3.5 - Effect of nocodazole concentration, length of exposure to nocodazole 
and embryo stage upon subsequent development 
of the treated embryos to blastocyst.* 
N2 replicates N2 embryos % Blastocysta 
concentrationb 	2.5 lIM 22 224 70 
5jiM 33 992 74 
7.5 j.LM 12 216 80 
10pM 14 277 74 
Length of 12 h 81 1709 74 	(1.02) 
exposureC 
16 h 12 266 47 (-0.13) 
20 h 18 279 9 	(-2.37) 
24 h 13 162 4 	(-3.21) 
Embryo staged 2cella 38 878 57 
4cella 29 359 66 
8cella 33 499 50 
MorulaB 24 680 21 
* Data from a series of experiments. Percentage of development to blastocyst in the 
non-exposed (control) group was 98 % from 20 replicates with a total of 336 
embryos. 
a Values are batch transformed from the logistic analysis. (Values on logistic 
scale). 
b ( 235, df=3, p>0.3) 
C (x2= 160.55, df=3, p<0.001) 
d (X 236.52, df=3, p<0.001) 
a B Different superscripts have statistically different (p<0.001) rates of blastocyst 
formation from control group and each other. 
Table 3.6 - Synchronization of 4-cell stage mouse embryos in mitosis with 
nocodazole (lOjiM, 9h).* 
Timea 	N9 	N2 	N2 	Premitotic 	Mitotic Postmitotic 
replicates embryos nuclei nucleib nuclei 	nucleic 
Completion of mitosis from 4-cell into 8-cell stage 
0 2 35 146 0d 	146 (100) 	0 
1 2 34 169 0 	103 	(63) 	66 	(37) 
1.5 2 37 296 0 	0 	296 (100) 
2 1 21 166 0 	2 	(1) 	164 	(99) 
Mitosis from 8-cell to 16-cell stage 
11 1 10 82 75 (91) 3 (4) 4 (5) 
12 3 38 309 253 (81) 45 (15) 12 (4) 
13 3 37 337 190 (57) 62 (19) 85 (23) 
14 1 15 163 42 (26) 35 (21) 86 (53) 
15 2 27 326 55 (17) 47 (13) 224 (70) 
17 1 17 238 18 (8) 16 (6) 204 (86) 
* Completion of mitosis and second mitosis after release from nocodazole. 
a Hours after release from nocodazole (10 .tM). 
b Interphase nuclei in the previous stage. 
C Interphase nuclei in the next stage. 
d Number (%) of nuclei. Determined by staining with Hoechst 33342. 
Table 3.7 - Effect on development to term of a 12 h. exposure of mouse embryos to 5 tM 
nocodazole at different stages of development. 
GROUP 	Pregnancies / Transfer (%) Offspring / Embryos (%) 
(Pregnancies only) 
Controla 	 6/14 	(43) 	27/68 	(39)*  
2-cell 	 7/9 (77) 34/95 (35)* 
4-cell 	 8/11 (73) 33/122 -,-, 	*** ( ia). 
8-cell 	 4/7 (57) 10/60 (17)** 
Morula 	 4/13 (31) 7/47 (15) 
a Non-exposed embryos cultured in vitro from 2-cell stage until blastocyst stage. 
** Groups with different superscripts have a statistically significant ( x=15.20 df=3, p <0.01) 
different rate of development to term. 
By contrast, there was no effect upon development to blastocyst of 4-
cell embryos when they were exposed to 10tM nocodazole for 9 h (95% 
nocodazole treated vs. 98% control, with 12 replicates and 185 and 120 
embryos respectively; X 2=2.14, df=l, p>O.l). Over 98 % of 4-cell embryos at 
58 h post-hCG injection transferred into 10 tM nocodazole supplement gM16 
were in mitosis by the end of a nine hours culture period and they progressed 
synchronously at least until the completion of mitosis. Mitosis was completed 
in all embryos in 90 mm (Table 3.6). 
3.3.2.1.3 - Effect of embryo stage upon development to term after exposure to 
As there was no effect of treatment upon the proportion of recipients 
that become pregnant, only data from embryo transfer procedures that resulted 
in pregnancy were used to assess the proportion of transferred embryos that 
developed to term. There was a significant effect of embryo stage upon 
development to term following 12h exposure to 5jtM nocodazole. There was 
a significant decrease in survival as cell number of the embryo at time of 
treatment increased (X 2-15.20, df=3, p<0.01; Table 3.7). Development to term 
of embryos treated at 2-cell and 4-cell stage was not significantly different 
from the control group. However, survival of 8-cell and 16-cell embryos was 
significantly lower than that of the control group (p<z0.001). 
When the blastocysts that were transferred had developed from 4-cell 
embryos exposed to lOp.M nocodazole for 9h there was no apparent effect 
upon development to term (in 6 pregnant recipients 29 of 73 embryos (40%) 
developed to term). 
3.3.2.2 - Effect of length of exposure to colcemid on development to 
blastocyst. 
A significant effect of the length of the exposure to colcemid upon the 
development of 2-cell and 4-cell embryos was detected. As the period of 
exposure to 0.1 j.Lg/ml colcemid increased from 9 to 12 h, the proportion of 
embryos developing to the blastocyst stage decreased (p<zO.00l) (Table 3.8). 
No difference was found between control non-exposed embryos and embryos 
exposed to colcemid for four hours. Increasing the length to nine hours had 
some damaging effect upon further development and when the embryos were 
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exposed for 12 hours less than 50 % of 2-cell stage embryos (p<O.00l) and 25 
% of 4-cell stage embryos developed to blastocyst (p<O.00l). As with embryos 
exposed to nocodazole, most of the embryos which failed to reach the 
blastocyst stage showed a disorganized morphology with blastomeres of 
irregular size, small fragments of cytoplasm, or large intracellular vacuoles. 
Over 80 % of 2-cell embryos at 48 h post-hCG injection transferred 
into 0.1 .tg/ml colcemid supplemented gM16 were in mitosis by the end of a 
four hour culture period. From a total of 46 nuclei, 38 (83 %) were in mitosis 
and 8 (17 %) in the previous interphase (3 replicates and a total of 23 
embryos). Once washed and transferred into gM16 no effect of the treatment 
was found in the proportion that developed to blastocyst (Table 3.8). 
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Table 3.8 - Effect of length of exposure to colcemid and embryo stage on development 
of the treated embryos to blastocyst. 
Embryo stage Exposure No replicates N° embryos Blastocyst 
total (%) 
Control 3 41 41 (100) 
2-cell 4 hours 3 54 54 (100) 
9 hours 4 86 68 	(78)* 
12 hours 3 60 27 (44)** 
4-cell 4 hours 1 15 15 (100) 
9 hours 3 57 46 (80)* 
12 hours 3 54 14 	(25)*** 
- Different superscripts have statistically different (p< 0.001) 
proportion of development to blastocyst. 
3.3.2.3 - Comparison between colcemid and nocodazole: completion of 
mitosis after treatment. 
Differences in the time necessary for completion of mitosis once the 
embryos were released from the synchronization treatment of four hours were 
detected between 2-cell exposed to colcemid or to nocodazole (at 90 minutes 
p<0.001; see fig. 3.2 below). Whereas over 95 % of the embryos exposed to 
nocodazole were in the next interphase 90 minutes after release from the 
treatment, a longer period of more than 120 minutes was needed before 85 % 
of the embryos exposed to colcemid completed mitosis. 
Figure 3.2 - Completion of mitosis after treatment 
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3.3.3 - Discussion. 
These studies demonstrate that it is possible to use nocodazole and 
colcemid to synchronise embryonic cells in 01. Nocodazole was effective in 
arresting over 94% of cells in mitosis provided that the concentration of 
nocodazole was at least 5p.M (Tables 3.2 and 3.3). The chromosomes were 
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condensed and grouped in the centre of the blastomere, with no indication of 
chromosome dispersal (fig. 3.1). A similar situation was described in cultured 
Chinese hamster V79 cells when exposed to griseofulvine (Adair, 1974). In 
other studies of the role of the cytoskeleton in early development, 104M 
nocodazole has been used routinely (Maro and Bornens 1980; Maro and 
Pickering, 1984; Johnson and Maro, 1985; Maro et al., 1986; Johnson et al., 
1988; Kato and Tsunoda, 1992). 
The effect of nocodazole upon the subsequent development of mouse 
embryos depended upon the stage of development of the embryo at the time of 
exposure and the duration of exposure to nocodazole. If treatment was for 
more than 12h then development was significantly reduced, but the reduction 
was greatest when later stages of development were treated than with 2 or 4-
cell embryos. The effect on 8-cell embryos is similar to the previous report 
that, as the treatment period of isolated 8-cell blastomeres exposed to 10.tM 
nocodazole was increased beyond 6h, they had a reduced ability to progress to 
"miniblastocyst" (Johnson a al., 1988). 
Nocodazole has been used for the synchronization of division in mouse 
2-cell embryos in a previous study (Kato and Tsunoda, 1992). It was observed 
that following culture for 12.5 to 14.5h in the presence of 10 j.LM nocodazole 
there was no significant reduction in the proportion of 2-cell embryos that 
developed to blastocyst or to term. The apparent difference between these 
results and our observations may reflect minor differences in treatment 
protocols, such as the use of low temperature storage of the embryos prior to 
treatment (Kato and Tsunoda, 1992). In addition, there are reports of variation 
in the activity of different preparations of such drugs (Margulis, 1973). 
Although there was a difference in the proportion of treated embryos that 
became blastocysts, when those blastocysts were transferred to 
pseudopregnant mice, a similar proportion developed to term in the two 
experiments. 
The harmful effects of nocodazole may reflect a disruption of 
microtubules other than those required for spindle formation. Important 
changes within the blastomeres are mediated by the microtubules, particularly 
during polarisation of the cells and compaction of the morula (see Maro et al., 
1991). Since exposure to the drug had relatively little effect upon 2-cell 
embryos and increasingly harmful effects on embryos at 4-cell, 8-cell and 16-
cell stages, it seems likely that this reflects, at least in part, disruption of 
differentiation of the blastomeres and the organisation of the embryo. 
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As with the use of nocodazole, a significant effect of the length of the 
treatment upon the ability of the treated embryos to reach blastocyst stage was 
found with colcemid. Since both, nocodazole and colcem id, have the same 
mechanism of action that is not entirely surprising. However, this effect 
appears sooner, nine hours instead of twelve, when the embryos are treated 
with colcemid. This together with the observation that embryos required 30 
minutes longer for completion of mitosis, may indicate stronger binding of 
colcemid to the tubulin monomers. This observation was not reported in a 
comparative study of the action of colcemid and nocodazole (Kato and 
Tsunoda, 1992) when all the treated embryos divided one hour after their 
release from the cytoskeleton inhibitors. This may arise from differences in the 
method of assessment since Kato's observations were made by checking 
blastomere division rather than nuclear membrane reformation in the daughter 
blastomeres. Nevertheless, other studies observed that no recovery of the 
microtubule network was recognized in mouse 2-cell embryos even 1 hour 
after removal of coichicine (Ohsugi ci' a!, 1993). No apparent effect of the 
stage of development was detected between exposed 2-cell and 4-cell embryos. 
No harmful effect upon development to blastocyst was detected when 2-cell 
embryos recovered 48 h post-hCG injection were transferred into 0.1 jLg/ml 
colcemid supplemented gM16 for four hours. 
In summary, both nocodazole and colcemid efficiently inhibit 
completion of mitosis and, therefore, either can be used to synchronise the 
embryonic cell-cycle in mitosis. When reversibility of this inhibition is 
important, as in the preparation of nuclear donor embryos for nuclear transfer 
experiments, the fact that length of the treatment affected development very 
significantly after exposure to nocodazole and colcemid must be considered. 
A short treatment combined with a post-treatment selection of non-
synchronized embryos would provide a reliable method for synchronizing 
nuclear donor embryos in mitosis. For a longer overnight exposure of 4-cell 
embryos nine hours treatment with nocodazole was chosen. Since no 
deleterious effect of the concentration was detected in those experiments 10.tM 
was chosen for the treatment because it is the concentration commonly used by 
other researchers and thus would simplify comparison of results. To 
synchronize 2-cell embryos in mitosis, exposure for four hours in 0. 1tg/ml of 
colcemid was chosen because at that time other laboratories were using this 
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compound (Collas et al., 1992; Cheong et a!, 1993) and this would eliminate 
one difference when comparing results. 
3.4 - INHIBFION OF DNA SYNTHESIS. 
Two different approaches were used to prevent DNA replication. The 
embryos were either exposed to substances that might hold them in 01-phase 
(trichostatin A and mimosine) or to drugs that might inhibit DNA replication 
(aphidicolin and hydroxyurea) in other cells. In the second case the cells were 
considered to be stopped at the G 1/S-phase border since they were ready to 
replicate DNA although this was prevented by the drugs. Trichostatin A was 
originally isolated as an anti-fungal antibiotic from a culture broth of 
Streptomyces strain (Tsuji et al, 1976) and was later revealed to cause specific 
arrest of the cell cycle of normal rat fibroblasts in both 01 and 02 phases 
(Yoshida and Beppu, 1988). Further analysis using a trichostatin-resistant 
mutant cell line established that trichostatin is a potent and specific inhibitor of 
the mammalian histone deacetylase and that inhibition of the enzyme is the 
primary reason for the inhibition of cell proliferation by trichostatin (Yoshida 
et a!, 1990). Mimosine, a plant amino acid, reversibly arrests the mammalian 
cell-cycle in late 01 phase, but the precise mechanism of action is unknown 
(Lalande, 1990). Aphidicolin inhibits DNA replication by interfering with the 
binding of deoxynucleotide triphosphates to DNA polymerase (Huberman, 
1981) thus blocking DNA polymerase cx activity. Molecular (Heintz et a!, 
1982; Heintz et a, 1983; Tribioli et al, 1987; Leu et a!, 1989; Anachkova et a!, 
1989) and kinetic (Pedrali-Noi et a!, 1980; Tobey et a!, 1988) studies indicate 
that aphidicolin blocks cell cycle progression in S phase cells which are 
undergoing active DNA replication and prevents the entry of cells into S phase 
at the 01/S border. Hydroxyurea reversibly inhibits the-action of the enzyme 
ribonucleotide reductase which catalyzes the reduction of ribonucleotides to 
the corresponding deoxyribonucleotides (Engstrom et a!, 1979), thus playing a 
critical role in DNA synthesis (Thelander et a!, 1979). 
3.4.1 - Experimental Design 
Four and 8-cell stage embryos were used to assess the ability of 
mimosine, trichostatin A, aphidicolin and hydroxyurea to prevent entry into 
the S-phase. Two-cell and 4-cell stage embryos were synchronized in mitosis 
using the methods based in microtubule inhibitors established previously (see 
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3.4.3). Thus synchronized embryos were released, allowed to cleave and 
treated with the DNA synthesis inhibitors under study. Microdrops containing 
the substance in gM16 media either with or without 100 PM 
bromodeoxyuridine (BrdU) were prepared a few hours in advance and put into 
the incubator to allow temperature and CO2 equilibration. The embryos were 
washed twice through 50 p.1 drops of gM16 with the substance and then placed 
into a 30j.tl drop of the same medium for culture. Four-cell and 8-cell stage 
embryos were cultured in the presence of the would be inhibitor for 3 and 7 
hours respectively. At the end of the treatment the embryos were fixed and 
DNA synthesis was determined by immuno-detection of BrdU incorporation 
by the embryo (see section 2.6). Embryos cultured in gM16 with 100p.M BrdU 
were used as the positive group to control that the embryos have incorporated 
BrdU in the absence of the would-be inhibitory substance (i.e.- they have 
progressed into the S-phase), whereas embryos cultured in gM16 alone were 
used as the negative control group to detect any non-specific reaction of the 
antibody. 
The degree of BrdU incorporation was measured on an arbitrary scale. 
with four points. The nuclei were considered negative (BrdU -ye) when no 
incorporation was detected. The treated embryos were recorded positive, 
according to the degree of BrdU incorporation detected as +ve, ++ve and 
+++ve from less to more intense (see fig. 3.3). 
To study the effect of the treatment upon development to blastocyst, 
after culture in gM16 plus trichostatin A, 4-cell and 8-cell embryos were 
washed for one minute in 100p.l of M16 without trichostatin and then through 
five 70 p.1 drops before introducing them in a 30 p.1 of gM16 culture drop. The 
embryo number was kept below a maximum of approximately 30 embryos per 
30 p.1 drop. The proportion that reached blastocyst stage was recorded. 
After exposure to aphidicolin, 4-cell and 8-cell embryos were washed 
as explained above and placed either in gM16 without or with 100p.M BrdU. 
Six hours later, the embryos cultured in the presence of BrdU were fixed and 
BrdU incorporation was assessed, whereas the others were used to assess 
aphidicolin effect upon development. 
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Figure 3.3 - Immuno-detection of bromodeoxyuri dine (BrdU) 
incorporation by the embryos. 
Four and 8-cell stage embryos were used to assess the ability of mimosine, trichostatin 
A, aphidicolin and hydroxyurea to prevent entry into the S-phase. The embryos were 
cultured in microdrops containing the DNA synthesis inhibitors under study in gM16 
media either with or without 100 jiM bromodeoxyuridine (BrdU). At the end of the 
treatment the embryos were fixed and DNA synthesis was determined by immuno-
detection of BrdU incorporation (sections 2.6 and 3.4.1): (-) no incorporation 
detected; (+, ++, +++) different degrees, from less to more intense, of BrdU 
incorporation. 
Negative control (-): embryos cultured in gM16 alone used as control to detect any 
non-specific reaction of the antibody. In this figure an 8-cell stage embryo that showed 
no incorporation of BrdU (-). Note non specific staining in the cytoplasm. 
Positive control (+++): embryos cultured in gM16 with lOOjiM BrdU used as 
control that the embryos have incorporated BrdU in the absence of the would-be 
inhibitory substance (i.e.- they have progressed into the S-phase). In this figure an 8-
cell stage embryo showing strong (-H-+) BrdU incorporation. 
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Table 3.9 - Effect of the compound and compound concentration used on inhibition 
of DNA synthesis in the treated embryos.* 
Compound 	Concentration Embryo Embryo Replicates Intensity of Brdu 
stage number incorporation 
Trichostatin A 	0.0001 .tg / ml 8-cell 42 2 
0.001 	.tg / ml 8-cell 42 2 
0.01 .tg / ml 8-cell 42 2 -H-I- 
0.1 	p.g / ml 8-cell 92 4 
1 p.g/ml 8-cell 92 4 -i--H- 
10 	j.Lg / ml 8-cell 50 2 +++ 
100 p.g / ml 8-cell 50 2 
Mimosine 	 200 iM 8-cell 67 4 
4-cell 21 2 
400 jiM 8-cell 27 2 
2000 LM 8-cell 29 2 ++ 
Aphidicolin 	0.1 	.tg / ml 8-cell 30 1 ++ 
0.5 	.tg / ml 8-cell 47 3 - /15%+  
4-cell 37 3 - 
1 	p.g / ml 8-cell 137 7 - 
4-cell 27 3 - 
Hydroxyurea 	 5 mM 8-cell 95 7 
4-cell 46 4 ++ 
10 mm 8-cell 29 2 +++ 
20 m 8-cell 26 2 + 
Control BrdU + a 8-cell 124 12 +++ 
4-cell 60 6 +++ 
Control BrdU ..b 8-cell 124 12 - 
4-cell 60 6 - 
*Twce1l and 4-cell stage embryos were synchronized in mitosis using the methods based in microtubule 
inhibitors established previously (see 3.3.3). Thus synchronized embryos were released, allowed to cleave and 4-
cell and 8-cell stage embryos were cultured, for 3 and 7 hours respectively, in microdrops containing the DNA 
synthesis inhibitors under study in gM16 media either with or without 100 p.M bromodeoxyuridine (BrdU).At 
the end of the treatment the embryos were fixed and DNA synthesis was determined by immuno-detection of 
BrdU incorporation (sections 2.6 and 3.4.1): (-) no incorporation detected; (+, ++, +++) different degrees, from 
less to more intense, of BrdU incorporation. 
a Embryos cultured in gM16 with 100p.M BrdU used as control that the embryos have incorporated BrdU in the 
absence of the would-be inhibitory substance. 
b Embryos cultured in gM16 alone used as control to detect any non-specific reaction of the antibody. 
Figure 3.4 - Bromodeoxyuridine (BrdU) incorporation in mimosine 
treated embryos. 
Two 8-cell stage embryos fixed after 7 hours culture in gMl6 plus 200 jtM mimosine 
and 100 iM BrdU showing strong (+++) BrdU incorporation. 
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Table 3.10 - Effect of Trichostatin A concentration and embryo stage on 
development of the treated embryos to blastocyst. 1,2 
Concentration Embryo stage N° replicates N° embryos N° blastocyst (%) 
Control (none) 4-cell 2 25 25 (100) 
8-cell 2 41 40 (98) 
0.0001 tg/ml 8-cell 2 41 41 (100) 
0.001 J.Lg/ml 4-cell 2 24 24 (100) 
8-cell 2 43 41 (95) 
0.01 	J.tg/ml 4-cell 2 24 24 (100) 
8-cell 2 46 19 (40) 
0.1 	p.g/ml 4-cell 2 24 23 (95) 
8-cell 4 83 11 (13) 
1 	j.tg/ml 4-cell 2 22 13 (67) 
8-cell 4 86 6 (7) 
10 	j.tg/ml 4-cell 2 23 8 (40) 
8-cell 2 38 0 (0) 
100 	i.g/m1 4-cell 2 25 1 (6) 
8-cell 2 40 0 (0) 
1 Two-cell and 4-cell stage embryos were synchronized in mitosis using the methods 
based in microtubule inhibitors established previously (see 3.4.3). Thus 
synchronized embryos were released, allowed to cleave and 4-cell and 8-cell stage 
embryos were cultured in gM 16 with trichostatin A for seven hours. After culture the 
embryos were washed before introducing them in a gM16 culture drop. The 
proportion that reached blastocyst stage was recorded. 
2 Due to the lack of variation in half of the treatments, no statistical analysis was 
conducted on these data. 
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Table 3.11 - Effect of DMSO concentration in culture media on 
development of mouse embryos to blastocyst. 
DMSO Osmolarity Embryo Blastocyst 
(p1/ml gM16) (mosm) number number 
Control 0 265 37 36 
0.01* 265 52 52 
0.1* 265 51 51 
1* 280 54 51 
10* 415 61 60 
20 561 65 64 
50 995 71 6 
Four-cell and 8-cell stage mouse embryos were cultured for 14 hours in gMl6 plus 
DMSO. At the end of the culture period, they were washed in gM16 and cultured in 
vitro. The number of embryos that developed to blastocyst was recorded. Two 
replicates were done for each treatment. 
* Concentrations of DMSO in gM16 used during the Trichostatin A experiment. 
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Figure 3.5 - Bromodeoxyuridine (BrdU) incorporation in aphidicolin 
treated embryos. 
8-cell stage embryo fixed and immuno-stained after culture for 7 hours in gM16 
plus 1 tg/ml aphidicolin and 100 p.M BrdU, showing no incorporation (-) of BrdU. 
8-cell stage embryo fixed and immuno-stained after culture for 7 hours in gM16 
plus 0.5 p.g/ml aphidicolin and 100 p.M BrdU, showing no incorporation (-) of BrdU. 
8-cell stage embryo fixed and immuno-stained after culture for 7 hours in gM16 
plus 0.5 p.g/ml aphidicolin and 100 p.M BrdU. It is possible to detect "DNA synthesis 
points" in three of the nuclei (arrow). This type of BrdU incorporation was recorded 
as (+). 
same embryo as in c) at higher magnifications. 
negative control: 4-cell stage embryo cultured in gM16 only, showing no 
incorporation (-) of BrdU. 
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Figure 3.6 - Bromodeoxyuridine (BrdU) incorporation in hydroxyurea 
treated embryos. 
8-cell stage embryo fixed and immuno-stained after culture for 7 hours in gM16 
plus 5 mM hydroxyurea and 100 j.LM BrdU, showing strong (+++) incorporation of 
BrdU. 
4-cell stage embryo fixed and immuno-stained after culture for 3 hours in gM16 
plus 5 mM hydroxyurea and 100 p.M BrdU, showing incorporation (-H-) of BrdU. 
8-cell stage embryo fixed and immuno-stained after culture for 7 hours in gM16 
plus 20 mM hydroxyurea and 100 p.M BrdU. It is posible to detect "DNA synthesis 
points" in the nuclei. This type of BrdU incorporation was recorded as (+). 
negative control: 8 -cell stage embryo cultured in gM16 only, showing no 
incorporation (-) of BrdU. Note non specific staining of the cytoplasm againts which 
the nuclei can be seen as "black holes". 
In those microphotographs different exposure periods were used. When BrdU 
incorporation was detected, the photographic camera was set up for a shorter exposure 
than when no incorporation was detected. This resulted in clearer pictures of embryos 
that have incorporate BrdU since the non specific staining of the cytoplasm did not 
appear in the pictures. It is important to know this to avoid confusion between pictures 
showing BrdU low incorporation (see c), in wich only points of BrdU incorporation 
appear in the picture, with pictures of negative controls. In those (see d), a longer 
exposure period resulted in the non specific staining of the cytoplasm appearing in the 
pictures. However, no incorporation of BrdU was detected in the nuclei that appear 









A simpler statistical analysis was used in those experiments where 
differences between means were assessed by a chi square test. However, the 
absence of variation in some treatments made an adequate statistical analysis 
difficult. 
3.4.2 - Results 
3.4.2.1 - Synchronization in Gi with mimosine and trichostatin A. 
3.4.2.1.1- Effect upon DNA synthesis. 
There was no evidence that mimosine or trichostatin A were able to 
prevent DNA synthesis in embryos. BrdU incorporation of 8-cell stage 
embryos cultured in the presence of 10 to 102  p.g/ml of trichostatin A for 
seven hours was similar to the positive controls (Table 3.9). No reaction was 
detected in the negative control groups. Similar results were obtained when 8-
cell embryos were cultured in the presence of 200 and 400 j.tM mimosine for 
seven hours or 4-cell embryos were exposed to 200.tM mimosine for three 
hours (fig. 3.4). However, a lower degree of incorporation was detected in 8-
cell stage blastomeres cultured in the presence of 2000tM mimosine.(Table 
3.9). 
3.4.2.1.2- Development to blastocyst alter release from trichostatin A. 
An effect of the exposure to trichostatin upon development to 
blastocyst was observed. However, due to the lack of variation in half of the 
treatments no statistical analysis was conducted. Although low concentrations 
did not impair further development, when the embryos were exposed to 
concentrations from 10-1  to  102  j.tg/ml progressively fewer embryos reached 
the blastocyst stage (Table 3.10). Embryos synchronized in mitosis, but not 
exposed to trichostatin A were used as control groups. This effect appeared to 
be entirely due to the trichostatin A present in the media. In a separate 
experiment set up to evaluate whether the amount of DMSO used to dissolve 
the trichostatin had any consequence on the development to blastocyst, no 
difference was found in the proportion of embryos that formed blastocyst 
between control (non exposed) and embryos exposed for 14 hours to same 
concentrations of DMSO as in the previous experiment, but in the absence of 
trichostatin A (table 3.11). 
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3.4.2.2 - Synchronization at Gi / S border with aphidicolin and 
hydroxyurea. 
3.4.2.2.1- Effect upon DNA synthesis. 
The effect of aphidicolin varied with its concentration. Aphidicolin 
inhibited BrdU incorporation of 4-cell and 8-cell embryos cultured in the 
presence of 0.5 or lp.g/ml of the drug (fig. 3.5 a-b); but not when a lower 
concentration of 0.1j.Lg/ml was used (Table 3.9). In addition it was possible to 
detect "DNA synthesis points" in a proportion (15%) of 8-cell embryos 
exposed for seven hours to aphidicolin (fig. 3.5 c-d). This may indicate that 
DNA synthesis is not completely inhibited with the aphidicolin concentrations 
used in these experiments. 
Hydroxyurea treated 4-cell and 8-cell embryos incorporated BrdU. The 
degree of incorporation was similar to the control group in 8-cell embryos 
exposed to 5 and 10 mM, but of a lower intensity (++) in 4-cell embryos 
cultured with 5mM (fig. 3.6 a-b). In all 8-cell embryos cultured in the 
presence of 20mM for seven hours "DNA synthesis points" were visible. 
Those embryos were scored as +ve (fig. 3.6 c) (Table 3.9). 
3.4.2.2.2- DNA synthesis and development to blastocyst after release from the 
aphidicolin. 
After release from aphidicolin all the embryos resumed DNA synthesis. 
No difference was found with the BrdU positive control group (positive 
control 80++-i-ve / 80; after aphidicolin 85+-i-+ve / 85). No deleterious effect of 
aphidicolin upon development to blastocyst was detected when development 
of 8-cell embryos synchronized in mitosis with nocodazole and later exposed 
to 1.Lg/ml of aphidicolin was compared (aphidicolin exposed 181/230, 
nocodazole treated controls 66/79) or when development of 4-cell embryos 
synchronized in mitosis with colcemid and later exposed to lp.g/ml and 0.5 
pg/ml of aphidicolin was compared (exposed to 1.tg/ml aphidicolin 30/30, 
exposed to 0.5.Lg/ml aphidicolin 30/30, colcemid treated controls 25/25). 
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3.4.3.- Discussion 
Trichostatin A blocks the cell cycle of normal rat diploid fibroblast 
(3Y1 cells) at 01 and 02 (Yoshida and Beppu, 1988). It is supposed that this is 
achieved by interfering with the expression of genes regulating the 01 to S 
progression. Trichostatin A has been shown to induce hyperacetylation of 
histones in mouse mammary carcinoma FM3A cells through specific inhibition 
of histone deacetylase (Yoshida et a!, 1990). Histone acetylation influences 
changes in chromatin structure which are associated with transcriptional 
activation and cell cycle progression (see review by Turner, 1991). There is an 
apparent association between degree of acetylation and transcription. 
Chromatin preparations that are rich in transcribed genes are also rich in 
acetylated histones, and, vice versa, acetylated chromatin is rich in transcribed 
genes (Allegra et a!, 1987; Johnson et a!, 1987; Ridsdale and Davie 1987; 
Hebbes et a!, 1988). However, in a recent experiment (Ikegami et a!, 1993), 
trichostatin A did not arrest embryonic cells of starfish embryos at the mid 
blastula stage. Although histones in the treated blastula stage embryos were 
hyperacetylated, it was only at the early gastrula stage when cell cycle 
progression was arrested at 01 and G2. This indicates that whatever the effect 
of histone acetylation on progression of the cell-cycle the regulatory point 
upon which it acts is acquired after the early embryonic stages in starfish. 
However, trichostatin A inhibited embryonic development of treated blastulae 
(Ikegami et a!, 1993). 
In this study it was found that the cell cycle of embryonic 8-cell stage 
blastomeres was not arrested in 01 and, therefore, DNA replication was not 
prevented. These results indicate that trichostatin A cannot prevent cell-cycle 
progression in mouse 8-cell embryos. On the other hand, embryos exposed to 
10-1 to  102  p.g/ml of trichostatin A for seven hours failed to continue their 
development after release from the drug. As the presence of DMSO at the 
concentrations used in those experiments has no detrimental effect on 
development to blastocyst, this suggests that the observed effect was caused 
entirely by the amount of trichostatin A in the culture media. Failure of 4-cell 
and 8-cell treated embryos to develop, although not proven, may be caused by 
inappropriate gene expression through inhibition of histone deacetylation 
(Ikegami et a!, 1993). 
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Mimosine has been reported as a cell-cycle inhibitor which acts 
reversibly in late 01 on cultures of growing human lymphoblasts (LAZ463), 
but its mechanism of action is unknown (Lalande, 1990). In the present study 
mimosine did not prevent DNA synthesis in 4-cell and 8-cell embryos, 
suggesting that the regulatory point upon which mimosine acts was not present 
in the embryonic cell-cycle at the stages used here. However, there was no 
evidence to demonstrate that mimosine entered the blastomeres. Recently 
Ouhibi (1994) reported that 18 - 20 h incubation in the presence of mimosine 
induced irreversible arrest of 4-cell stage embryos, suggesting that somehow 
mimosine does act on the embryos. In the same report a shorter exposure (4 
hours) did not affect development after release, and auto radiographic studies 
showed that mimosine inhibited DNA synthesis. The contradiction between 
these results and those presented in this thesis may be related either to the use 
of different methods to detect DNA synthesis or to the interpretation of the 
collected data. In summary, although the reasons are not clear, neither of the 
two compounds tested were able to stop the cell-cycle in G1 -phase. 
Aphidicolin has been shown to inhibit DNA polymerase a (Oguro et 
al, 1978), and doses in the range of 5-15 pg/m1 completely block DNA 
synthesis in sea urchin embryos (Oguro eta!, 1978), rat liver cells (Ohasshi et 
a!, 1978) and human embryonic lung cells (Bucknall et a!, 1973). In the 
experiments reported here, embryos at the 4-cell and 8-cell stage exposed to 
11g/m1 of aphidicolin showed no incorporation of BrdU, and after release they 
resumed cell-cycle progression through DNA synthesis without any deleterious 
effect detected upon development to blastocyst. However, in a proportion of 
the nuclei cultured in the presence of aphidicolin for seven hours, it was 
possible to detect points of BrdU incorporation which suggest that inhibition of 
DNA synthesis was not complete. These observations confirm  previous reports 
(Cozad et a!, 1982) where 20 J.tg/ml of aphiclicolin was needed to block DNA 
synthesis by mouse 8-cell stage embryos when assessed by 3H-thymidine 
incorporation. More recently, experiments have also been carried out with 
rabbit embryos (Collas et a!, 1992). When DNA synthesis was assessed by 3H-
thymidine incorporation complete block was only achieved with 2tg/ml of 
aphidicolin. However at this concentration DNA synthesis inhibition was 
irreversible. Despite the apparent need for a higher concentration of 
aphidicolin to achieve complete inhibition, the authors claimed reversible 
synchronization of rabbit embryos at the 01/S border by using 0.1tg/ml of 
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aphidicolin (Collas et a!, 1992). The explanation for this apparent contradiction 
is not known. 
Hydroxyurea reversibly inhibits ribonucleotide reductase from calf 
thymus at doses of 5 mM (Engstrom et a!, 1979) and has been widely used 
with tissue cultured cells (eg Tobey et al., 1990). In the study described in this 
thesis hydroxyurea was not able to completely inhibit DNA incorporation in 4-
cell and 8-cell stage embryos exposed to 5, 10 and 20mM concentrations. 
Again, since there was no evidence of the drug entering the cells, it is not 
possible to be sure of the real reason for this failure; but it may be due to very 
high pools of deoxyribonucleoside triphosphates in the embryonic cells. In 
summary, from the two compounds tested for their ability to inhibit DNA 
synthesis, only aphidicolin showed potential to be used as a method of 
synchronizing the nuclear donor blastomeres at the 01/S phase border. 
3.5 SYNCHRONIZATION IN G2-PHASE. 
Two compounds: Hoechst 33342 and cycloheximide were used to 
assess their ability to synchronize blastomeres in G2-phase. Hoechst 33342 
inhibits DNA topoisomerase II activity and has been used to synchronize in 
02-phase cultured hamster and human cells (Tobey et al., 1990). 
Topoisomerase II is involved in the regulation of DNA topological conversions 
and DNA relaxation and decatenation reactions (Woynarowski et a!, 1989; 
Liu, 1989). Hoechst 33342 and its structural analogues bind on the outside of 
DNA within the minor groove with preference for A+T-rich regions of the 
genome (Woynarowski et a!, 1989; Neidle et a!, 1987; Hilwig and Gropp, 
1973) and they inhibit topoisomerase II -mediated DNA relaxation and 
decatenation reactions (Woynarowski et a!, 1989) by a process other than 
stabilization of the cleavable complex (Liu, 1989; Woynarowski et a!, 1989). 
In doing so, they arrest cells in G2 by preventing the activation of MPF which 
is essential for the onset of mitosis (see section 4.5). Cycloheximide is a 
translation inhibitor (Obrig et a!, 1971) that would inhibit the synthesis of 
cyclin-proteins needed to activate mitosis promoting factor (MPF) and induce 
entry into mitosis (see section 4.5). Cycloheximide has been used to study the 
effect of protein inhibitors in DNA replication (Stimac et a!, 1977; Hand, 
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1975) and meiotic arrest in the oocyte (Siracusa et al, 1978; Clarke and Masui, 
1983; Moor and Gandolfi, 1987; Sirard et a!, 1989). 
3.5.1 - Experimental Design 
The ability of Hoechst and cycloheximide to hold the cells in G2 was 
assessed by exposing four and eight-cell stage embryos to their action. 
Embryos were synchronized in mitosis as explained before (see 3.4.3). 
Cleavage was allowed, and when the embryos were in their S-phase, they were 
transferred into drops of gM16 plus Hoechst or cycloheximide. The 8-cell 
stage embryos were exposed to the inhibitors for nine hours whereas the 4-cell 
stage embryos were exposed for 12 hours. In both cases the exposure to the 
compound was long enough to ensure that all the embryos from the control 
non-exposed group had cleaved. At the end of the incubation period, the cell 
number as well as the presence or absence of a nucleus was recorded by 
observing the embryos under the dissecting microscope. They were washed in 
gM16 as described before and cultured in vitro. The number of embryos that 
developed to blastocyst was recorded. 
35.2 - Results 
Both cycloheximide and Hoechst prevented the cells from entering 
mitosis in a concentration related manner. (Table 3.12). Although Hoechst was 
more effective, both drugs had a very dramatic effect upon development and 
although some of the exposed embryos managed to cleave one or twice after 
release from the treatment, few of them reached the blastocyst stage (Table 
3.13). It is interesting to note that even embryos exposed to the lowest 
concentrations that did not completely prevent mitosis failed to develop to 
blastocyst (Table 3.13). Due to the lack of variation in some of the treatments 
no statistical analysis was conducted on those data. 
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Table 3.12 - Effect of concentration of Hoechst 33342 and cycloheximide on the 
proportion of mouse embryo cells prevented from cleaving 
(presumptive G2-phase synchronization) *• 
Compound 	Concentration E stage 	No embryos N° embryos in G2 
Hoechst 33342 	0.1 jLg/ml 4-cell 20 2 
8-cell 9 0 
1 j.tg/ml 4-cell 20 20 
8-cell 12 11 
10 ig/ml 4-cell 20 20 
8-cell 6 6 
Cycloheximide 	0.5 j.tg/ml 4-cell 19 11 
8-cell 21 8 
5 p.g/ml 4-cell 20 13 
8-cell 20 17 
50 .tg/m1 4-cell 21 15 
8-cell 19 18 
* Embryos were synchronized in mitosis as explained before (see 3.4.3). Cleavage 
was allowed, and when the embryos were in their S-phase, they were transferred into 
drops of gM16 plus Hoechst or cycloheximide. The 8-cell stage embryos were 
exposed to the inhibitors for nine hours whereas the 4-cell stage embryos were 
exposed for 12 hours. In both cases the exposure to the compound was long enough 
to ensure that all the embryos from the control non-exposed group had cleaved. At 
the end of the incubation period, the cell number as well as the presence or absence 
of a nucleus was recorded by observing the embryos under the dissecting 
microscope. 
a Number of embryos with the same number of cells at the end of exposure to the 
compound under study. Assessed by counting the number of blastomeres in live 
embryos. 
['1'] 
Table 3.13 - Effect of concentration of Hoechst 33342 and cycloheximide on 
development of the treated embryos to blastocyst.* 
Compound 	Concentration 	E stage 	N° embryos N° blastocyst 
4-cell 20 6 
8-cell 12 6 
4-cell 20 0 
8-cell 12 0 
4-cell 20 0 
8-cell 6 0 
4-cell 19 4 
8-cell 21 12 
4-cell 20 0 
8-cell 21 5 
4-cell 21 0 
8-cell 19 3 
4-cell 20 20 
8-cell 20 17 








* Embryos were synchronized in mitosis (see 3.3.3). Cleavage was allowed, and 
when the embryos were in their S-phase, they were transferred into drops of gM16 
plus Hoechst 33342 or cycloheximide. The 8-cell stage embryos were exposed to the 
inhibitors for nine hours whereas the 4-cell stage embryos were exposed for 12 
hours. In both cases the exposure to the compound was long enough to ensure that 
all the embryos from the control non-exposed group had cleaved. At the end of the 
incubation period, they were washed in gM16 and cultured in vitro. The number of 
embryos that developed to blastocyst was recorded. 
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3.5.3 - Discussion 
Exposure of the embryos to Hoechst 33342 did prevent mitosis. It was 
not clear if this effect was achieved through synchronization of the cells in G2 
or by interfering with DNA synthesis. However this drug proved to be very 
toxic to the embryos and experiments were not continued. These observations 
extended those by Tsunoda et al., (1988) who reported this toxicity previously 
in 1-cell embryos exposed to concentrations of Hoechst higher than 5tgJml for 
3 minutes. Similarly, when cycloheximide was used, a low proportion of the 
treated embryos developed to blastocyst and the experiment was discontinued. 
3.6 CHAPTER DISCUSSION 
Two methods of synchronizing embryos were established. Embryos 
could be held in mitosis by culture for nine hours in lOj.LM nocodazole or 
culture for four hours in 0.1 .tg/ml colcemid. Secondly, treatment with 1 ig/ml 
of aphidicolin of embryos previously synchronized in mitosis was able to 
synchronize the blastomeres at the G 1/S border without any apparent effect 
upon development to blastocyst. 
By contrast, none of the treatments carried out to synchronize cells in 
01 phase or G2 phase was successful. Mimosine and trichostatin A did not 
prevent progress through 01 phase, while Hoechst and cycloheximide had 
very dramatic toxic effects on development. Although Hoechst was able to 
prevent the cell from entering mitosis, its effect was irreversible. This plus the 
deleterious effect upon development of both Hoechst and cycloheximide 
impeded the establishment of a reliable method of synchronization of 
embryonic blastomeres in G2. 
Cell-cycle progression in the first embryonic stages is very different to 
that in normal growing cells. The cell-cycle in the early embryonic stages is 
characterised by the lack of a growing period, indeed the cytoplasm of the 
cleaving blastomere is divided. between the resulting two daughters. It has 
been suggested that the more subtle check-points that regulate cell-cycle in the 
somatic cells are not present in these early embryonic cell-cycles where 
progression would be controlled by a more general mechanism such as 
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completion of mitosis and DNA replication (Gerhart et al., 1984). This idea is 
supported by the very short G 1 and G2 phases in early embryonic cell-cycle, 
except when dramatic changes in gene expression are involved as in the late 2-
cell stage in the mouse embryo. Conversely, embryonic blastomeres have large 
stocks of the molecules they need to develop at these relatively high speeds, 
and substances that could be used to synchronise somatic cells, due to their 
interference with the biosynthesis process involved in the building up of these 
molecules, may fail to hold the cell-cycle when used in embryonic 
blastomeres. This may explain why only substances that inhibit crucial 
processes, as chromosome separation during mitosis or DNA polymerization 
at replication, were able to stop the cell-cycle in the experiments reported here; 
while other substances that are able to inhibit cell-cycle progression in 
cultured mammalian cells failed to do so in embryonic blastomeres. 
The substances tried during these experiments are only a very small 
example of the several compounds reported to interfere with the normal cell-
cycle progression (see review by Pardee and Keyomarsi, 1992). It would be 
very interesting to check the differential effect of these compounds on the 
cell-cycle of the embryonic blastomeres compared to cultured cells and also 
their effects on embryonic development. 
Another problem to be addressed is that although the cell-cycle is 
apparently arrested at a given point, what really is happening is that the 
completion of a normal cellular process is inhibited and it is expected that 
checkpoint controls would arrest the cell cycle at this point. However, 
checkpoint controls are not inflexible and in considering these results it is 
important to recognise that the cells may well be arrested in a state where the 
cell-cycle controls are distorted and which does not correspond to anything 
that occurs in the normal undisturbed cell-cycle. As an example, levels of 
cyclins characteristic of cell-cycle phases other than the ones which they were 
synchronized in have been reported in various experiments (Marraccino et al., 
1992; Yamashita etal., 1990; Steinmann etal., 1991; Pines and Hunter, 1990). 
These findings suggested that instead of a model of the cell-cycle as a 
linear progression with different steps that must be accomplished in 
succession in which, if the completion of one of those steps is inhibited, the 
cell-cycle is arrested at that point; a model in which the cell-cycle is imagined 
as parallel paths that are loosely inter-related may be more appropriate. In this 
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alternative model, if one of the paths is blocked the processes regulated down 
that path would be inhibited, however, processes that are regulated by other 
paths would continue happening creating, as a consequence, an anomalous 
asynchrony in the events constituting the cell-cycle. 
To minimize the effect of such anomalous asynchrony in nuclear 
transfer experiments, it was decided to minimize the length of cell-cycle 
synchronization treatments. Also, since none of the treatments carried out to 
synchronize cells in Gi phase or G2 phase was successful, it was necessary to 
conduct cell-cycle progression mapping experiments in order to know when 
the embryonic blastomeres will be at those phases and therefore, use them as 








To study the influence of cell-cycle phases of the recipient cytoplasm at 
the moment of nuclear transfer upon the subsequent development of the 
reconstituted embryo, the precise cell-cycle phase of the recipient cytoplasm 
at the time of fusion must be known. Extrusion of the first polar body is 
completed just prior the time of ovulation and ovulated oocytes are 
subsequently arrested at the second metaphase of meiosis. At fertilization, the 
sperm-oocyte fusion triggers the cascade of biochemical events leading to the 
extrusion of the second polar body and pronuclear formation. This 
phenomenon has been named "oocyte activation" and initiates the first cell-
cycle of the embryo. It has been known for several years that a variety of 
physico-chemical stimuli can activate the oocyte in the absence of sperm (see 
Kaufman, 1983). This phenomenon is known as parthenogenetic activation, 
and the developing "embryo" resulting from it is called "parthenogenone" 
(Kaufman 1983). It has been accepted that when the recipient cytoplast is an 
oocyte in metaphase II, embryos reconstituted by nuclear transfer have to be 
exposed to an activation stimulus in order to mimic the effect of the sperm at 
fertilization and trigger the initiation of the first cell-cycle (Tarkowski and 
Balakier, 1980; Czolowska et al., 1984; Sz011ösi et al., 1986). In consequence, 
by controlling the time of its parthenogenetic activation and mapping the 
occurrence of the subsequent events of the cell cycle, it would be possible to 
know the cell-cycle phase of the recipient oocyte. 
Following natural mating, fertilization occurs almost immediately after 
ovulation. This indicates that the oocyte is ready for sperm-induced activation 
as soon as it is released into the oviduct. However, freshly ovulated oocytes are 
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not activated when exposed to agents capable of inducing parthenogenetic 
activation in aged oocytes. It is well documented that postovulatory aged 
oocytes activate more readily than do recently ovulated oocytes (Kaufman, 
1973; O'Neill and Kaufman, 1988). The postovulatory age of the oocyte at the 
time of activation also controls the incidence of the various classes of 
parthenogenone that are induced (Kaufman, 1973; Kaufman and Surani, 1974). 
This is most likely to be a consequence of the age related changes that occur in 
the tangential orientation and cortical location of the second meiotic spindle 
and the cortical granules, and the state of polymerisation of the cytoskeletal 
elements (Szöllösi, 1971, 1975; Longo, 1980). The manipulations involved in 
the nuclear transfer procedures expose, both the oocyte and the reconstituted 
embryo to a variety of conditions (e.g.; changes of temperature, osmolarity, 
absence of calcium in the medium) and other stimuli (e.g.; hyaluronidase) that 
are able to trigger the parthenogenetic activation of the recipient oocyte. A 
consequence of the postovulatory ageing process is that the proportion of 
oocytes activated due to handling increases in those more aged oocytes, 
making it more difficult to control the activation time of the aged oocytes used 
as recipient in the nuclear transfer experiments. Also, it has been suggested 
that it is important that recently ovulated oocytes are used in nuclear transfer 
experiments to optimise the development of the reconstituted embryo (Smith 
and Wilmut, 1990). Postovulatory aged oocytes undergo degenerative changes, 
and consequently have a reduced long-term viability (Smith and Lodge, 1987; 
Kaufman, 1993). Moreover, several nuclear transfer procedures were improved 
when recipient oocytes were used prior to the changes associated with in vitro 
postovulatory ageing-related processes. Thus the efficiency of enucleation in 
mice (Kono et al; 1991b) and enucleation, fusion rate and development after 
nuclear transfer in rabbit (see Collas and Rob!, 1990) were greater when 
recently ovulated oocytes were used as recipient. 
To study the influence of cell-cycle phases of both nuclear-donor and 
recipient at the moment of nuclear transfer upon the subsequent development 
of the reconstituted embryo, it was necessary (as well as to develop the 
methods for nuclear donors synchronization described in the previous chapter) 
to establish a method of parthenogenetic activation that would induce 
activation in very recently ovulated oocytes. This would be essential in order 
to avoid any detrimental changes related to the ageing process and minimize 
the proportion of oocytes which activate spontaneously. 
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Two principal methods of parthenogenetic activation are routinely used 
in nuclear transfer experiments: electric pulses and exposure to ethanol. Short 
exposure to dilute solutions of ethanol has routinely been used in mouse 
nuclear transfer studies when fusion is mediated by inactivated Sendai virus 
(Howlett et al, 1987; Kono et al, 1991b, 1992; Tsunoda et al, 1989). But 
ethanol has consistently been observed to induce cytoskeletal damage and high 
rates of aneuploidy in the resultant parthenogenones (Kaufman, 1982; O'Neill 
and Kaufman, 1989). Single or multiple electric pulses of microsecond 
duration induce both activation of the enucleated recipient and fusion of the 
karyoplast-cytoplasm. This method is the most widely used in embryo cloning 
experiments (see for example, Campbell et al., 1993, 1994; Collas et a! 1992; 
Cheong et al, 1993). Recent studies in mouse and rabbit embryos have shown 
that by the administration of repetitive electrical pulses it is possible to mimic 
closely the intracellular calcium transients in the oocyte that are induced by the 
sperm at fertilization (Ozil, 1990; Vitullo and Ozil, 1992). These methods 
increased the efficiency of parthenogenetic activation in terms of proportion of 
activated oocytes, ability to activate recently ovulated oocytes and 
development of the parthenogenones thus produced. However, the methods 
and equipment required are very complex and not yet commercially available. 
An alternative approach to activation was provided by the observation 
that exposure to strontium ions induced both the resumption of meiosis and 
cortical granule release in freshly ovulated oocytes (Fraser, 1987). More 
recently O'Neill et al., (1991) have shown that a brief exposure of mouse 
oocytes to calcium free M16 supplemented with strontium chloride induced a 
high incidence of parthenogenetic activation. However, if exposure to this 
media was longer than 10 minutes the activation frequency decreased and a 
high proportion of the oocytes degenerated. This negative effect can be 
avoided if magnesium is removed from the activation medium (Bos-Mildch, 
personal communication). Moreover, in contrast to other activation stimuli, 
exposure to Sr supplemented media initiates Ca transients in oocytes much 
like those initiated by the sperm at fertilization (Kline and Kline, 1992). 
In this chapter are described the experiments conducted to optimize a 
method of parthenogenetic activation of oocytes by exposing them to strontium 
in a calcium magnesium free M16. To study recipient cell-cycle effect in 
nuclear transfer, it is necessary to determine the time of initiation of the first 
cell cycle triggered by the activation stimulus. Therefore it is necessary to 
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know when the oocyte is exposed to the activation stimulus. The ideal 
activation method must be easy to administer to the oocytes (ie: no complex 
machines or repetitive procedures), very effective (must induce activation in 
more than 95 % of the exposed oocytes) and should activate very early 
ovulated oocytes to avoid "spontaneous" activation induced during oocyte 
manipulation. 
4.2 MATERIALS AND METHODS 
4.2.1 - Animals and Oocytes. 
Four week old mice were superovulated and used as oocyte donors. 
The timing of eCG and hCG injections was scheduled around midnight to have 
oocytes at the post-hCG time required for the experiments during the working 
hours. The details of the procedures employed for the harvest of oocytes are 
explained in the second chapter (see 2.3). Oocytes were recovered before (8, 9 
and 10 hours after hCG) or after ovulation (14 and 18 hours after hCG 
injection). In these experiments the mice started to ovulate 11 to 12 hours after 
hCG (data not shown). 
4.2.2 - Strontium Activation Media. 
The activation media consisted of calcium magnesium free M16 
supplemented with strontium chloride. Different concentrations of strontium 
(Sr) were achieved by adding different volumes of the Sr stock solution to 
the final activation media (see section A2.3 and tables A2.3, A2.4 and A2.5). 
To avoid precipitation of the salts in the medium the different stock solutions 
were mixed at 4°C and in a determined order: stock solution A first, then C, 
then Sr and then B. Stock solution B was added in 200 j.tl volumes and the 
mixture was agitated before adding a new aliquot. Predeionized distilled sterile 
water at 4°C was added up to 25 ml. Then BSA was added at a concentration 
of 4 gIl, allowed to dissolve and the solution sterilised by filtration. Aliquots 
were placed in 1.5 ml Eppendorfs tubes and they were kept at 4°C. New 
solutions were made after two weeks. Microdrop cultures were equilibrated at 
37°C in 5% CO2 in air few hours before exposing the oocytes to the activation 
stimulus. 
No measures (ie, reducing sodium chloride) were taken to correct the 
osmolarity of the activation media to levels similar to the culture and 
M. 
manipulation media (approximately 260 and 280 moms respectively). 
Therefore the osmolarity of the activation media was higher than the usual 
260-280 moms (see below). 
Sr mM in medium Osmolarity (moms) 
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4.2.3 - Exposure of the Oocytes to Strontium Supplemented M16. 
After recovery, the oocytes were treated with hyaluronidase to denude 
them of the surrounding cumulus cells (see section 2.4.4.1), they then were 
washed twice in gM16 and exposed to strontium activation medium. At the 
end of the exposure period, the oocytes were washed three times in gM16 and 
cultured. 
43 EXPERIMENTAL DESIGN 
Experiments were conducted to study the effect of i) the post-hCG age 
of the oocytes, ii) the length of exposure to the activation media and iii) the 
strontium concentration in the activation media on oocytes activation. The 
proportion of oocytes that cleaved to 2-cell 24 hours after the activation 
treatment was regarded as the proportion of oocytes that had been activated. It 
was considered that if the activation stimulus induced pronuclear formation but 
failed to achieve development to the 2-cell stage, then the activation thus 
induced was not good enough. Development to both morula and blastocyst 
were also recorded and used to evaluate the quality of the activation stimulus. 
In each experiment a control group was used to detect any spontaneous or 
handling induced activation. The oocytes in these control groups were 
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manipulated as the experimental groups except that they were not exposed to 
the strontium activation medium. 
From these experiments the optimum method of activation was 
selected. This method was then used in a subsequent series of experiments 
designed to study the effect upon activation of preovulatory oocytes of i) post-
hCG age and ii) in vitro ageing or preincubation before exposure to the 
activation stimulus. 
Finally oocytes were exposed to the method of activation chosen and 
the developmental pathways, proportion of blastocyst formation and blastocyst 
cell number were recorded. 
The statistical analysis of the data was done by a two way ANOVA 
with t-tests of treatment differences. In each experiment the data consisted of a 
randomized block design with days as blocks and the parameter(s) being 
studied as treatments. Those parameters are specified in each experiment. 
4.4 RESULTS 
4.4.1 - Effect of length of exposure and post-hCG age of the oocyte upon 
activation. 
In the first experiment oocytes recovered before (10 hours post-hCG) 
and after ovulation (14 and 18 hours post-hCG) were exposed for none 
(spontaneous activation control group), 30 and 60 minutes to 5mM Sr 
activation medium. A second experiment was conducted exposing oocytes 
recovered at 10 and 14 hours post-hCG to 10mM Sr activation media for none 
(control group), 30 and 60 minutes. In these two experiments the data 
consisted of a randomized block design with days as blocks and length of 
exposure to Sr activation media and post-hCG age of the oocytes as treatment. 
Their effect on the proportion of treated oocytes developing to 2-cell, morula 
and blastocyst stage was analysed. Differences between means were assessed 
by a Student's t test. 
A significant effect (p<zO.00l) of the oocyte age on both induced and 
spontaneous activation was found. Forty per cent of the oocytes recovered at 
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Table 4.1 - Effect of length of exposure and post-hCG age of the 
oocyte upon activation. 
(Exp 1; 5mM Sr) 1 
Flours Exposure No 2-cell Mo Blast 
p-hCG (miii) Oocytes (%) (%) (%) 
10 0 70 5* 0 0 
30 81 1* 0 0 
60 81 1* 0 0 
14 0 83 6* 0 0 
30 95 22** 10 0 
60 99 52*** 31 7 
18 0 70 40*** 17 12 
30 79 88 6 54 16 
60 77 89B 60 13 
*, **, ***, 13 Different superscripts have statistically different (p<0.001) rates of 
cleavage to 2-cell. (4 replicates in each group). 
1 Oocytes recovered before (10 hours post-hCG) and after ovulation (14 and 18 hours 
post-hCG) were exposed for 0 (spontaneous activation control group), 30 and 60 
minutes to 5mM Sr activation medium. 
Table 4.2 - Effect of length of exposure and post-hCG age of the oocyte 
upon activation. 





2-cell (%) Mo (%) Blast (%) 
10 	0 40 0 0 0 
30 47 2* 0 0 
60 48 6* 6 6 
14 	0 40 5* 0 0 
30 54 17** 0 0 
60 49 71 48 28 
, 	*** Different superscripts have statistically different (p<O.00l) rates of 
cleavage to 2-cell (2 replicates in each group) 
1 Oocytes recovered at 10 and 14 hours post-hCG were exposed to 10mM Sr 
activation media for 0 (control group), 30 and 60 minutes. 
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18 hours post-hCG were activated during the procedures, compared with 5 % 
of the oocytes recovered at 10 hours after hCG or 6.45 % of the oocytes 
recovered at 14 hours after hCG (see table 4.1). Increasing the length of 
exposure to the activation media did not increase significantly the proportion 
of oocytes activated either at 10 hours after hCG (<2 % of activation) where 
activation was negligible or 18 hours after hCG (> 87 % of activation) where 
activation was already very high. However when oocytes recovered 14 hour 
after hCG were exposed for 60 minutes instead of 30, the proportion of 
activated oocytes increased significantly (p<0.001) (22% versus 51%) (see 
table 4.1). Similar results were obtained when oocytes recovered at 10 and 14 
h after hCG were exposed to 10mM Sr for 30 and 60 minutes (see table 4.2). 
However, in this second experiment, 10 mM Sr was able to activated more 
(6%) of the oocytes recovered 10 hours after hCG than the 5mM Sr 
concentration used in the previous experiment. 
Oocytes recovered at 10 hours after hCG were found to be quite 
refractory to the activation stimulus utilised. On the other hand, oocytes 
recovered at 18 hours after hCG were too easily activated. However oocytes 
recovered at 14 hours appeared to react gradually to the intensity, in terms of 
duration, of the activation stimulus. This is why they were selected for the next 
experiment. 
4.4.2 - Effect of strontium concentration upon activation. 
In the third experiment the effect of strontium concentration upon 
activation was studied by exposing oocytes recovered 14 hours post-hCG to 0, 
5, 10, 25, 50 and 100mM Sr activation media for 60 minutes. In this 
experiment the data consisted of a randomized block design with days as 
blocks and Sr concentration as treatment. Sr concentration effect on the 
proportion of treated oocytes developing to 2-cell, morula and blastocyst stage 
was analysed. Differences between means were assessed by a Student's t test. 
No effect of Sr concentration in the activation medium was detected 
when Sr concentrations from 5 to 50 mM were used (see table 4.3). However a 
significant effect was found between those treatments and exposure to none or 
100 mM Sr (p<0.001;see table 4.3). In two of the three replicates of this 
experiment unusually high levels of oocyte degeneration occurred (p<0.05). 
Although this degeneration did increase the background level, no significant 
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Table 4.3 - Effect of strontium concentration upon activation. 
(Exp. 3) 
Sr mM Total Oo No deg 2-cell 
% / total 	% I Nd 
Morula 
% / total 	% I Nd 
Blastocyst 
% / total 	% I Nd 
0 55 46* 9 9* 5 5* 5 5* 
5 56 46* 65 84** 51 66** 17 25** 
10 59 47* 71 89** 63 79** 36 46** 
25 59 51* 84 98** 76 89** 27 31** 
50 58 50* 73 89 56 68** 31 38** 
100 54 35** 19 27* 1 2* 1 2* 
** Different superscripts within the same column are statistically different (p<O.Ol) (3 replicates in each group). 
I Oocytes recovered 14 hours post-hCG were exposed to 0, 5, 10, 25, 50 and 100mM Sr activation media for 60 minutes. 
Results are shown as percentage over total oocytes (% / total) and as percentage over no degenerated oocytes (% / Nd). 
effect of Sr concentration was found between the control group and Sr 
concentrations 5 to 50. Nevertheless when the oocytes were exposed to 100 
mM Sr activation media the level of degeneration increased. This increase, 
although statistically not significant (p>0.05 but p<0. 1), suggested an effect of 
this concentration on oocyte degeneration. In table 4.3 the figures are given 
both as activation over total number of oocytes exposed to the activation 
stimulus and over total of no degenerated oocytes. 
Although no significant effect of the concentration was found, exposure 
to 25 mM Sr activation media resulted in a slightly higher proportion of 
cleavage to 2-cell and development to morula (see table 4.3). For these 
reasons, exposure for 60 minutes to 25 mM Sr activation media was selected as 
the routine method of activation. 
4.4.3 - Activation of preOvulatory oocytes: effect of post-hCG age and in 
vitro preincubation. 
In two separate experiments preovulatory oocytes recovered at 9 and 10 
hours after hCG were exposed to the activation media after different periods of 
culture in vitro (experiments 4 and 5). In the first (exp.4), oocytes recovered 
nine hours post-hCG were cultivated for either 4 or 8 hours in gM16 and then 
exposed to activation media of 10 or 25 mM Sr for 60 minutes. Oocytes 
recovered at the same time but not exposed to the activation media were used 
as controls to detect any spontaneous activation. In the second experiment 
(exp.5), oocytes were recovered 10 hours after hCG and further cultured in 
vitro for 5 or 8 hours in gM16 before being exposed to 25 mM Sr activation 
media for 60 minutes. A control group was also used in this experiment. A 
third experiment was conducted in which preovulatory oocytes were recovered 
at 8 and 10 hours after hCG and cultured in vitro for none, four and eight hours 
before exposing them to 25 mM Sr activation media for 60 minutes 
(experiment 6). In these experiments the data consisted of a randomized block 
design with days as blocks and length of culture in vitro prior to exposure to 
the Sr activation media, Sr concentration (only in exp. 4) and post-hCG age of 
the oocytes (only in exp. 6) as treatment. 
These experiments shown an effect of oocyte post-hCG age and of in 
vitro incubation period. A significant (p 0<05) effect upon activation of the in 
vitro incubation period before exposure to the activation media was found in 
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two of three experiments (see table 4.4). When oocytes recovered 9 hours after 
hCG were preincubated for 8 hours, 77 % cleaved to the 2-cell stage in 
comparison to 25 % when they were preincubated for 4 hours (p<0.05). 
However, no significant effect of the Sr concentration in the activation media 
(10mM vs. 25mM) was found. A higher proportion of oocytes exposed to the 
activation media cleaved to 2-cell when oocytes recovered at 10 hours after 
hCG were cultured in vitro for 8 hours than when the preincubation period was 
kept to 5 hours, although the difference was statistically no significant. Results 
from these two experiments suggested an effect of the post-hCG age of the 
oocyte upon activation. Also a "day of experiment" effect was observed in both 
experiments (data not shown). In two out of five replicates in the first 
experiments and one out of four replicates in the second the activation results 
obtained were lower than the rest of the days, although the ratio between 
different treatments on the same day remained unchanged. This observation 
stresses the importance of setting activation control groups in each and every 
experimental day. 
The third experiment of this series (exp 6) was set up to make a direct 
comparison between oocytes recovered at 8 or 10 hours after hCG. A 
significant effect of both the post-hCG age of the oocyte (p<0.05) and the in 
vitro preincubation time (p<0.05), although no of its interaction upon 
activation was found (see table 4.4). 
104 
Table 4.4 - Activation of preovulatory oocytes. 
Effect of post-hCG age and in vitro preincubation. 
(25 mM Sr ihour. Exp. 4, 5 and 6) 
Hours 	Preincb 	Exposed 	Sr mM Total 2-cell 	Mo 	Blast (%) 
p-hCG to Sr (%) (%) 
Experiment 4 (5 replicates) 
9 	0 	no - 90 0 	- 	 - 
4 	yes 10 130 25* 	- 	 - 
4 	yes 25 137 29* 	- 
8 	yes 10 133 77** 	- 	 - 
8 	yes 25 130 75** 	- 	 - 
Experiment 5 (4 replicates) 


















Experiment 6 ('4 replicates) 
8 	0 	no - 65 0 0 0 
0 	yes 25 67 0 0 0 
4 	yes 25 73 12* 6 3 
8 	yes 25 71 70** 62 34 
10 	0 	no - 70 0 0 0 
0 	yes 25 71 5 3 3 
4 	yes 25 79 49** 46 30 
8 	yes 25 75 92** 81 45 
Different superscripts within each experiment have statistically different 
(p<0.05) rates of cleavage to 2-cell. No comparation was done between 
experiments. 
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Table 4.5 - Development pathways after Sr induced activation. 
Hours Preincb Total Oo 	PN 	1PN+1PB 1PN 	2PN 	>2PN 
p-hCG 	 visiblea 
10 6 232 213 176 (83)b - 	 31(14) 	6(3) 
14 0 194 191 164 (86) 1 	26(13) 	- 
Activation was induced by exposing the oocytes to 25 mM Sr M16 for 60 
minutes. 
a Presence and number of pronuclei were assesses seven hours after the start of the 
oocytes culture in the Sr M16 medium. 
b Number of oocytes (percentage over activated). 
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Table 4.6 - Development to blastocyst after Sr 	induced activation 
(25 mM Sr for 1 hour). 
Hours Replicates 	Exposed Total Blastocyst Blastocyst 
p-hCG to Sr oocytes day 4 (%) day 5 (%) 
10 8 no 114 0 0 
9 yes 145 14 35 
14 11 no 221 0 2 
11 yes 232 13 33 
15 2 no 34 0 0 
2 yes 42 16 71 
16 3 ilo 23 10 20 
3 yes 23 28 44 
17 2 no 26 27 27 
2 yes 33 7 41 
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Figure 4.1 - Parthenogenetic development to blastocyst. 
It was possible to distinguish two groups within the parthenogenones that 
developed to blastocyst: those which started to cavitate by day 4 after activation 
(marked as 4 in b) and those which cavitate a day later (marked as 5 in b). Note that 






4.4.4 - A method of activation: development pathways, development to 
blastocyst and cell number. 
Over 83 % of oocytes recovered 10 hours after hCG, and cultured in 
vitro for six hours before activating them by exposure to 25 mM Sr in calcium 
magnesium free M16 for sixty minutes, developed as 1PN parthenogenones 
(Table 4.5). The same pathway was seen in over 85 % of the oocytes recovered 
14 hours after hCG injection. 
Although most of the oocytes which cleaved to the 2-cell stage 
continued development to the compacted 8-cell-morula stage, fewer 
parthenogenones completed development to blastocyst (see tables 4.3 and 4.4). 
In addition it was possible to distinguish two groups within the blastocysts: 
those which started to cavitate by day 4 after activation and those which 
cavitate a day later (Fig 4.1; table 4.6). Cell number of the parthenogenones 
that developed to blastocyst, determined by UV microscopy after staining the 
nuclei with Hoechst 33342, was within a range of 60 to 80 cells. 
4.5 DISCUSSION 
An optimum method of parthenogenetic activation of recently ovulated 
oocytes was established, involving the culture of the oocytes for 60 minutes in 
25 mM strontium in a calcium magnesium free M16 medium. This method 
was also able to induce the resumption of meiosis and parthenogenetic 
development of oocytes recovered before ovulation and cultured in vitro prior 
to exposure to the activation stimulus. 
The parthenogenetic activation of mouse oocytes after exposure to 
divalent ions such as strontium, barium and manganese has been reported 
previously (Whittingham and Siracusa, 1978; Fraser 1987; O'Neill et a!, 
1991). It has been suggested that these ions displace calcium ions from 
intracellular stores such as the mitochondria and endoplasmic reticulum (Van 
Blerkom and Runner, 1984; Eisen and Reinolds, 1985). In muscle cells, 
strontium can be taken up by the sarcoplasmic reticulum, can compete with 
calcium for the uptake by the ATP-dependent transport system of the 
sarcoplasmic reticulum, and can cause calcium release from isolated 
sarcoplasmic reticulum (Mermier and Hasselbach, 1976; reviewed in Endo, 
1985). 
Calcium has been considered to be the primary intracellular signal 
responsible for the resumption of meiosis following fertilization (Wittingham, 
1980; Jaffe, 1983; Whitaker and Steinhardt, 1985). In mouse and hamster 
oocytes, the fertilising sperm produces a surge of intracellular calcium 
followed by smaller repetitive rises which occur at regular intervals for up to 
four hours (Cuthbertson et a!, 1981; Cuthbertson and Cobbold, 1985; Igusa 
and Miyazaki, 1986; Miyazaki et al., 1986; Miyazaki 1988, 1990). The 
resumption of meiosis and cortical granular exocytosis is dependent on this 
intracellular rise in Ca (Kline and Kline 1992). Although most of methods 
normally used for parthenogenetic activation only induce a single large 
increase in intracellular calcium (Cuthbertson eta!, 1981; Eusebi and Siracusa, 
1983; Miyazaki, 1991), there are some compounds, such as inositol (InsP3), 
that can induce repetitive calcium transients in hamster oocytes (Swann et a!, 
1989; Miyazaki, 1991) though they are not as effective as sperm. When mouse 
oocytes were exposed to strontium in a calcium magnesium free medium 
calcium transients that were "lower in relative amplitude, somewhat longer in 
duration, and occurred less frequently than those induced by sperm in normal 
calcium containing media" were observed (Kline and Kline, 1992). The 
importance of using a method of parthenogenetic activation which induces 
repetitive intracellular oscillations of calcium in the oocyte that closely 
simulate those that occur at fertilization has been proved in rabbit (Ozil, 1990) 
and mouse (Vitullo and Ozil, 1992). The use of an activation method based in 
the ability of strontium to induce these oscillations provides a simple, but 
effective method for the parthenogenetic activation of mouse eggs. 
Although the whole process of activation is not yet fully understood at 
the molecular level, the more important factors and their interactions are 
beginning to be known. In mouse as in most other vertebrates, oocytes are 
arrested at the second meiotic metaphase by a cytostatic factor (CSF) (Masui 
and Markert, 1971). The regulation of both meiosis and mitosis (M phase) is 
controlled by the activity of the M-phase promoting factor (MPF) (Nurse, 
1990). This factor is composed of a protein kinase (p34 2) that is associated 
with a molecule of cyclin B. Levels of p34(C2  remain constant through the 
cell-cycle, but the amount of cyclin varies and thus, MPF activity is regulated 
by the availability of cydins and by changes in the phosphorylation state of 
p34 2. Progress into M-phase is triggered by the activation of MPF activity 
and results in nuclear envelop break down, chromosome condensation, 
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reorganization of the cytoskeleton and changes in cell morphology (Nurse, 
1990; Maller, 1991). Cell-cycle transition from M-phase to interphase is 
characterized by degradation of the associated cyclin and inactivation of 
p34 2 kinase activity (Murray et a!, 1989). However, at the meiotic arrest 
CSF prevents ubiquitin-dependent degradation of mitotic cyclins and thus 
inactivation of MPF (Glotzer et a!, 1991; Murray et a!, 1989). Two 
components of CSF have been identified so far: Mos, the product of c-mos 
proto-oncogen (Sagata et a!, 1989), and cyclin-dependent kinase 2 (Cdk2) 
(Gabrielli et a!, 1993). At fertilization, the sperm triggers a transient increase in 
the cytoplasmic free Ca (see Jaffe, 1983 and Berridge, 1993) which 
inactivates both MPF and CSF in a reaction mediated by calmodulin-
dependent protein kinase II (Lorca et a!, 1993). This first overcomes the ability 
of CSF to prevent ubiquitin-dependent degradation of cyclin and thus 
inactivates MPF. This is then followed by a slower disappearance of CSF 
(Lorca era!, 1991; Lorca eta!, 1993). 
In the experiments reported here oocytes recovered before ovulation (8 
to 10 hours after hCG) were refractory to the activation stimulus able to induce 
resumption of meiosis and cleavage to 2-cell in oocytes recovered 14 hours 
after hCG. However after a period of culture in vitro they acquired the ability 
to respond to this activation stimulus. At the same time oocytes recovered at 14 
hours needed a stronger stimulus to activate than oocytes recovered 18 hours 
after hCG. These results suggest that the mechanism which triggers activation 
is probably present in very early ovulated oocytes, but to reassuming complete 
meiosis it is necessary to give a very strong activation stimulus to the egg. 
Alternatively it is possible to wait a period of time and use a weaker stimulus. 
It is not clear why recently ovulated oocytes are more difficult to 
activate parthenogenetically than aged ones. It has been reported previously 
(Kubiak, 1989) that oocytes develop the ability to respond to the activation 
stimulus gradually. Sometimes mouse oocytes subjected to an activation 
stimulus (either sperm or parthenogenetic), resumed completion of meiosis, 
extruding the second polar body. However, the female pronucleus failed to 
form and the oocytes did not progress into the normal interphase phase. 
Instead, the chromosomes remained in a condensed state arranged on a new 
metaphase complex. This phase has been called metaphase III. Cytogenetic 
analysis of these oocytes revealed the presence of unichromatid chromosomes. 
This finding suggests that a certain level of maturity has to be achieved in 
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order to complete meiosis. However, if a strong parthenogenetic activation 
stimulus is used (heat or cold shock), it can activate recently ovulated oocytes, 
but this causes damage in the cytoskeletal components of the oocyte 
(Kaufman, 1983). Others have found also that early oocytes lyse rather that 
activate when exposed to single electrical pulses (Collas et al, 1989; Henery 
and Kaufman, 1993). Nevertheless, Vitullo and Ozil (1992) reported that by 
using a complex method of activation consisting of repetitive electrical 
stimulation it is possible to activate oocytes as early as 12 hours after hCG. 
They have also shown that variation of the total duration of the electrical 
pulses resulted in quite dramatic changes in the response of the oocytes. Either 
100% of the oocytes had a second polar body and one pronucleus or 95 % of 
them had a second polar body and metaphase ifi arrest. Moreover the strength 
of the stimuli was able to increase or decrease the timing of pronuclear 
formation. The female pronucleus appears between 4 to 8.5 hours after 
fertilization (Howlet and Bolton, 1985). In oocytes activated by repetitive 
electrical pulses pronuclear formation varied between 3.5 hours with the 
stronger treatment to 10 hours when the weakest treatment was used (Vitullo 
and Ozil, 1992). Similar results were obtained in experiments (Bos-Mikich et 
al, 1993) in which oocytes recovered 12 hours after hCG and activated by 
exposing them to Sr activation media in the presence or absence of 
cycloheximide (a transcription inhibitor, see section 3.5) showed both a higher 
proportion of activation and a quicker pronuclear formation in the presence of 
cycloheximide. 
It has been reported before that in amphibians (Mailer, 1985) mice 
(Siracusa et a!, 1978; Clarke and Masui, 1983), sheep (Moor and Gandolfi, 
1987) and cattle (Sirard et a!, 1989) a certain amount of protein synthesis is 
needed to maintain the metaphase II meiotic arrest, otherwise chromatin 
condensation occurs and a pronucleus-like structure appears. Recently has 
been shown by two different research groups (Colledge et a!, 1994; Hashimoto 
et a!, 1994) that c-mos proto-oncogene knockout female mice had severe 
fertility problems due to the parthenogenetic activation of their oocytes and the 
development of ovarian cysts and teratomas. This results indicate than c-mos 
(or more exactly its product Mos) is necessary for the arrest in metaphase II of 
mice oocytes. As mentioned before, Mos is an active component of the 
cytostatic factor (CSF), believed to be responsible for the maintenance of the 
meiotic arrest in metaphase U. It can be suggested that by preventing protein 
synthesis (ie by cycloheximide), Mos production is inhibited and as a 
consequence MPF is degraded, this releases the oocyte from the metaphase 
arrest and triggers the initiation of parthenogenetic development. However 
others studies reported a delay of at least six hours for chromosomes to 
decondense in the absence of MPF, suggesting the involvement of other factors 
in the process (Hashimoto and Kishimoto, 1988). This delay has been also 
reported in the cattle oocytes (Campbell, 1993) where a nuclear envelope 
break-down activity was found in oocytes where no MPF activity was 
expected. Results from separate experiments in mouse oocytes (Szollösi et al., 
1986; Choi et al., 1991) support the existence of a factor other that MPF that 
causes nuclear envelop breakdown when nuclei are transferred into cytoplasm 
where MPF activity levels are low. It seems probable that during the ageing 
process either in vivo or in vitro changes occur in the regulation of protein 
synthesis and/or post-translational (ie; phosphorylation) mechanisms that 
stabilise the arrest in metaphase II. A direct consequence of these changes may 
be a loosening of these controls and therefore an easier release from the 
metaphase arrest. 
Another observation in these experiments was the relatively high 
proportion of oocytes recovered at 18 hours after hCG that were activated as a 
result of the handling during the procedures. This was most probably due to the 
action of hyaluronidase, since the oocytes were briefly (5 mm) cultured in M2 
media supplemented with hyaluronidase to denude them of cumulus cells, and 
exposure to hyaluronidase has been reported to trigger parthenogenetic 
activation (Kaufman, 1973, 1983; Kaufman and Surani 1974). This conclusion 
is also supported by the findings in a recent experiment where a lower 
proportion (9.4 %) of oocytes recovered at 18 hours after hCG activated due to 
the handling when a shorter period in hyaluronidase was utilised (Henery and 
Kaufman, 1993). 
Culture of the oocytes in calcium free media induces parthenogenetic 
activation (Whittingham and Siracusa, 1978; Whittingham et al, 1978; 
Kaufman, 1983), and less strontium chloride is required to induce calcium 
transients in a calcium magnesium free media than in a calcium containing 
medium (Kline and Kline, 1992). Therefore, it is possible that the lack of 
calcium in the media had enhanced the activation stimulus induced by the 
"strontium" method of activation described in these experiments. Similarly it is 
necessary to recognise that the osmolarity of the activation media was higher 
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than in the culture media, and that these changes in osmolarity can induce also 
parthenogenetic activation (Kaufman, 1983). 
The ability of most of the activated oocytes to develop as 1PN 
parthenogenones confirms previous reports (O'Neill et a!, 1991) that indicate 
that the activation stimulus induced by strontium does not interfere 
significantly with the reorganisation of cytoskeletal elements during 
completion of the second meiotic division. This may confer an advantage to 
activation methods based on strontium over those based on ethanol, which 
induces a lower proportion of 1PN parthenogenones (Kwon et a!, 1991). In 
addition, activation by ethanol induces a high proportion of aneuploidy in the 
resultant parthenogenones (Kaufman, 1982, O'Neill and Kaufman, 1989), in 
contrast to strontium, which does not increase the incidence of chromosomal 
segregation errors (O'Neill et al, 1991). The data presented in this chapter 
regarding incidence of developmental pathways, proportion of activated 
oocytes developing to morula and blastocyst and the two types of blastocyst 
observed when cavitation day and cell number was taken into account 
suggested that most of the activated oocytes developed as haploid 
parthenogenones either failing to form blastocyst or developing more slowly 
(Henery and Kaufman, 1992). The observed blastocyst cell number was within 
the normal range (O'Neill et a!, 1991). 
In summary, spontaneous activation was almost non existent in oocytes 
recovered from the ovary or in those recovered very early after ovulation (14 
hours after hCG). The method of activation based on strontium established in 
the experiments related in this chapter, was able to induce activation of these 
oocytes either with or without a preincubation period in vitro. It was possible 
now to conduct experiments on nuclear transfer in which the timing of 
activation need to be strictly controlled. 
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CHAPTER 5 
DEVELOPMENT OF NEW 
PROCEDURES FOR NUCLEAR TRANSFER 
5.1 INTRODUCTION 
The source of cytoplast has a very important effect on the outcome of 
nuclear transfer experiments. Early experiments found that nuclei from mouse 
embryonic blastomeres were not able to support development after being 
transferred into enucleàted zygotes (McGrath and Solter, 1984; Robl et al., 
1986; Tsunoda et al, 1987; Kono and Tsunoda, 1988; Smith and Wilmut 1989) 
or parthenogenones (Howlett et al 1987). It was concluded that this was due to 
a loss of totipotency of the transferred nucleus and to the impossibility of 
reprogramming it by the enucleated zygote (McGrath and Solter, 1984; 
Howlett et al, 1987). Also, it was suggested that such a change in nuclear 
potential occurs during the 2-cell stage (Howlett et al, 1987). However, other 
studies suggested that some degree of nuclear totipotency is retained after the 
2-cell stage (Tsunoda et al., 1987). When oocytes were used as recipients 
development to blastocyst was reported after transfer of 8-cell nuclei (McGrath 
and Solter, 1986; Kono et al., 1991b), 1CM cells (Tsunoda et al, 1989; Kono et 
al, 1991), mouse thymocyte nuclei (Kono et a!, 1991a) and male PGC 
(Tsunoda, 1989). 
Another observation made in those experiments was that the cell-cycle 
phase of the nuclear donor blastomere affects the subsequent development of 
the embryos reconstituted by nuclear transfer (Howlet et a!, 1987; Smith and 
Wilmut, 1988; Tsunoda et al., 1989; Kono et a!, 1992). However, the 
interaction between nuclear donor cell-cycle effect, cytoplasts donor type and 
cytoplast cell-cycle was not clear as a comparison of nuclear transfer from 2-
cell embryos into cytoplast from different donors (metaphase II oocytes, 
pronuclear zygotes and pronuclear parthenogenones; see table 5.1) shows. 
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Table 5.1 - Development to blastocyst of mouse embryos reconstituted by 
nuclear transfer of nuclei from 2-cell stage embr yos*. 
Nuclear donor 
Hours after-hCG (cell-cycle phase**) 
Reference Cytoplast 
cell-cycle phase 
at fusion 30-32 34-36 	40-42 48-50 
(G1-S) (S) (G2) (G2) 
Howlett et al. 19871 G1 71 - 	 - 3 
Tsunoda et al. 19892 Me H - - 	 36 0 
Kono et al. 19923 Me II 0 1 	26 25 
Smith et al. 19884 01 2 - 	 20 20 
G1-S 12 - 	 43 30 
S 66 - 	 50 60 
* Results are presented as percentage of blastocyst over reconstituted embryos. (-) 
Indicates that no observations were made. Sendai virus induced fusion was the method 
used in the four experiments. 
** Supposed cell-cycle phase of nuclear donor and cytoplast donor was assessed 
according with Bolton et al., 1984; Howlett and Bolton 1985; Smith and Johnson, 1986 
and Pratt, 1987. 
'Oocytes recovered 17 hours post hCG (h p-hCG) were activated with ethanol (7 minutes 
in 7% ethanol in culture media; Cuthbertson, 1983). Five hours later, parthenogenones 
showing a single pronucleus and a second polar body were enucleated and used as 
cytoplasts. Nuclear transfer was conducted immediately after enucleation. 
2 Ocytes recovered 15-17 h p-hCG were enucleated and used as cytoplasts immediately. 
The reconstituted embryos were exposed to ethanol (see above) within 15 minutes of 
nuclear transfer. 
3 Preovulatory oocytes recovered 10 h p-hCG were enucleated. They were then cultured 
for 4 - 6 hours before used as cytoplast. The reconstituted embryos were exposed to 
ethanol (see above) 60 minutes after fusion. At the time of fusion the cytoplasts were 
considered to be in metaphase II (Kono etal., 1991). 
4 Zygotes recovered 16-20 h p-hCG, 20-24 h p-hCO and 24-26 h p-hCG were enucleated 
and used as cytoplasts. Nuclear transfer was carried out immediately after enucleation. 
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Data from Howlett et al., (1987) and Tsunoda et al., (1989) suggested 
that a progressive lost of totipotency happens during the 2-cell stage in the 
mouse embryo (Howlett et al. 1987). However, data conflicting with this 
conclusion were reported by Smith et al. (1988). When embryos late in the 2-
cell stage were used as nuclear donors the proportion of development to 
blastocyst increased. Similar results were reported by Kono et al., (1992) using 
as recipients enucleated metaphase II oocytes (Kono et al. 1991). Moreover, 
this nuclear donors cell cycle effect was lost when late pronuclear stage 
zygotes were used as cytoplast donors (Smith et al. 1988; Cheong and 
Kanagawa, 1993). 
There are contradictory suggestions about which would be the best 
cytoplast for nuclear transfer. Experiment with mouse embryos suggested that 
an advantage may exist in using cytoplast where MPF activity levels are low 
(Smith et al., 1988). As it has been discussed before (see section 1.4), this 
advantage may be due to preservation of nuclear envelope integrity after 
nuclear transfer and, by avoiding abnormal DNA replication, maintenance of 
normal ploidy. However, in nuclear transfer experiments conducted with rabbit 
embryos, it was found that activation of the oocyte prior to blastomere fusion 
prevented premature chromosome condensation and nuclear swelling, and 
subsequent development of the reconstituted embryos was impaired (Collas 
and Rob!, 1991). Other studies have suggested also that exposure of the 
transferred nucleus into cytoplast in metaphase II where MPF is at high levels 
is required for a better nuclear reprogramming (DiBenardino, 1989; 
DiBenardino and Hoffner Orr, 1992). 
In nuclear transfer procedures used with mammalian embryos, fusion 
of the nuclear donor (karyoplast) with cytoplast from a metaphase stage oocyte 
is accomplished by using either a electrical pulse, which also activates the 
cytoplast, or by other methods (Sendai virus, polyethylene glycol) which need 
administration of an activation stimulus to the cytoplast. This stimulus can be 
also an electrical pulse (Tsunoda et al., 1987; Kono and Tsunoda, 1988) or. 
ethanol (Howlett et a!, 1987; Kono et a!, 1991, 1992; Tsunoda et a!, 1989). 
Regardless of the method used, the transferred nucleus undergoes nuclear 
envelope break-down and premature chromosome condensation before 
remodelling. However, when zygotes or previously activated oocytes are used 
as cytoplast donors, the transferred nucleus does not undergo nuclear envelope 
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break-down and premature chromosome condensation. Moreover, the 
transferred nucleus did not swell in this situation (Barnes et al., 1987). Thus, at 
least some of the difficulty to study the hypothetical separate effects of MPF 
(nuclear envelope break-down and premature chromosome condensation) and 
remodelling on reprogramming after nuclear transfer is due to experimental 
protocols that do not separate the action of these factors. 
5.1.1 - Experimental Approaches. 
The experiments which are described in this chapter were carried out to 
establish the protocols which are required to separate out the effects of MPF 
activity and hypothetical remodelling factors present in the cytoplasm on 
reprogramming after nuclear transfer. The objective was to establish 3 different 
protocols. The first was intended to reveal the presence of any remodelling 
factor present in the cytoplasm in the absence of MPF activity. The second was 
designed to allow MPF activity to have a greater effect on chromatin 
remodelling by prolonging the period of chromosome condensation. The third 
treatment was a control based upon procedures used in other laboratories. 
If reprogramming is due to the action of a remodelling factor present in 
the cytoplasm of the oocyte, capable of introducing itself into a transferred 
nucleus with intact nuclear envelope, the use of cytoplast where MPF activity 
is not longer detected, but where remodelling factor is still present, may be 
beneficial for the subsequent development of embryos reconstituted by nuclear 
transfer. Therefore nuclei were fused into cytoplast which, theoretically, 
contained remodelling factor, but with no MPF activity, to check if 
remodelling alone is sufficient for reprogramming. These cytoplasts were 
obtained from oocytes recovered in metaphase II that were enucleated and 
activated before nuclear transfer. The rationale in this treatment was that by 
enucleating the oocyte before MPF activity declines after oocyte activation, 
sequestration of remodelling factor during female pronucleus remodelling 
would be avoided. Therefore, in this group the transferred nuclei were exposed 
to any remodelling factor present in the cytoplast, but not to the action of MPF. 
Another possibility that has been suggested (Collas and Robl, 1991), is 
that reprogramming occurs on the chromosomes of the transferred nuclei when 
it is condensed after nuclear envelope break-down and (premature) 
chromosome condensation induced by MPF present in the oocyte cytoplasm. If 
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this is the case, a longer period during which the transferred nucleus remains 
condensed and somehow exposed to reprogramming might have a beneficial 
effect on development of the reconstituted embryo. The hypothesis that 
chromatin without a nuclear envelope is more easily reprogrammed was tested 
by increasing the length of time during which the transferred nucleus remains 
in premature chromosome condensation. In this experimental group the 
transferred nucleus would be exposed to reprogramming in a condensed 
chromatin state for several hours. Oocytes enucleated in telophase I - 
metaphase H (see section 5.1.2) were used as cytoplasts where MPF activity 
was at high levels (Kono et al., 1991b). The oocytes were enucleated, nuclear 
transfer was conducted and the transferred nucleus was allowed to remain in a 
condensed stage for several hours. Then the reconstituted embryos were 
activated and their development to blastocyst recorded. 
Finally, in the control treatment, nuclei were transferred into a cytoplast 
in meiosis H that was activated 60 minutes after the nuclear transfer procedure, 
(Tsunoda et al., 1989; Kono era!, 1991b). 
The ability to support development to blastocyst was used as evidence 
of reprogramming. Two series of experiments were conducted. In the first, the 
hypothetical advantage of using enucleated, preactivated cytoplast as recipients 
was compared with controls. In the second, the possible advantage of fusing 
nuclei into non-activated cytoplasts that remains thus for several hours was 
tested. 
The experiments described in this chapter were carried out to establish 
the necessary protocols and to obtain preliminary information about the effects 
upon development of the two new protocols. During the course of these 
experiments a number of unexpected technical difficulties were found and over 
come. The results are presented in five sections . In the first (5.2) the stage of 
meiosis at the time of enucleation is recorded. In the second (5.3) experiments 
are described which investigated spontaneous activation which was observed 
during the nuclear transfer procedures. In the third section (5.4) a method is 
described to prevent fragmentation of activated enucleated oocytes. In the fifth 
section the level of MPF activity after activation is described before in the final 
section preliminary observations on the developmental potential of embryos 
produced according to the three different protocols are recorded. 
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Table 5.2- Meiotic phase at enucleation. 
Recovery 	Number 	Number 	Presence of 	Metaphase I 	Anaphase I- 	Metaphase II 





8 2 127 4 96.65 3.34 0 0 
9 11 289 265 8.84 81.02 10.13 0 
10 16 412 410 0.85 53.08 46.07 0 
14 22 643 643 0 0 99.88 0.12 
15 5 147 147 0 0 87.31 12.68 
16 5 115 115 0 0 90.71 9.29 
17 4 113 113 0 0 58.19 41.81 
18 2 37 37 0 0 49.12 50.88 
5.2 STAGE OF MEIOSIS AT ENUCLEATION. 
It is not clear how the changes in the oocyte cytoplasm during meiosis 
would influence reprogramming after nuclear transfer. Therefore it is 
necessary to know the point of their meiotic maturation at which the oocytes 
were used as recipients in these experiments. The data presented in this section 
were collected during the experiments described elsewhere in this thesis. Pre-
ovulatory oocytes were collected 8, 9 or 10 hours after hCG administration, 
whereas post-ovulatory oocytes were recovered 14, 15, 16, 17 and 18 hours 
after hCG (see 2.3.3). After recovery, cumulus-cell free oocytes were kept in 
M2 at room temperature until enucleation (see 2.4.4.1). The oocytes were 
enucleated within three hours of recovery. During the enucleation procedure, 
the chromosomes were visualised in order to check the success of each 
enucleation (see 2.4.4.3) and this opportunity was used to assess and record 
the meiotic phase of the oocyte being enucleated. These results are shown in 
table 5.2. 
When extrusion of the first polar body was assessed by bright field 
microscopy, very few (3 %) of the oocytes recovered eight hours after hCG 
administration had started the extrusion of the first polar body. However, a 
polar body was clearly visible in 91 % of oocytes recovered nine hours after 
hCG and almost all of the oocytes (99 %) recovered one hour later (10 h p-
hCG) had a polar body. 
Visualization of the chromosomes stained with Hoechst 33342 (see 
A2.7.7) by exposing them to UV light gave a more accurate picture. The 
transition from the first meiotic metaphase to the second meiotic metaphase 
started 8 h p-hCG, when only 3 % of the oocytes were at anaphase-telophase I, 
and 9 hours p-hCG when only 9 % of the oocytes remained in metaphase I. By 
10 hours after hCG 46 % of the oocytes had completed the transition and were 
arrested at the second metaphase. 
The majority (99.88 %) of oocytes recovered at 14 hours after hCG 
were at metaphase H at the time of enucleation. However, a proportion (12 % 
and 9 %, respectively) of the oocytes recovered one (15 h p-hCG) or two (16 h 
p-hCG) hours later had progressed into anaphase-telophase II by the time 
enucleation was carried out. This proportion increased to 50 % in oocytes 
recovered at 18 hours after hCG. These observations suggested the existence of 
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an activation stimulus, probably the brief exposure to hyaluronidase (O'Neill 
and Kaufman 1988), during the procedures of oocyte recovery (see 2.4.4.1). 
In later experiments the recipient cytoplasts were at one of three stages 
:i) pre-ovulatory oocytes, recovered 9 or 10 hours after hCG, that were 
finishing meiosis I (anaphase-telophase I) ii) early in meiosis II (metaphase II) 
or iii) post-ovulatory oocytes, recovered 14 to 15 hours after hCG that were 
arrested in the metaphase H. 
5.3 SPONTANEOUS ACTIVATION DURING NUCLEAR 
TRANSFER. 
In a preliminary experiment evidence was obtained that during nuclear 
transfer activation was induced in reconstructed embryos which were not 
deliberately activated by any treatment. Preovulatory oocytes were recovered 
9-10 hours after hCG administration and enucleated as soon as possible before 
cultured for 6 hours in gMl6. Two cell stage embryos were used as nuclear 
donors. The embryos were recovered 44 hours after hCG administration when 
blastomeres were at the late 2-cell stage. In a group of reconstructed embryos 
that were cultured but not deliberately activated, it was noted that 15 of 28 
embryos developed to the 2 cell stage and of these 4 become blastocysts. 
Clearly some factor or mechanism was inducing activation in an unexpected 
manner. Two experiments have been carried out to try to define the nature of 
this factor. 
5.3.1 - Effect Of Manipulations On Activation After Nuclear Transfer. 
This experiment was conducted to study the effect of manipulations 
during enucleation and nuclear transfer procedures on polar-body-like structure 
extrusion and nuclear envelope reformation after nuclear transfer. Karyoplasts 
from late 2-cell stage embryos were transferred into cytoplast of oocytes 
recovered 10 hours after hCG. The oocytes were enucleated immediately after 
recovery. The nuclear transfer was done either after an incubation period of six 
or eleven hours after enucleation. No activation method was used in this 
experiment. The extrusion of polar-body-like structures and appearance of a 
nucleus was recorded. 
It was expected that the transferred nucleus, due to the absence of 
activation of the cytoplasts (Tarkowski and Balalder, 1980; Czolowska et al., 
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1984; Sz011ösi et al., 1986), would undergo nuclear-envelope break-down and 
premature chromosome condensation and would remain with condensed 
chromosomes. However, if during the procedures involved in enucleation and 
nuclear transfer, any non-intended activation stimulus induces activation of the 
cytoplast, extrusion of polar-body-like structures (Kono ci al, 1991, 1992) and 
nuclear envelope reformation (Czolowska ci al., 1984; Sz011ösi et al., 1986) 
would be observed. 
Statistical analysis: The data consisted of a randomized block design 
with days as blocks and incubation periods as treatments. Their effect on the 
proportion of reconstituted embryos that extruded a polar-body-like structure 
and formed a pronucleus size nucleus was analysed by unbalanced analysis of 
variance. Differences between means were assessed by a Student's t test. 
5.3.1.1 - Results 
After nuclear transfer all the transferred nuclei underwent nuclear 
envelope break-down and premature chromosome condensation. Nevertheless, 
it was found that even without intentional exposure to an activation stimulus 
the reconstituted embryos extruded a polar-body-like structure and the 
transferred nucleus formed a pronucleus size nucleus. No differences were 
observed between the two groups either in the proportion of embryos that 
became activated or the timing of polar-body-like structure extrusion and 
nuclear reformation. The polar-body-like was extruded by three hours after 
nuclear transfer, and a nucleus was present by six hours after nuclear transfer 
(see table 5.3). 
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Table 5.3 - Effect of manipulations during enucleation and nuclear 
transfer procedures on polar-body-like structure extrusion 
and nuclear envelope reformation after 
nuclear transfer 
Fusion* Total 	3 fiours 	6 hours 	9 hours 
h p-enu 
PB PN 	PB PN 	PB PN 
6 36 27 0 34 25 34 34 
11 37 20 5 23 26 23 31 
* Karyoplasts from late 2-cell stage embryos were transferred into cytoplast from 
oocytes recovered 10 hours after hCG and enucleated immediately after recovery. The 
nuclear transfer was done either after an incubation period of six or eleven hours after 
enucleation (h p-enu). No activation method was used in this experiment. 
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5.3.1.2 - Discussion And Conclusions 
The results obtained in those experiments indicated that the activation 
of the cytoplast was not happening when and as intended. A non-intended 
stimulus, able to induce activation of the reconstituted embryo was detected. 
It was not clear what caused the activation. Nuclear envelope break-
down after nuclear transfer was recorded in the two groups. This observation 
and the lack of differences in the timing of polar body-like structure extrusion 
and nuclear reformation between the two groups suggested that the stimulus is 
acting during the manipulations associated with nuclear transfer procedures, 
rather than with enucleation. Nevertheless, it may be necessary to discount 
activation of the cytoplast during or as a result of enucleation due to the 
removal of MPF associated preferentially to the metaphase chromosomes of 
the oocyte (Czolowska et al, 1986). Experiments conducted to assess if the 
enucleation procedures induce activation of the cytoplast are explained in the 
next section (5.3.2). Also, the results reported here suggested that, in nuclear 
transfer experiments where the timing of parthenogenetic activation of the 
cytoplast is crucial, it may be important to include a control group of 
reconstituted embryos, not exposed to the activation stimulus used, to detect 
any non-intended activation. 
5.3.2 - The Effect Of Enucleation On Activation 
The mechanical manipulations involved in the enucleation process 
could activate the oocyte. This possibility was assessed by studying 
development of oocytes after pseudo-enucleation. Also, it is possible that a 
high proportion of MPF present in the oocyte cytoplasm was removed with the 
metaphase complex during enucleation (Czolowska et al, 1986) and, as a 
consequence, the cytoplast would be more readily activated due to 
manipulation. To check this second possibility, a method able to detect 
activation of the cytoplast in the absence of a nucleus, and therefore by other 
means than pronuclear formation and cleavage to 2-cell, was needed. Fusion to 
a karyoplast to observe nuclear envelope break-down could not be used either 
because it was important to assess separately the effect of enucleation and of 
nuclear transfer procedures on the activation of the cytoplast. Thus, assessment 
of cortical granule exocytosis or "cortical reaction" was chosen as the way to 
check if enucleation induces activation of the cytoplast. 
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Cortical granule exocytosis is part of the oocytes mechanism to prevent 
polyspermic fertilization in mammals (see Kaufman 1983; Cran and Esper, 
1990; Hoodbhoy and Talbot, 1995). It is also one of the earliest events which 
takes place in response to the activation stimulus (Kaufman, 1983). In mouse 
oocytes, the competence to undergo fertilization induced cortical reaction 
appears after metaphase I (Ducibella and Buetow, 1994) and would be present 
in the oocytes used in these experiments. Cortical granule exocytosis happens 
also after parthenogenetic activation and, although in some cases activation 
occur without cortical granular exocytosis (see Kaufman 1983), exposure to 
strontium ions induced cortical granule release in freshly ovulated oocytes 
(Fraser, 1987). This is dependent on the intracellular rise in Ca (Kline and 
Kline 1992). 
5.3.2.1 - Experimental design 
Oocytes recovered either at 10 hours p-hCG or 14 hours p-hCG were 
used in this experiment. In the first approach, oocytes were subjected to sham 
or pseudo-enucleation procedures. In these oocytes were manipulated in a 
similar way to those being enucleated, but when a portion of cytoplasm was 
removed the chromosomes were left inside the oocyte. The amount of 
cytoplasm removed in these pseudo-enucleations was approximately the same 
volume as in the actual enucleation procedures. Afterwards, the pseudo-
enucleated oocytes were incubated in gM16 and cleavage to 2-cell was 
assessed. 
In the second approach, where cortical granular exocytosis was 
determined, oocytes recovered either at 10 hours p-hCG or 14 hours p-hCG 
were enucleated and separated in two groups. When 10 hour oocytes were 
used, they were incubated in gM16 for six hours before the next step. Oocytes 
recovered after 14 hours were used immediately after enucleation. One group 
(enucleated-activated, E - A) was activated by exposure to the 'strontium' 
activation media (see chapter 4) for one hour at 37°C whereas the other 
(enucleated-non activated, E - NA) was cultured in gM16 for the same amount 
of time. In control groups non-enucleated oocytes were also included in these 
activated and non-activated groups (non enucleated-activated, NE - A; non 
enucleated-non activated, NE - NA). After one hour the oocytes were washed 
in several drops of PBS and a simple staining method based in the detection of 
fucosil- and sialyl-glycoconjugates that appear in the oocyte cellular membrane 
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shortly after sperm penetration or parthenogenetic activation (Lee et al, 1988), 
was used to detect the cortical granular release (see fig 5.1). For a detailed 
account of the methodology used see section 2.8. This release was evaluated as 
negative (-) when no fluorescence was seen (see fig. 5.2a) and as positive 
(+++) when an intense staining was detected in the oocyte cellular membrane 
(see fig 5.1 and fig 5.2c). In some cases a less intense staining was detected 
that was recorded as weak positive (+) (see fig 5.2b). 
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Figure 5.1 - Determination of cortical granular exocytosis after 
activation. 
A simple staining method based in the detection of fucosil- and sialyl-
glycoconjugates that appear in the oocyte cellular membrane shortly after sperm 
penetration or parthenogenetic activation (Lee et al, 1988), was used to detect the 
cortical granular release (see section 2.8). An intense fluorescence staining with a 
granular appearance was detected in the oocyte cellular membrane. Pictures showed 
the same oocyte in different focal planes: 
top. 
superior half 
equatorial plane. Note bright labelling of the first polar body. 

Figure 5.2 - Assessment of degree of cortical granular exocytosis after 
activation. 
A simple staining method based in the detection of fucosil- and sialyl-
glycoconjugates that appear in the oocyte cellular membrane shortly after sperm 
penetration or parthenogenetic activation (Lee et a!, 1988), was used to detect the 
cortical granular release (see section 2.8). This release was evaluate as negative (-) 
when no fluorescence was seen (a) and as positive (+++) when an intense staining 
was detected in the oocyte cellular membrane (c). In some cases a less intense staining 
was detected that was recorded as weak positive (+) (b). 

Table 5.4 - Effect of pseudo-enucleation on oocyte activation. 
h phCG* 	Replicates 	Total 	 2-cell 
10 	 2 	 22 	 0 
14 	 2 	 18 	 0 
* Oocytes recovered 10 and 14.hours p-hCG were manipulated in a similar way to 
those enucleated, but when a portion of cytoplasm was removed the chromosomes 
were left inside the oocyte. The amount of cytoplasm removed in these pseudo-
enucleations was approximately the same volume as in the actual enucleation 
procedures. 
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Table 5.5 - Effect of oocyte enucleation on cortical granules 
exocytosis. 
Group * 	Oocyte 	Total 	Cortical granules exocytosis ** 
(h p-hCG) 	 - 	+ (weak) 
NE-NA 10 35 34 1 0 
14 60 53 7 0 
E-NA 10 36 35 1 0 
14 49 45 4 0 
NE-A 10 83 1 0 82 
14 65 0 0 65 
E-A 10 59 0 0 59 
14 50 0 0 50 
* Oocytes recovered 10 and 14 hours p-hCG were enucleated and separated in two 
groups. One group (enucleated-activated, E - A) was activated by exposure to the 
'strontium' activation media whereas the other (enucleated-non activated, E - NA) was 
cultured in gM16 for the same amount of time. In control groups non-enucleated 
oocytes were also separated in these activated and non-activated groups (non 
enucleated-activated, NE - A; non enucleated-non activated, NE - NA). 
** A simple staining method (Lee et al, 1988), was used to detect the cortical granular 
exocytosis. This was evaluate as -negative (-) when no fluorescence was seen (see fig. 
5.2) and as positive (+++) when an intense staining was detected in the oocyte cellular 
membrane (see fig 5.1 and fig 5.2). In some cases a less intense staining was detected 
that was recorded as weak positive (+) (see fig 5.2). 
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5.3.2.2 - Results 
None of the oocytes subjected to sham or pseudo-enucleation 
procedures cleaved (Table 5.4). 
A clear positive cortical reaction was observed in the oocytes exposed 
to the activation media, with no difference being seen between the reaction of 
enucleated and non-enucleated oocytes. The oocytes that were enucleated but 
were not exposed to the activation media were negative for the cortical 
reaction as were also the non-enucleated, non-activated oocytes. However a 
weak positive reaction was detected in some of the non-activated oocytes (see 
fig 5.2b). The proportion of oocytes which presented this weak staining was 
higher (8-11%) in the older oocytes than in the younger ones (3%) (Table 5.5). 
5.3.2.3 - Conclusions 
These results suggested that, when the enucleation procedure was 
carried out in early oocytes, the removal of the chromosomes and the 
manipulation involved, was not enough by itself to activate the manipulated 
oocyte. None of the oocytes subjected to pseudo-enucleation cleaved which 
supported the idea that the mechanical stimuli caused by the enucleation 
procedure did not induce activation. Similarly, the enucleation procedure alone 
was not enough to trigger the cortical granular reaction. 
Therefore, it was concluded that the activation detected in the previous 
studies was not due to the enucleation procedure and that some other 
manipulation during the nuclear transfer procedure or the nuclear transfer by 
itself was inducing activation of the recipient cytoplast. 
5.4 FRAGMENTATION OF THE RECIPIENT-CYTOPLAST. 
5.4.1 - Effect Of Activation On The Enucleated Oocyte: 
After a reliable activation method based on strontium was developed 
(see section 4.5) an experiment was set up to evaluate if, by delaying fusion of 
karyoplast and cytoplast a time sufficient for the disappearance of MPF 
activity in the cytoplast, any beneficial effect would be detected on 
development to blastocyst, of the embryos reconstituted by nuclear transfer. 
Nuclei were fused into cytoplast obtained from oocytes recovered in 
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metaphase II that were enucleated and activated before nuclear transfer. 
Therefore, in this group the transferred nuclei were exposed to any remodelling 
factor present in the cytoplast, but not to the action of MPF. Whereas, in the 
control treatment, nuclei were transferred into a cytoplast in meiosis II that was 
activated 60 minutes after the nuclear transfer procedure. In this case the 
transferred nucleus will undergo nuclear envelope break-down and premature 
chromosome condensation before remodelling. 
5.4.1.2 - Experimental design 
Early 8-cell stage embryos were used as nuclear donor in this 
experiment. The karyoplasts were fused either to i) a non activated cytoplast 
which was activated after 60 minutes (group 0); ii) a cytoplast activated six to 
nine hours before (group 6 - 9) or iii) a cytoplast activated 12 to 14 hours 
before (group 12- 14). Non-enucleated oocytes were used as control group to 
assess the ability of the activation method to induce parthenogenetic activation 
in the oocytes used as cytoplast-recipient in the experimental groups. 
In preactivated oocytes (groups 6 - 9 and 12 - 14), MPF activity is 
expected to have declined by the time when fusion happens (Czolowska et a!, 
1986; Choi eta!, 1991) and the transferred nucleus will be remodelled without 
undergoing premature chromosome condensation, thus avoiding any 
detrimental effect on development after nuclear transfer associated with 
premature chromosome condensation; whereas in the control group (group 0) 
the transferred nucleus will undergo nuclear envelope break-down and 
premature chromosome condensation before remodelling. A better 
development to blastocyst in the 6 - 9 and 12 - 14 groups than in the 0 group 
was expected. The third protocol (12-14 group) was used to check if the 
cytoplast ability to support development after nuclear transfer would be 
increased, as suggested by previous nuclear transfer experiments where late 
pronuclear stage zygotes were used as cytoplast (Smith et al. 1988; Cheong 
and Kanagawa, 1993), by allowing the activated cytoplast to progress into the 
first cell cycle before conducting nuclear transfer (see section 5.1 and table 
5.1). 
5.4.1.2 - Embryos, material and methods. 
Nuclear donor embryos were collected as 4-cell embryos and were 
synchronized in mitosis by culturing them in 10 jtM nocodazole gM16 for nine 
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hours (see section 3.3.3). At the end of the synchronization period, the 
embryos were washed in gM16 and cultured at 37 °C until they divided. These 
early 8-cell stage embryos were then placed in M2 at 4°C until the time of 
nuclear transfer. 
Oocytes recovered at 9 to 10 hours after hCO administration were used 
as recipient-cytoplast . They were enucleated and incubated for a further six 
hours before nuclear transfer. Both cytoplasts and nuclear donor embryos were 
incubated in 10 .tgfml cytochalasin B gM16 at 37°C for 30 min before being 
transferred to the micromanipulation chamber. Nuclear transfer was conducted 
as described before. Fusion was induced by Sendai virus. 
The activation method used was incubation for one hour at 37°C in a 
25 mM strontium solution in calcium and magnesium free M16 (see section 
4.5). In an activation control group, non-enucleated oocytes that were exposed 
to the same activation method as the experimental groups were used each day 
to monitor the quality of activation. 
5.4.1.3 - Results 
The activation level achieved in the experiment was good, as indicated 
by the high proportion of oocytes in the activation group which developed to 
the 2-cell (97 %) and blastocyst (26 %) stages (Table 5.6). When the control 
transfer procedure was used, 66 % of the reconstituted embryos cleaved once 
and 5 % developed to blastocyst (Table 5.6). However, a major problem was 
found when the other two treatments were involved. The activated cytoplasts 
were almost all fragmented at 14 hours after activation making their use as 
recipients impossible (Table 5.6; fig 5.3). When cytoplasts activated six to nine 
hours before were used as recipients, although a lower proportion of them were 
fragmented before nuclear transfer, most of them fragmented either during or 
after the nuclear transfer procedures. Nevertheless, the reconstituted embryos 
that did not fragment cleaved to the 2-cell stage and 33 % of them developed 
to blastocyst (Table 5.6). 
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Table 5. 6 - Effect of cytoplast cell-cycle on development after 
nuclear transfer. 
Fragmentation of the enucleated activated cytoplats. 
Group * Replicates Totala N intacta % 2-ce! Nia % Bla / Nia 
0 7 110 89 66 5 
6-9 4 29 6 100 33 
12-14 	4 	- 	- 	- 	 - 
Act - co 	6 	122 	117 	97 	26 
* Early 8-cell stage embryos were used as nuclear donor. Karyoplasts were fused to 
i)non activated cytoplasts (group 0); ii) cytoplast activated six to nine hours before 
(group 6 - 9) or iii) cytoplasts activated 12 to 14 hours before (group 12 - 14). Non-
enucleated oocytes were used as control group (Act-co) to assess the ability of the 
activation method to induce parthenogenetic activation in the oocytes used as cytoplast- 
in the experimental groups. 
a Total = total number of reconstituted couplets. N intact = number of intact couplets. 
% 2-ce! Ni = percentage of 2-cell over number of intact couplets. % Bla / Ni = 
percentage of blastocyst over number of intact couplets. 
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5.4.1.4 - Discussion and conclusions 
The observed development to blastocyst when preactivated cytoplasts 
were used, although not significant at all due to the small number of embryos 
involved, did encourage further investigation into ways to avoid fragmentation 
of the cytoplast. 
Two aspects of the problem were observed. One was that it was related 
to the activation of enucleated oocytes, since this fragmentation was not 
observed either in enucleated oocytes that were incubated for up to 48 hours or 
in non enucleated oocytes that were incubated for several days (data not 
shown). The second aspect was related to the appearance of the fragments. 
They presented a relatively normal looking cytoplast (see fig 5.3). Once 
fragmented no further degeneration was observed in the next few days. 
These observations suggested that it could be related to some normal 
event occurring in the oocyte after fertilization. The most obvious one is the 
changes in microtubules that happen around six hours after fertilization and 
that are involved in the formation of the cytoskeleton and the migration of the 
pronuclei to the centre of the embryo (see Maro et al., 1986) Therefore if this 
fragmentation was either related to or mediated by microtubules an agent able 
to inhibit microtubule polymerisation might inhibit this fragmentation. It was 
decided to test this hypothesis using nocodazole (for a description of 
nocodazole activity see section 3.3). 
A second question to consider was the period of time that the oocytes 
were without a nucleus. When preovulatory oocytes were used as cytoplast 
donors an incubation period of several hours before activation was necessary to 
increase their activation rate (Kwon et a!, 1991; sections 4.4.3 and 4.5). A 
subsequent delay in transferring the nucleus would put the total time without a 
nucleus at 18 to 20 hours, more than an average cell-cycle. It was considered 
that this would be detrimental for the cytoplast. Therefore, to reduce the period 
of time that the oocytes were without a nucleus, it was decided that oocytes 
recovered 14 hours after hCO administration were to be used when protocols 
of delaying fusion were to be tested. 
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5.4.2 - Effect Of Inhibition Of Microtubule Polymerization By Nocodazole 
On Fragmentation Of The Recipient Cytoplast. 
This experiment was conducted to test the hypothesis that nocodazole, 
by inhibiting microtubule polymerization, would also inhibit the fragmentation 
observed in enucleated and activated cytoplasts. 
5.4.2.1 - Experimental design 
Oocytes were recovered .14 hours after hCG, enucleated and separated 
in three groups. The first group (enucleated-activated, EA) was activated and 
placed in gM16. The second (enucleated-non activated, ENA) was placed 
directly in gM16. The third (enucleated-activated plus noco, EA+noco) was 
enucleated activated and placed in 10 gM nocodazole gM16. Two control 
groups consisting of non-enucleated oocytes were used to assess the activation 
procedure. As before, the activation method employed was exposure to a 25 
mM strontium solution in calcium and magnesium free M16 (see chapter 4) for 
one hour at 37°C. The proportion of cytoplast and oocytes which fragmented 
was recorded 20 hours after activation. Also the proportion of oocytes in the 
control groups that developed to 2-cell stage was recorded. 
Statistical analysis: The data consisted of a randomized block design 
with days as blocks and enucleation-activation protocols and use of 
nocodazole as treatments. Their effect on the proportion of cytoplast 
fragmentation was analysed by unbalanced analysis of variance. Differences 
between means were assessed by a Student's t test. 
5.4.2.2 - Results 
Nocodazole was able to inhibit cytoplast fragmentation after activation 
(table 5.7). Twenty hours after activation, 86 % of the enucleated and activated 
oocytes were fragmented, but only 5 % of the enucleated-non activated ones. 
None of the enucleated and activated oocytes cultured in the presence of 
nocodazole had fragmented (with nocodazole vs. without nocodazole, 
p<zO.00l). The activation achieved in this experiment was relatively good; 78 
% of the oocytes in the activated control group cleaved to 2-cell and 35 % 
develop to blastocyst. A small 'spontaneous' activation was detected in the non 
activated control group where 8 % cleaved to 2-cell and 5 % developed to 
blastocyst (table 5.7). 
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Table 5.7 - Effect of inhibition of microtubule polymerization by 
nocodazole on fragmentation of the recipient cytoplast. 
Group * Replicates Total % Frag.** 	% 2-cell 13 
EA 7 60 86 	- 
ENA 6 49 5 	- 
EA+noco 7 96 0 	- 
Act co+ 7 154 1 	78 
Act co- 6 140 1.5 	8 
a Different superscripts have statistically different (p<0.001) rates of cytoplast 
fragmentation. 
* Oocytes were recovered 14 hours after hCG, enucleated and separated in three 
groups. The first group (enucleated-activated, EA) was activated and placed in 
gM16. The second (enucleated-non activated, ENA) was placed directly in gMl6. 
The third (enucleated-activated plus nocodazole, EA+noco) was activated and 
placed in 10 j.LM nocodazole gM16. Two control groups of non-enucleated oocytes 
(Act co + and Act co -) were used to assess the activation procedure (25 mM 
strontium solution in calcium and magnesium free M16 for one hour at 37 0C). 
** Proportion of cytoplast and oocytes fragmented was recorded 20 hours after 
activation. 
13 Proportion of oocytes in the control groups that developed to 2-cell stage was 
recorded. 
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5.4.2.3 - Discussion 
These results supported the idea that the fragmentation observed before 
was related to the activation of the enucleated cytoplast and that it was 
mediated, at least in part, by microtubules. The results from the activation 
control groups may help to explain both the proportion of enucleated and 
activated oocytes that remained as one cell (13 %), and the proportion of 
enucleated but non activated oocytes that fragmented (5 %). 
It was decided that to avoid fragmentation, the activated cytoplast 
would be cultured in 10 .LM nocodazole until the time for nuclear transfer. 
Nocodazole would be present also in the manipulation chamber and the 
reconstituted couplet would be placed in gMl6 plus nocodazole for one hour, 
to allow time for fusion between the karyoplast and cytoplast, before, the now 
nucleated reconstituted embryos, were washed and further cultured in gM16 to 
assess development. 
5.5 DETERMINATION OF MPF ACTIVITY AFTER 
ACTIVATION 
The aim of this experiment was to determine what was the level of 
MPF activity in the oocytes used as cytoplast in the nuclear transfer 
experiments conducted in this project. 
As has been mentioned before (see section 4.5) one of the changes that 
activation produces in the oocyte is the loss of mitosis promoting factor (MPF) 
activity. This phenomenon can be studied either by assessing the level of MPF 
activity using biochemical methods such as determination of histone Hi kinase 
activity (Choi et al, 1991; Kubiak et al, 1991), or by direct observation of the 
effect that MPF has on a nucleus transferred into cytoplast. If it is active, it 
induces nuclear envelope break-down and premature chromosome 
condensation (see fig. 5.4) (Czolowska et a!, 1986; Hashimoto and Kishimoto 
1988; Fulka et a!, 1992; Campbell et al., 1993). 
5.5.1 - Material And Methods 
To assess the level of MPF activity in the cytoplasts used as recipients, 
oocytes recovered 14 hours after hCG administration were enucleated and 
separated into two groups. One of them was activated using the 'strontium' 
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method (section 4.5) and cultured in gM16 plus 10 xM nocodazole. The other 
was cultured in gM16 plus 10 .tM nocodazole without being exposed to the 
activation media. Embryos at different stages of development (1-cell, 2-cell 
and 4-cell) were used as nuclear donors. Nuclear transfer procedures were 
carried out as described before (see 2.4.4.4) at 0, 5, 8, 12, 14, 15 and 16 hours 
after activation of the cytoplast. The reconstituted couplets were cultured at 37 
°C for 1.5 to 2 hours before being stained with Hoechst and observed under 
UV light. Only fused couplets were considered. The proportion of transferred 
nucleus which underwent chromosome condensation was recorded. 
5.5.2. Results 
Nuclear-envelope break-down and chromosome condensation were 
observed in most (92 %) of the nuclei transferred to non-activated cytoplast 
immediately after enucleation. The proportion of nuclei that underwent 
chromosome condensation remained high (94-100 %) when non-activated 
cytoplasts cultured at 37°C for several hours after enucleation were used as 
recipients (Table 5.8). However, when activated cytoplasts were used, none or 
a very low proportion of the reconstituted embryos had condensed 
chromosome between 5 and 14 hours after activation. An increase in the 
proportion of embryos with condensed chromosomes (35 %) was observed 
when nuclei were transferred into cytoplast activated 15 hours before, and 
most (78 %) of the embryos appeared with a condensed nucleus when 
cytoplast activated 16 hours before were used as recipients (Table 5.8). 
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Figure 5.4 - Effect of MPF on nuclear morphology after transfer. 
The loss of mitosis promoting factor (MPF) activity can be studied by direct 
observation of the effect that MPF has on a nucleus transferred into cytoplast where it 
is active, that is nuclear envelope break-down and premature chromosome 
condensation. 
a) and b) A reconstituted embryo showing nuclear envelope break-down and 
premature chromosome condensation of the transferred nucleus due to the MPF 
activity in the cytoplasts. 
c) and d) However, when activated cytoplasts were used, the loss of MPF activity 
was detected as the inability of the cytoplast to induce nuclear envelope break-down 
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Table 5. 8 - Effect of activation on MPF activity levels in enucleated 
cytoplast.* 
Hours after activation 
0 5 8 12 14 15 16 
Act + 	Replicates - 5 5 5 4 4 3 
Total - 18 72 25 28 34 23 
%PCC - 0 0 20 11 35 78 
Act - 	Replicates 13 2 5 5 4 4 3 
Total 79 22 45 35 30 30 17 
% PCC 92 96 95 97 100 94 98 
* Oocytes recovered 14 hours after hCG administration were enucleated and separated 
into two groups. One of them (Act+) was activated and cultured in gM16 plus 10 .tM 
nocodazole. The other (Act-) was cultured in gM16 plus 10 p.M nocodazole without 
being exposed to the activation media. Nuclear transfer procedures were carried at 0, 
5, 8, 12, 14, 15 and 16 hours after activation of the cytoplast. The reconstituted 
couplets were cultured at 37 °C for 1.5 to 2 hours before being stained with Hoechst 
and observed under UV light. Only fused couplets were considered. The proportion of 
transferred nucleus which underwent chromosome condensation was recorded. 
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5.5.3 - Conclusions 
These results suggested that the activation method used produced MPF 
inactivation in a high proportion of the enucleated oocytes. It is not clear if this 
inactivation is only temporal as approximately 15 hours after activation the 
levels of MPF increased again or if the results observed in the last two groups 
reflect a failure to activate the cytoplasts. However, the activation method used 
in this experiment consistently produced high (over 80 %) activation rates and 
the time when levels of MPF started increasing correlates well with the 
disappearance of the pronuclei observed in activated oocytes at the end of the 
first cell-cycle (tables 6.1 and 6.2). These data suggest an actual increase of the 
levels of MPF activity after 15 hours post-activation. 
In several studies, nuclear transfer was carried out in three different 
circumstances. In the first a high level of MPF activity was observed in non-
activated cytoplast and the transferred nucleus underwent chromosome 
condensation. Between five to fourteen hours after activation the level of MPF 
activity remained low, and the nuclear envelope of the transferred nucleus was 
intact. After 15 hours post-activation an increase in MPF levels induced 
nuclear-envelope break-down and chromosome condensation in a proportion 
of the reconstituted embryos. 
5.6 ABILITY OF THE RECIPIENT CYTOPLAST TO 
SUPPORT DEVELOPMENT 
After confirming that nocodazole was able to prevent fragmentation of 
enucleated and activated cytoplast, the effect of cytoplast cell-cycle phase was 
investigated by checking the ability of the cytoplast from young oocytes 
receiving a nucleus from a late 2-cell stage embryo to support development 
after nuclear transfer. Two experiments were conducted. In the first, the 
hypothetical advantage of using enucleated, preactivated cytoplast as recipients 
was investigated by comparing the development of embryos reconstituted at 
the time of activation or several hours later. Also, this experiment was used to 
check if the cytoplast, after being enucleated, activated and cultured in the 
presence of nocodazole for several hours, was still able to support 
development. In the second experiment, the possible advantage of fusing 
nuclei into non-activated cytoplasts that remain thus for several hours was 
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tested by comparing the development of embryos reconstituted before 
activation with embryos reconstituted at the time of activation. 
Late 2-cell stage embryos were selected as nuclear donors for these two 
experiments. As mentioned in the introduction (see section 5.1), they have 
been used in several experiments described in the literature and although 
earlier experiments concluded that they were too differentiated to direct 
development after nuclear transfer into enucleated zygotes or parthenogenones 
(McGrath and Softer, 1984; Howlett et a!, 1987), development to blastocyst 
(Kono et al., 1991b) and to term (Kono et al., 1991b) has been reported after 
transfer into enucleated oocytes. 
5.6.1 - Embryos, Material And Methods. 
Late 2-cell embryos were collected 44 hours after hCG administration. 
Their zona pellucida was cut (see 2.4.4.2) and they were placed in M2 at 4°C 
until nuclear transfer. Oocytes were collected at different times after hCG (see 
section 5.6.2). Both nuclear-donors and cytoplasts were incubated at 37 °C in 
cytoskeletal inhibitor (10 ig/ml cytochalasin B in gM16) for 30 min before 
nuclear transfer. Nuclear transfer procedures were carried out as described 
before (see 2.4.4.4). The reconstituted embryos were cultured in gM16 and 
development to 2-cell and blastocyst stages was recorded. 
Activation was induced by the 'strontium' activation media (section 
4.5). Each experimental day, activation control groups of non enucleated 
oocytes were used to assess the quality of the activation of the oocytes used as 
cytoplast donors in the experimental groups. 
To determine development to term, the reconstituted embryos that 
developed to blastocysts were transferred into the uterus of pseudopregnant 
mice (see 2.3.4). To keep blastocysts from each experimental treatment group 
separate, but at the same time have a good chance of establishing pregnancy, 
blastocysts recovered from MF1 mice were used as 'helpers' to increase the 
total number of blastocysts transferred into each mouse. However, no 
blastocysts recovered from MF1 mice were used as 'helpers' in the last embryo 
transfer procedure conducted in the second experiment. Mice were allowed to 
give birth and the number of pups born was recorded. 
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5.6.2 - Experimental Design: 
-6 hours 	0 hours 	12 hours 
Experiment 1 (see 5.6.2.1): 
Preactivated 	 activate 	fuse 
Control 	 fuse+activate 








5.6.2.1 - Effect of delaying karyoplast-cytoplast fusion on development. 
Oocytes recovered 14 hours after hCG were used as recipient cytoplast 
in this experiment. Two treatments were compared. Nuclei were transferred 
into i) non-activated cytoplasts that were activated immediately after nuclear 
transfer (control group ) or ii) cytoplast activated 12 to 16 hours earlier and 
cultured in 10 iM nocodazole gM16 after activation (Preactivated). Two 
activation control groups formed by reconstituted embryos, not exposed to the 
activation stimulus used, were included to detect any non-intended activation. 
In these groups the nuclei were fused to non-activated cytoplasts that were not 
expose to the activation media and to non-activated cytoplast cultured in 10 
l.i.M nocodazole gM16 for 12 to 16 hours. 
In most of the cytoplasts in the preactivated group, MPF activity would 
be low when fusion happened (Czolowska et a!, 1986; Choi et a!, 1991; table 
5.8) and the transferred nucleus would be remodelled without undergoing 
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premature chromosome condensation, thus avoiding any detrimental effect on 
development after nuclear transfer associated with premature chromosome 
condensation; whereas in the control group the transferred nucleus would 
undergo nuclear envelope break-down and premature chromosome 
condensation before remodelling. A better development to blastocyst in the 
preactivated group than in the control group was expected. Also an increase in 
the cytoplast ability to support development after nuclear transfer would occur, 
as suggested by previous nuclear transfer experiments where late pronuclear 
stage zygotes were used as cytoplast (Smith et al. 1988; Cheong and 
Kanagawa, 1993), due to the progression of the activated cytoplast into the 
first cell cycle (see section 5.1 and table 5.1). 
5.6.2.2 - Effect of delaying activation of the cytoplast on development. 
Oocytes recovered 10 hours after hCG were used as recipient cytoplast 
in this experiment in order to minimise the occurence of spontaneous 
activation. Two treatments were compared. Nuclei were transferred into i) non-
activated cytoplasts immediately after enucleation and the reconstituted 
embryos were incubated in gM16 for six hours before activation, (Prolonged 
Condensation) or ii) non-activated cytoplasts incubated in gM16 for six hours 
after enucleation and the reconstituted embryos were activated immediately 
after nuclear transfer (control group). Two activation control groups formed by 
reconstituted embryos, not exposed to the activation stimulus were included to 
detect any non-intended activation. In these groups the nuclei were fused either 
to non-activated cytoplasts immediately after enucleation or to non-activated 
cytoplasts incubated in gM16 for six hours after enucleation. 
This experiment tested the hypothesis that chromatin is more easily 
reprogrammed when it is condensed provided that no other factor intervened. 
Statistical analysis: The data consisted of a randomized block design with 
days as blocks and fusion-activation protocols as treatments. Their effect on 
the proportion of reconstituted embryos developing to the 2-cell and blastocyst 
stage was analyzed by unbalanced analysis of variance. Differences between 
means were assessed by a Student's t test. 
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5.6.3 - Results 
Development to blastocyst: In the first experiment, a beneficial effect of 
fusing karyoplast to cytoplasts activated 12 to 16 hours earlier was found 
(p<O.Ol). The proportion of reconstituted embryos that developed to blastocyst 
when recipient cytoplasts were used at the time of activation or 12 to 16 hours 
after activation was 24% and 41% respectively (see table 5.9). The activation 
level achieved in this experiment was good; as 82 % of the oocytes in the 
activated group cleaved to 2-cell and 31 % developed to blastocyst. A 3 % 
spontaneous activation was detected in the non activated group. Nuclear 
transfer procedures induced activation of the reconstituted embryo, as a 
significant difference (p<0.05) was found in the proportion that cleaved to 2-
cell between the reconstituted but non-activated embryos (5%v 35% see table 
5.9). 
In the second experiment, no differences were found, between the 
Control and Prolonged condensation groups, in the proportion of reconstituted 
embryos that developed to 2-cell or to blastocyst (see table 5.10). The 
activation level achieved in this experiment was good; as 89 % of the oocytes 
in the activated group cleaved to 2-cell and 18 % developed to blastocyst. A 
very low (1 %) spontaneous activation was detected in the non activated group. 
However, activation induced by nuclear transfer procedures on the 
reconstituted embryo was detected, as a significant difference (p<0.05) was 
found in the proportion that cleaved to 2-cell between the reconstituted but non 
activated embryos and the non activated oocytes (Act co-). Nevertheless, a 
difference in the "nuclear transfer" induced activation was detected between 
the two non-activated experimental groups (p<z0.05), which suggested that 
embryos reconstituted immediately after enucleation with cytoplast from 
oocytes recovered 10 h after hCG may be more resilient to this "nuclear 
transfer" induced activation. 
Development to term: No development to term was achieved after blastocysts 
which developed from embryos reconstituted by nuclear transfer in experiment 
1 were transferred into pseudopregnant mice (see table 5.11). Control 
blastocysts derived from F2 embryos cultured in vitro for three days did 
develop to term when transferred accompanied by "helper" MF1 blastocyst. 
From these results it was not clear if the experimental blastocysts were unable 
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to develop to term of if they were not able to compete with the supposedly 
"helping" MF1 blastocysts. 
Similar results were obtained in the first embryo transfer conducted 
with blastocyst obtained in experiment 2 (see table 5.11). Due to this 
observation and also due to the lack of differences found in the development to 
blastocyst between the two treatments of experiment 2, in the last embryo 
transfer procedure blastocysts from different treatment groups were pooled 
together to increase the numbers and avoid the use of "helpef blastocyst. In 
this last case, development to term and adulthood was achieved after 
blastocysts developed from embryos reconstituted by nuclear transfer were 
transferred into pseudopregnant mice (see table 5.11 and fig.5.5b). 
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Table 5.9 - Effect of delaying karyoplast-cytoplast fusion on 
development after nuclear transfer. 
Group* 	Activation 	Replicates Total % 2-cell % Blast 
Control 	+ 	5 47 62a 24a  
- 	3 25 35b 
Preactivated 	+ 	9 97 68ab 41C 
- 	3 32 SC Ob 
Act co 	+ 	10 207 82a 31ac  
- 	10 197 3C 
a,b,c Different superscripts have statistically different (p<z0.05) rates of development 
within each column. 
* Two treatments were compared. Nuclei were transferred into i) non-activated 
cytoplasts that were activated immediately after nuclear transfer (Control group) or ii) 
cytoplast activated 12 to 16 hours earlier and cultured in 10 p.M nocodazole gMl6 after 
activation (Preactivated). Two control groups formed by reconstituted embryos, not 
exposed to the activation stimulus used, were included to detect any non-intended 
activation. Activation control groups of non enucleated oocytes (Act co + and -) were 
used to assess the quality of the activation in the oocytes used as.--recipient 
in the experimental groups. 
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Table 5.10 - Effect of delaying activation of the cytoplast on 
development after nuclear transfer. 
Group * 	Activation Replicates 	Total 	% 2-cell 	% Blast 
Prolonged 	+ 6 53 73a 43 
Condensation 
- 6 46 30b 9b 
Control 	+ 5 46 83a 27a 
- 6 38 74a 29 
Act co 	+ 6 107 89a 18b 
- 6 90 
a,b,c Different superscripts have statistically different (p<0.05) rates of development 
within each column. 
* Two treatments were compared. Nuclei were transferred into i) non-activated 
cytoplasts immediately after enucleation and the reconstituted embryos were incubated 
in gM16 for six hours before activation, (Prolonged Condensation) or ii) non-activated 
cytoplasts incubated in gM16 for six hours after enucleation and the reconstituted 
embryos were activated immediately after nuclear transfer (Control group). Two 
control groups formed by reconstituted embryos, non exposed to the activation 
stimulus used were include to detect any non-intended activation. Activation control 
groups of non enucleated oocytes (Act co + and -) were used to assess the quality of 
activation in the oocytes used as .. ?_--..,,: ..recipient 
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Table 5.11 - Effect on development to term of cytoplast cell-cycle 
phase ability to support development after nuclear transfer. 
Total embryos transferredt 
Group * 	 Pregnancies 
NT Culture MF1 	/transfer 
Total offspring 
NT Culture MF1 Total 
Effect of delayed fusion 
Control 	5 	- 	22 	2/3 	0 	- 	7 	7 
Preactivated 	8 	- 10 1/2 0 	- 	 3 	3 
Culture 	- 	 26 26 3/4 - 	 5 	6 	11 
Effect of delayed activation 
Prolonged 	11 	- 14 2/3 0 	- 	 6 	6 
Condensation 
Control 	5 	- 6 0/1 - 	 - 	 - 	 - 
pooled 	17 	- 0 1/2 2 	- 	 - 	 2 
* Effect of delayed fusion: nuclei were transferred into i) non-activated cytoplasts that 
were activated immediately after nuclear transfer (Control) or ii) cytoplast activated 12 
to 16 hours earlier and cultured in 10 iM nocodazole gM16 after activation 
(Preactivated). 
Effect of delayed activation: nuclei were transferred into i) non-activated cytoplasts 
immediately after enucleation and the reconstituted embryos were incubated in gMl6 
for six hours before activation, (Prologed condensation) or ii) non-activated cytoplasts 
incubated in gM16 for six hours after enucleation and the reconstituted embryos were 
activated immediately after nuclear transfer ( Control). 
t NT: blastocyst from embryos reconstituted by nuclear transfer. Culture: control 
blastocysts derived from F2 embryos cultured in vitro for three days . MF 1: 
blastocysts recovered from MF1 mice used as "helpers". 
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Figure 5.5 - Development to term after nuclear transfer. 
Development to term achieved by an embryo reconstituted after transfer of an early 
Gi-phase 4-cell stage nucleus into an metaphase II stage cytoplasts (see section 6.3.1 
for details). 
Development to adulthood achieved by an embryo reconstituted after transfer of an 
late 2-cell stage nucleus into a cytoplasts in metaphase II (see section 5.6 for details). 
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5.6.4 - Discussion 
The experiment described in this chapter have established three 
different approaches to nuclear transfer and provided preliminary information 
on the effects upon development. Live young were obtained from a small 
number of embryos. A number of technical difficulties were identified and 
overcome in establishing the procedures. In addition, MPF activity in different 
cytoplasts has been measured. 
When cytoplast from 14 h oocytes was activated, MPF activity levels 
fell and remained low from 5 to 14 hours after activation, after which they 
started to rise again (see section 5.5). Another phenomenon occurring after 
activation was the fragmentation of the cytoplast. Although it is not clear how 
or why this happens, it appears to be mediated by the microtubules, since 
culture of activated cytoplast with inhibitors of microtubules polymerization 
(nocodazole) inhibits fragmentation (see section 5.4). Such treatment had no 
apparent damaging effect upon the ability of the recipient cytoplast to support 
development to blastocyst when nuclei from late 2-cell stage embryos were 
transferred into cytoplasts treated in this way. 
The proportion of reconstituted embryos that developed to blastocyst 
when the control treatment was used was similar to that reported in the 
literature (Kono et al., 1991b; 1992; Cheong et al., 1993). Delaying fusion of 
karyoplast to activated cytoplast appeared to have a beneficial effect on the 
development to blastocyst of the reconstituted embryos (p<zO.Ol). It is not clear 
if this was due to the fact that in most of the embryos in the preactivated group 
the transfered nucleus was reprogramed without undergoing changes 
associated with induction of DNA replication at an inappropriate time of the 
nuclear cycle or if the observed improvement was induced by the progression 
of the activated cytoplast well into the first cell cycle prior to nuclear transfer, 
as suggested by previous nuclear transfer experiments (Smith et al. 1988; 
Cheong and Kanagawa, 1993; see section 5.1 and table 5.1). The effect of this 
delayed fusion on the ability of the reconstituted embryos to develop to term is 
not known. More experiments in which the ability to develop to term of 
blastocyst produced using these treatments is assessed may be necessary. 
No significant effect of delaying activation was found in those 
experiments, which suggested that chromatin is not more easily reprogrammed 
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when it is condensed. However, the results suggest a mild beneficial effect of 
fusing nuclei from late 2-cell stage embryos to non-activated cytoplasts and 
culturing them for six hours before activating them. Unfortunately, 
interpretation of these results is complicated by the "nuclear transfer" induced 
activation observed in these experiments. 
Recent studies (Kono et al., 1994) have confirmed that the "nuclear 
transfer" induced activation is due to the introduction of a nucleus from a 
fertilized embryo into the non activated cytoplast. It has been suggested that 
this activation is induced by an activation factor introduced by the sperm into 
the oocyte cytoplast that is present in the cytoplast of fertilized embryos up to 
the 4-cell stage (Kono et al., 1994). This "nuclear transfer" induced activation 
may have heavily influenced the outcome of some experiments, probably 
undoing most of the difference between the group activated immediately after 
nuclear transfer with the one activated six hours later. One way to overcome 
this problem may be to use younger oocytes that would be more resilient to 
activation. 
When embryos reconstituted with cytoplast from oocytes recovered 10 
hours alter hCG were transferred into pseudopregnant mouse, development to 
term and normal adulthood was achieved, confirming reports that nuclei from 
late 2-cell stage embryos are able to support development after transfer into 
oocyte cytoplasts. 
In conclusion, during the experiments reported in this chapter, nuclear 
transfer procedures that will allow the study of the effect of interactions 
between donor blastomere and recipient cytoplast cell-cycle phases were 
established. Therefore, the experiments described in the next chapter were 
conducted with this aim. 
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CHAPTER 6 
EFFECT OF INTERACTION BETWEEN 
DONOR BLASTOMERE 
AND RECIPIENT CYTOPLAST 
CELL-CYCLE PHASE 
ON DEVELOPMENT 
AFTER NUCLEAR TRANSFER 
6.1 INTRODUCTION 
The objective of the experiments described in this final chapter was to 
begin to separate from other factors, the effects upon development after 
nuclear transfer of possible errors in ploidy caused by abnormal DNA 
replication. By using several different approaches to nuclear transfer one 
important objective was to assess development to blastocyst with different 
combinations of cell cycle phases, several of which were expected to maintain 
normal DNA replication. In order to carry out such an analysis it was essential 
to have oocytes and donor cells at specific cell cycle phases. These were 
defined by preliminary observations (see section 6.2). 
Also (see section 5.1 and table 5.1), earlier experiments found that the 
cell-cycle phase of the nuclear donor embryo affected the subsequent 
development of the embryos reconstituted by nuclear transfer (Howlet et al, 
1987; Smith et al, 1988; Tsunoda et a!, 1989; Kono et a!, 1991b). However, 
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that effect was no longer detected when late pronuclear stage zygotes were 
used as cytoplast donors (Smith et al, 1988). More recently, increased 
development after nuclear transfer was reported when nuclei in Gi were 
transferred to enucleated meiosis II oocytes in both rabbit (Collas et al, 1992a) 
and mouse (Cheong et a!, 1993). In this last paper development to term of 
embryos reconstituted with nuclei in Gi from 4-cell and 8-cell stage mouse 
embryos was reported. 
Embryos at the 4-cell stage were selected as nuclear donors for most of 
the experiments described in this chapter. During this stage there are no major 
changes in gene expression, of the same scale as those seen at the 2-cell and 8-
cell stages. Nor is there evidence of cell commitment and differentiation as 
seen at the 8-cell and 16-cell stages. It was judged that such changes in the 
nature of the cells would interfere with the interpretation of the results. In one 
of the experiments 8-cell stage embryos were used as nuclear donors to 
confirm that the observed results were due to changes in cell-cycle and not to 
advances in development. 
Recently ovulated oocytes (14 to 15 hours after hCG administration) 
were used as cytoplasts in most of the experiments. In the last experiment, 
zygotes were used to assess their ability to reprogram the transferred nucleus. 
The techniques and procedures used during these experiments are explained in 
detail in chapter 2. 
It was not possible. to carry out all of the treatments on the same day. 
When possible, different treatments were applied on every day, according to a 
specific pattern. In a few cases, which are indicated, no comparisons within a 
day were practicable. 
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6.2 MAPPING CELL -CYCLE EVENTS 
Prior to the nuclear transfer experiments progression through the cell-
cycle of the oocytes and embryos used as cytoplast and nuclei donors was 
determined under the culture conditions used in these experiments. 
6.2.1 - The Oocyte: Pronuclear Formation, DNA Synthesis and First 
Mitosis 
Non-enucleated oocytes were used to determine when pronuclear 
formation, start of DNA synthesis and cleavage to 2-cell occurred after 
activation. This information was then used to decide the time after activation at 
which enucleated oocytes would be used as recipients. 
6.2.1.1 - Embryos, material and methods 
Oocytes were recovered 14 to 15 hours after hCG administration, 
activated with "strontium" (section 4.5) and cultured in pM 16. The start of the 
60 minutes activation period was considered as time zero. 
Oocytes exposed to "strontium" activation were examined every hour 
to assess pronuclear formation and cleavage into 2-cell stage. Presence of a 
pronucleus visible under DIC microscopy and number of 2-cell 
parthenogenones was recorded. To determine BrdU incorporation, 
parthenogenones were continuously labelled by culturing them in 100 .tM 
BrdU in pM16 after activation. The parthenogenones were then fixed every 
hour and DNA synthesis was determined by immuno-detection of BrdU 
incorporation as described before (sections 2.6 and 3.4.1). 
6.2.1.2 - Results 
Five hours after activation one or two pronuclei were visible in 80 % of 
the oocytes (Table 6.1). The proportion of oocytes with pronuclei remained 
high (80-90 %) until approximately 12 hours after activation when it started to 
decrease (Table 6.1) suggesting that by this time some of the activated oocytes 
had started to enter mitosis. First 2-cell stage parthenogenones were detected 
16 hours after activation (Table 6.2). Nineteen hours after activation over 70 % 
of the oocytes exposed to the activation media had cleaved once (Table 6.2). 
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Table 6.1 - Presence of pronuclei and first mitosis after activation 
induced by strontium medium * 
Hours 	N° replicates 	NO oocytes 	PN visible 
post-activation (%) 
1 1 12 0 
2 1 12 12 
3 1 12 12 
4 1 12 50 
5 4 40 81 
6 4 44 79 
7 6 87 87 
8 5 54 83 
9 3 33 85 
10 1 12 92 
11 2 24 96 
12 5 89 78 
13 4 65 72 
14 4 60 69 
15 3 56 32 
16 3 49 5 
* Non-enucleated oocytes were used to determine when pronuclear formation 
occurred after activation. Oocytes recovered 14 to 15 hours after hCG administration 
were activated by exposing them to 25 mM Sr' in calcium-magnesium free M16 for 
60 minutes and were then cultured in pM16. The start of the 60 minutes activation 
period was considered as time zero. Oocytes were examined every hour to assess 




Table 6.2 - Cleavage to 2-cell after activation induced 
by strontium medium * 
Hours 	N° replicates 	N°oocytes 	2-cell 
post-activation (%) 
16 5 119 32 
17 6 200 64 
18 4 48 75 
19 8 225 71 
* Non-enucleated oocytes were used to determine when cleavage into 2-cell 
stage occurred after activation. Oocytes recovered 14 to 15 hours after hCG 
administration were activated by exposing them to 25 mM Sr' in calcium-magnesium 
free M16 for 60 minutes and were then cultured in pMl6. The start of the 60 minutes 
activation period was considered as time zero. Oocytes were examined every hour to 
assess cleavage into 2-cell stage. Number of 2-cell parthenogenones was recorded. 
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Figure 6.1 - Immuno-detection of bromodeoxyuridine (BrdU) 
incorporation by parthenogenones after activation induced by 
strontium. 
Parthenogenones were continuously labelled by culturing then in 100 p.M 
bromodeoxyuridine (BrdU) in pM16 after activation. At the end of the treatment the 
parthenogenones were fixed and DNA synthesis was determined by immuno-detection 
of BrdU incorporation (sections 2.6 and 3.4.1): (-) no incorporation detected; (+, -i-+, 
+-i-+) different degrees, from less to more intense, of BrdU incorporation. 
In this figure an oocyte that showed no incorporation of BrdU (-). Note non 
specific staining in the cytoplasm. 
A 2PN parthenogenone showing BrdU incorporation (+) in both pronuclei. 
A 1PN+1PB parthenogenone showing BrdU incorporation (++) in both pronucleus 
and second polar body. 

Table 6.3 - Initiation of bromo deoxyuridine (BrdU) incorporation by 
the oocytes after activation induced by strontium medium * 
Hours 	N° replicates 	NO oocytes 	BrdU +ve 
post-activation 	 (%) ** 
5 3 30 4 
6 6 49 39 
7 6 55 56 
8 6 54 65 
9 6 54 78 
10 4 37 73 
11 4 43 77 
12 3 30 87 
13 4 41 85 
14 3 29 91 
* Non-enucleated oocytes were used to determine when start of DNA 
synthesis, detected by BrdU incorporation, occurred after activation. Oocytes 
recovered 14 to 15 hours after hCG administration were activated by exposing them to 
25 mM Sr in calcium-magnesium free M16 for 60 minutes. The start of the 60 
minutes activation period was considered as time zero. To determine BrdU 
incorporation, parthenogenones were continuously labelled by culturing them in 100 
iM BrdU in pM16 after activation. The parthenogenones were then fixed every hour 
and DNA synthesis was determined by immuno-detection of BrdU incorporation as 
described before (sections 2.6 and 3.4.1). 
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Figure 6.2 - Mapping cell-cycle events after parthenogenetic activation 
of oocytes with strontium. 
Non enucleated oocytes were used to determine when pronuclear formation, 
start of DNA synthesis and cleavage to 2-cell occurred after activation. Oocytes 
activated with strontium entered G1-phase 4 to 5 hours after activation, S-phase was 
initiated 6 to 8 hours after activation and mitosis to the 2-cell stage started 15 to 16 
hours after activation. On the basis of the above data, it was decided to use non-
activated cytoplasts as metaphase H recipients, cytoplast activated between 6 up to 8 
hours previously as "early S-phase" recipients and cytoplast activated from 12 up to 
16 hours before as "late S-G2 phase" recipients. 
PN visible (%): percentage of parthenogenones showing one or two pronuclei. 
BrdU +ve (%): percentage of parthenogenones showing BrdU incorporation. 
Cleavage into 2-cell: percentage of parthenogenones at the 2-cell stage. 
DNA synthesis as determined by BrdU incorporation was detected in 
some oocytes six hours after activation (Table 6.3). At nine hours after 
activation 78 % of the oocytes showed BrdU incorporation (Table 6.3). This 
corresponded well with the proportion of oocytes in which a pronucleus was 
visible (Table 6.1), suggesting that most of the activated oocytes had entered 
S-phase by this time. Over 90% of the oocytes had incorporated BrdU by 14 
hours after activation (Table 6.3). BrdU incorporation was detected in the 
pronucleus and polar body in 1PN 1PB pathway type activation (see fig. 6.1c) 
and in both pronuclei in 2 PN pathway type activation parthenogenones (see 
fig 6.lb). 
6.2.1.3 - Discussion 
The results obtained indicated that oocytes activated with strontium 
entered Gi-phase 4 to 5 hours after activation, S-phase was initiated 6 to 8 
hours after activation and mitosis to the 2-cell stage started 15 to 16 hours after 
activation. On the basis of the above data, it was decided to use non-activated 
cytoplasts as metaphase II recipients, cytoplast activated between 6 up to 8 
hours previously as "early S-phase" recipients and cytoplast activated from 12 
up to 16 hours before as "late S-G2 phase" recipients (see fig. 6.2). 
These results correlate well with measurements of MPF activity of 
enucleated and activated cytoplast described before (see section 5.5), in which 
low levels of MPF activity, assessed by induction of nuclear envelope break-
down in transferred nuclei, were detected between 5 to 14 hours after 
activation. Activated oocytes had a visible pronucleus during this period 
(Table 6.1). However pronuclei were present in few oocytes 16 hours after 
activation (Table 6.1). Similarly higher levels of MPF activity were detected in 
enucleated and activated cytoplast 16 hours after activation (Table 5.8). This 
suggested that, in the enucleated cytoplast, MPF levels may be regulated at a 
cytoplasmatic level, probably by maternal RNA mediated cyclin synthesis. 
The results obtained in these experiments agreed with observations 
made using ethanol activated mouse oocytes which reported an early start of 
DNA replication in parthenogenones. Thus, DNA synthesis was detected in 
ethanol activated mouse oocytes from 4.5 to 9.5 hours after activation (Dyban 
et a!,. 1993). However, it appears that activated oocytes progress slightly more 
rapidly than mouse zygotes during the first cell-cycle. Studies on the first cell- 
cycle of mouse zygotes reported start of pronuclear formation varying from 2 
to 4 hours (Luthardt and Donahue, 1973) or between 4 to 9 hours after 
insemination (Krishna and Generoso, 1977; Howlett and Bolton, 1985). The 
beginning of DNA replication was detected 7 to 9 hours after sperm 
penetration (Luthardt and Donahue, 1973) and its duration was estimated to be 
4 hours (Luthardt and Donahue, 1973). Others reported DNA replication from 
8 to 14 hours (Krishna and Generoso, 1977) or 11 to 18 hours after 
insemination (Howlett and Bolton, 1985). First cleavage was observed 16 to 19 
hours (Krishna and Generoso, 1977) and 18 to 22 hours (Howlett and Bolton, 
1985) after insemination. 
6.2.2 - The Nuclear Donor Embryo: Completion of Mitosis, DNA 
Synthesis and Next Mitosis: 
6.2.2.1 - After synchronization of 2-cell stage embryos with colcemid 
The aim of this experiment was to determine the timing of events at the 
4-cell stage (completion of mitosis and therefore initiation of the Gi phase, 
initiation and end of the DNA synthesis (S-phase) and initiation of cleavage to 
the next stage) in relation to the time of release from the colcemid 
synchronization media of 2-cell embryos synchronized in mitosis. 
6.2.2.1.1 - Embryos, material and methods. 
Late 2-cell embryos were collected 44 hours after hCG administration 
and synchronized in mitosis with colcemid (see section 3.3.3 for details). Once 
the embryos were released from the synchronization media, progression 
through anaphase and telophase and completion of mitosis was monitored 
every 15 minutes. Nuclear morphology was monitored either by differential 
interference contrast (DIC) microscopy or by examination of Hoechst stained 
embryos under UV microscopy. Initiation of DNA synthesis was assessed by 
continuous labelling with BrdU after release from the synchronization media. 
Embryos were fixed every 15 minutes, starting at the completion of mitosis, 
and the degree of BrdU incorporation was determined and scored as described 
previously (see sections 2.6 and 3.4.1). Completion of DNA synthesis was 
assessed by pulse labelling groups of embryos by culturing them in 100 AM 
BrdU in pM16 for two hours, every half an hour. The end of the labelling 
period was recorded as reference. Initiation of cleavage to the 8-cell stage was 
assessed by counting the number of blastomeres in each embryo. Time zero 
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was considered the moment at which the embryos were released from the 
colcemid synchronization media. 
6.2.2.1.2 - Results 
Mitosis was completed by approximately 120 minutes after removal 
from colcemid (Table 6.4). BrdU incorporation started at 180 minutes and all 
of the embryos were into S-phase by 210 minutes (Table 6.5; fig 6.3b). 
However a clear end of the S-phase was not detected. At 720 minutes, when 16 
% of the embryos had more than four blastomeres, it was possible to detect 
BrdU incorporation in 75 % of the nuclei of four cell stage embryos (Tables 
6.6 and 6.7; fig 6.3c). 
6.2.2.1.3 - Discussion 
These results indicated the start of the Gi-phase 120 minutes after 
release of the embryos from the colcemid synchronization media. The embryos 
recovered well from the mitotic arrest since BrdU incorporation was observed 
in all embryos by 210 minutes after their release. A minimum period of 45 
minutes incubation was required before incorporation of BrdU during DNA 
synthesis was detected when 4-cell and 8-cell embryos in S-phase were 
transferred to medium containing BrdU (Otaegui, data not presented). 
Therefore these observations suggested a Gl-phase of no more than 45 
minutes. It was not possible to clearly determine the end of S-phase in the 
population of embryos studied. This impossibility was due to the asynchrony 
in completion of DNA replication detected within the blastomeres of the 
embryos (see fig 6.3c), that made it very difficult to be completely sure of the 
cell-cycle phase of each blastomere in embryos finishing the 4-cell stage. 
Nevertheless, by 810 minutes after release over 70% of the embryos had 
entered mitosis. 
These findings are in disagreement with reported values of 1 to 1.5 
hours for Gi-phase at the 4-cell stage (see Smith and Johnson, 1986). Also, the 
present results suggested a slightly longer duration of S-phase (8 hours) than 
has been reported previously (7 hours, see Smith and Johnson, 1986). 
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Table 6.4 - Completion of mitosis from 2-cell into 4-cell stage after 
synchronization of 2-cell stage mouse embryos 
in mitosis with colcemid (O.lp.gImI, 4 hours). 
mnea Number Number Number mt 2-cell Mitosis mt 4-cell 
replicates embryos nuclei (%)b (%)C (%)d 
45 3 23 46 17 83 0 
60 6 44 89 8 90 2 
75 6 46 92 4 96 0 
90 6 43 101 5 85 10 
105 5 34 101 1 78 21 
120 6 40 139 0 10 90 
135 6 41 155 1 9 90 
150 5 35 138 1 0 99 
165 4 29 113 1 1 97 
* Once the embryos were released from the synchronization media, progression 
through anaphase and telophase and completion of mitosis was monitored every 15 
minutes. Nuclear morphology was monitored either by differential interference 
contrast (DIC) microscopy or by examination of Hoechst stained embryos under UV 
microscopy. Time zero was considered the moment at which the embryos were 
released from the colcemid synchronization media. 
a Minutes after release from colcemid (0.1 tg/ml). 
b Percentage of inierphase nuclei in the 2-cell stage. 
c Percentage of nuclei in mitosis. 
d Percentage of interphase nuclei in the 4-cell stage. 
Figure 6.3 - Immuno-detection of bromodeoxyuridine (BrdU) 
incorporation by the 4-cell stage embryos. 
Initiation of DNA synthesis was assessed by continuous labelling with BrdU 
after release from the synchronization media. To determine initiation of BrdU 
incorporation, embryos were continuously labelled by culturing then in 100 tM 
bromodeoxyuridine (BrdU) in pM16 after release of 2-cell embryos synchronized in 
mitosis. Embryos were fixed every 15 minutes, starting at the completion of mitosis. 
To determine completion of DNA synthesis, BrdU incorporation was assessed by 
pulse labelling groups of embryos by culturing them in 100 tM BrdU in pM16 for 
two hours, every half an hour. At the end of the labelling period, embryos were fixed 
and DNA synthesis was determined by immuno-detection of BrdU incorporation as 
described before (sections 2.6 and 3.4.1): (-) no incorporation detected; (+, ++, +1 1 ) 
different degrees, from less to more intense, of BrdU incorporation. Time zero was 
considered the moment at which the embryos were released from the colcemid 
synchronization media. 
In this figure a 4-cell stage embryo that showed no incorporation of BrdU (-). Note 
non specific staining in the cytoplasm. 
A 4-cell stage embryo showing strong BrdU incorporation (++-i-) in its 4 nuclei. 
A 4-cell stage embryo showing weak BrdU incorporation (+) in 2 nuclei at the end 
of the S-phase. 
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Table 6.5 - Initiation of bromo deoxyuridine (BrdU) incorporation in 
resulted 4-cell stage embryos after synchronization of 2-cell stage 
mouse embryos in mitosis with colcemid (O.ljtglml, 4 hours). 
Time 	N°replicates 	N° embryos 	BrdU +ve 
120 2 19 0 
135 3 25 0 
150 3 32 0 
165 3 24 7 
180 3 28 21 
195 2 16 62 
210 2 14 100 
225 3 28 100 
270 1 9 100 
285 2 14 100 
* To determine initiation of BrdU incorporation, embryos were continuously labelled 
by culturing them in 100 mM BrdU in pM16 after release from the colcemid 
synchronization media (see section 3.3.3). Embryos were fixed every 15 minutes, 
starting at the completion of mitosis, and DNA synthesis was determined by immuno-
detection of BrdU incorporation as described before (sections 2.6 and 3.4.1). Time 
zero was considered the moment at which the embryos were released from the 
colcemid synchronization media. 
** Minutes after release from colcemid (0. lp.g/ml). 
BrdU +ve (%): percentage of 4-cell stage embryos showing BrdU incorporation. 
Table 6.6 - End of bromo deoxyuridine (BrdU) incorporation in 
resulted 4-cell stage embryos after synchronization of 2-cell stage 
mouse embryos in mitosis with colcemid (O.lp.g/ml, 4 hours). 
Time** Number Number BrdU +ve (%)*** 
replicates embryos 
+ ++ 	+++ total 
630 3 38.. 0 12 	85 97 
660 2 20 0 0 	89 89 
690 3 36 0 0 	75 75 
720 2 18 0 20 	55 75 
750 3 26 0 37 	40 77 
780 2 14 0 29 14 43 
810 3 14 33 20 0 53 
* To determine completion of DNA synthesis, BrdU incorporation was assessed by 
pulse labelling groups of embryos by culturing them in 100 mM BrdU in pM16 for 
two hours, every half an hour. At the end of the labelling period, embryos were fixed 
and DNA synthesis was determined by immune-detection of BrdU incorporation as 
described before (sections 2.6 and 3.4.1). Time zero was considered the moment at 
which the embryos were released from the colcemid synchronization media. 
** Minutes after release from colcemid (0.lp.g/ml). The end of the labelling period 
was recorded as reference. 
BrdU +ve (%): percentage of 4-cell stage embryos showing different degrees (+, 
++, +++), from less to more intense, of BrdU incorporation. 
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Table 6.7 - Completion of mitosis from 4-cell to 8-cell stage after 
synchronization of 2-cell stage mouse embryos 















660 1 10 90 0 10 0 0 
690 3 35 97 3 0 0 0 
720 7 96 84 8 6 1 0 
750 5 64 70 12 15 4 0 
780 3 30 64 3 19 7 3 
810 3 52 29 22 19 9 18 
* Initiation of cleavage to the 8-cell stage was assessed by counting the number of 
blastomeres in each embryo using differential interference contrast (DIC) microscopy. 
Completion of mitosis from 4-cell to 8-cell stage was monitored every 30 minutes. 
Time zero was considered the moment at which the embryos were released from the 
colcemid synchronization media. 
a Minutes after release from colcemid (0.1 jig/ml). 
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Figure 6.4 Mapping cell-cycle events after synchronization in mitosis of 2-cell stage embryos with colcemid. 
The timing of completion of mitosis, initiation and end of the DNA synthesis (S-phase) at the 4-cell stage and cleavage to 8-cell stage in 
relation to the time of release from the colceniid synchronization media of 4-cell embryos synchronized in mitosis is shown in the graph 
above. Embryos between 120 and 160 minutes were used as donors of 01-phase 4-cell stage nuclei, embryos between 200 and 260 
minutes as donors of early S phase nuclei and embryos between 700 and 800 minutes as donors of a undetermined mixture of late S-
phase 02-phase nuclei in nuclear transfer experiments described in this chapter. 
Table 6.8 - Initiation of bromo deoxyuridine (BrdU) incorporation in resulted 8- 
cell stage embryos after synchronization of 4-cell stage mouse embryos in 
mitosis with nocodazole (10 tiM, 9 hours)*. 
Time** 	 Number 	Number total 	BrdU +ve 
	
replicates embryos (%)*** 
120 3 24 12 
150 4 33 90 
180 4 30 100 
210 4 28 100 
240 4 30 100 
270 	 4 	 31 	 100 
* To determine initiation of BrdU incorporation, embryos were continuously 
labelled by culturing them in 100 mM BrdU in pM16 after release from the 
nocodazole synchronization media (see section 3.3.3). Embryos were fixed every 30 
minutes, starting at the completion of mitosis, and DNA synthesis was determined 
by immuno-detection of BrdU incorporation as described before (sections 2.6 and 
3.4.1). Time zero was considered the moment at which the embryos were released 
from the nocodazole synchronization media. 
** Minutes after release from nocodazole (10 jiM). 
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Figure 6.5 - Mapping cell-cycle events after synchronization in mitosis 
of 4-cell stage embryos with nocodazole. 
The timing of completion of mitosis and therefore initiation of the Gi-phase, 
and initiation of the DNA synthesis (S-phase) at the 8-cell stage in relation to the time 
of release from the nocodazole synchronization media of 4-cell embryos synchronized 
in mitosis is shown in the graph above. Embryos between 75 and 90 minutes were 
used as donors of GI phase 8-cell stage nuclei and embryos after 195 minutes as 
donors of S phase 8-cell stage nuclei in the nuclear transfer experiment described in 
section 6.3.2. 
Mitotic nuclei (%) - Percentage of observed nuclei in mitosis 
BrdU +ve (%): percentage of 8-cell stage embryos showing BrdU incorporation. 
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In conclusion, it was decided to use embryos between 120 and 140 
minutes after release as donors of Gi phase nuclei, embryos between 200 and 
260 minutes as donors of early S phase nuclei and embryos between 700 and 
800 minutes as donors of an undetermined mixture of late S-phase G2-phase 
nuclei (see fig 6.4). 
6.2.2.2 - After synchronization of 4-cell stage embryos with nocodazole 
The aim of this experiment was to determine the timing of initiation of 
the DNA synthesis (S-phase) at the 8-cell stage, in relation to the time of 
release from the nocodazole synchronization media of 4-cell embryos 
synchronized in mitosis. Completion of mitosis and therefore initiation of the 
Gi phase has been determined in a previous experiment (see section 3.3.2.1.2). 
6.2.2.2.1 - Embryos, material and methods 
Late 2-cell embryos were collected 44 hours after hCG administration 
cultured in pM16 for 14 hours and synchronized in mitosis with nocodazole 
(see section 3.3.3 for details). The methods and criteria used have been 
explained in the section above (6.2.2.1). 
6.2.2.2.2 - Results 
BrdU incorporation into the nuclei was observed in all embryos within 
180 minutes after release from nocodazole (Table 6.8). 
6.2.2.2.3 - Discussion and conclusions 
The results obtained in this and a previously described experiment (see 
section 3.3.2.1.2) suggested that 4-cell embryos synchronized in mitosis 
entered Gi-phase 60 to 90 minutes after release from the synchronization 
media. Mitosis was completed by 37 % of the blastomeres 60 minutes after 
release and by all of them by 90 minutes (Table 3.6). Also, taking into 
consideration that a minimum period of 45 minutes incubation was required 
before incorporation of BrdU during DNA synthesis was detected when 8-cell 
embryos in S-phase were transferred to medium containing BrdU (Otaegui, 
data not presented), the approximate length of the G1-phase in these embryos 
could be estimated in no more than 45 minutes. Other studies had reported a 
longer Gi-phase of 2 hours at the 8-cell stage embryo (Streffer et al., 1980; 
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Smith and Johnson, 1986). These differences may arise from the methodology 
used for determination of DNA replication. 
It was decided to use embryos between 75 and 90 minutes after release 
as donors of 01 phase 8-cell stage nuclei and embryos after 195 minutes as 
donors of S phase 8-cell stage nuclei (see fig 6.5). 
6.3 EFFECT OF NUCLEAR DONOR CELL CYCLE 
Two experiments were conducted to determine the effect of the cell-
cycle phase of the nuclear donor embryo on development after nuclear transfer 
into a metaphase II cytoplast. In the first experiment embryos at the 4-cell 
stage were used as nuclear donors. In the second, embryos at the 8-cell stage 
were used. 
6.3.1 - Transfer of 4-Cell Stage Nuclei in GI-phase, at the GuS Border 
and in S-phase into Cytoplast in Metaphase II 
The aim of this experiment was to compare the ability to conduct 
development after nuclear transfer of nuclei in the 01-phase, in the S-phase 
and nuclei synchronized at the 01/S border with aphidicolin (see section 3.6). 
6.3.1.1 - Experimental design 
Nuclei in Gi-phase and early in S-phase as defined above where 
obtained as described previously (see section 6.2.2.1.3). To obtain nuclei at the 
01/S border, 2-cell embryos synchronized in mitosis with colcemid (see 
section 3.3.3) were released in pM16 with 1 .tg/ml aphidicolin and cultured 
until the nuclear transfer procedure. To maintain the aphidicolin block, 1 tg/m1 
aphidicolin was added to the media in the manipulation chamber and the 
reconstituted couplets were placed in pM16 with 1 .tg/m1 aphidicolin until 
fusion had occurred. Afterward the reconstituted embryos were released into 
pM16, activated by exposure to strontium and the rate of development in vitro 
to blastocyst was recorded. 
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Table 6.9 - Effect of the cell-cycle phase of the nuclear donor cell (4-
cell stage blastomere) on the development to blastocyst of embryos 
reconstituted by nuclear transfer into a metaphase II cytoplast 
Cell-cycle Number Number Number 
phase replicates embryos blastocyst 
Gi-phase 3 45 25 
01/S border 4 46 0 
S-phase 4 50 0 
* Nuclei in 01-phase and early in S-phase where obtained as described in section 
6.2.2.1.3. To obtain nuclei at the 01/S border, 2-cell embryos synchronized in 
mitosis with colcemid (see section 3.3.3) were released in pM16 with 1 tg/ml 
aphidicolin and cultured there until the nuclear transfer procedure. To maintain the 
aphidicolin block, 1 tg/m1 aphidicolin was added to the media in the manipulation 
chamber and the reconstituted couplets were placed in pMl6 with 1 ig/ml aphidicolin 
until fusion had occurred. Afterward the reconstituted embryos were released into 
pM 16, activated by exposure to strontium and the rate of development in vitro to 
blastocyst was recorded. 
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Figure 6.6 - Morphological differences between nuclei early in G1- 
phase and in S-phase. 
Nuclei in G1 -phase appeared smaller, being approximately 2/3 of the diameter 
of normal 4-cell stage interphase nucleus, and were localised in the periphery of the 
blastomere. They also had a high number (9 to 12) of visible nucleoli. On the other 
hand, both nuclei in S-phase and nuclei synchronized at the GUS border were 
localised in the centre of the blastomere and with one to five visible nucleoli. In the 
pictures the bigger arrow ( ) signals the nuclear membrane, the smaller arrow ( ) 
signals nucleoli. 
Embryos in S-phase. 
One embryo early in G1 -phase. Note the peripheral situation of the nucleus in the 
cytoplasm. There is another early gi-phase nucleus inside the enucleation pipette. 
Same embryo as in b) stained with Hoechst to facilitate the visualization of the 







6.3.1.2 - Results 
Development to blastocyst was achieved only when blastomeres in 01-
phase were used as nuclear donors. Six blastocysts were transferred into a 
pseudopregnant mouse which gave birth to one pup (fig 5.5a). None of the 
embryos reconstituted with nuclei either in S-phase or at the GuS border 
developed beyond the 2-cell stage (Table 6.9). 
The morphology of the transferred nuclei was recorded during this 
experiment. At the time of nuclear transfer, nuclei in GI-phase appeared 
smaller, being approximately 2/3 of the diameter of normal 4-cell stage 
interphase nucleus, and were localised in the periphery of the blastomere (see 
fig 6.6b and c). They also had a high number (9 to 12) of visible nucleoli. On 
the other hand, both nuclei in S-phase and nuclei synchronized at the GuS 
border were localised in the centre of the blastomere and with one to five 
visible nucleoli (see 6.6a). 
6.3.1.3 - Discussion 
The result reported in this experiment confirmed independent 
observations in mouse embryos that found an increased development after 
nuclear transfer when nuclei in 01 were transferred to enucleated meiosis II 
oocytes (Cheong et al., 1993). This increased development is known as nuclear 
donor cell-cycle effect. It is interesting to remark that similar results to Cheong 
et al. were obtained in this experiment using a different activation method, 
which suggests that the results were truly due to cell-cycle phase of the nuclear 
donor blastomere and were not influenced greatly by the complex 
electroactivation method used in that experiment. In the same paper, 
development to term of embryos reconstituted with nuclei in Gi-phase from 4-
cell was reported. The ability of nuclei in Gi-phase from 4-cell stage embryos 
to support development to term was also confirmed in the present experiment. 
This was not the main goal of the experiment and only a few blastocyst were 
transferred to pseudopregnant recipients. 
When nuclei at the 01 / S-phase border were used no development was 
achieved beyond the 4-cell stage. This is in disagreement with previous reports 
in nuclear transfer experiments conducted with rabbit embryos (Collas et al, 
1992a). The observed disagreement may be due to species differences in the 
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early stages of development. However, it must be noted that nuclei 
synchronized at the 01/S border theoretically are ready to start DNA 
polymerisation and, therefore, they have an S-phase DNA configuration, but 
no DNA replication has happened yet. 
There are two explanations for this apparent difference between nuclei 
in 01 phase and those at the 01/S boundary. It may be that cells at the 01/S 
boundary have sufficiently entered the S phase as to cause aneuploidy in the 
daughter cells because of errors during DNA replication. Alternatively, it may 
be that there are fundamental differences in chromatin structure between nuclei 
during these two phases of the cycle and that this influences the efficacy of 
reprogramming of gene expression. 
DNA configuration of the donor nucleus may be the key question 
influencing embryo survival. After mitosis, the assembly of chromatin 
precedes the assembly of a nuclear lamina and nuclear membrane. Once the 
nuclear membrane is complete the nucleus swells to its final volume. At this 
time proteins which are abundant in the nuclear matrix migrate into the 
nucleus (e.g. NuMa; see Compton and Cleveland, 1994). Studies of DNA 
configuration conducted in HeLa cells suggested a period in the early 01-
phase when the decondensing nucleus retains a DNA configuration similar to 
the more condensed one at mitosis (Pfeffer et al, 1991). This early 01-phase 
configuration may confer an advantage to these nuclei to support development 
after transfer and therefore this short period of time would be considered as a 
"nuclear transfer permissive window". 
This observation could also help to explain the apparent contradiction 
between the observed development to blastocyst when nuclei in 01-phase 
from early 2-cell stage embryos were transferred into metaphase II cytoplasts 
(Kono et al., 1992; Cheong et al., 1993). Cheong et al., (1993) did the transfer 
within 10 to 15 minutes after cleavage and obtained 77% development to 
blastocyst. Kono et a!, used an slightly wider window of 30 minutes after 
cleavage to conduct the nuclear transfer procedure and no development to 
blastocyst was observed in this experiment. It may be suggested that in the 
second case the nuclei were outside of the nuclear transfer permissive window 
detected in early 01-phase and that this was the reason for the failure to 
develop observed in the embryos reconstituted with these nuclei. 
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6.3.2.- Transfer of 8-Cell Stage Nuclei in Gi-phase and in S-phase into 
Cytoplast in Metaphase II 
The aim of this experiment was to compare the ability of nuclei, from 
8-cell stage embryos, in the early Gi-phase versus nuclei in the S-phase to 
conduct embryo development after transfer. 
When early Gi-phase nuclei from 4-cell stage embryos were used as 
nuclear donors, a possible criticism was that they were still too similar to the 
late 2-cell stage nucleus, and therefore rather than a cell cycle effect what was 
observed was an embryo stage effect. To rule out that possibility the present 
experiment was conducted in which 8-cell stage embryos were used as nuclear 
donors to confirm that the observed results were due to changes in cell-cycle 
and not to advances in development. 
6.3.2.1- Experimental design 
Nuclei from 8-cell stage embryos in GI or S-phase as defined above 
were obtained as described previously (see section 6.2.2.2.3) and transferred to 
the cytoplast of enucleated oocytes recovered 14 to 15 hours after hCG. The 
reconstituted embryos were activated by exposure to the strontium activation 
media and the rate of development in vitro to blastocyst was recorded. 
6.3.2.2 - Results 
The cell-cycle phase of the donor blastomere had a very dramatic effect 
on the proportion of reconstituted embryos that developed to blastocyst when 
nuclei from 8-cell embryos were transferred into enucleated oocytes (Table 
6.10). A proportion of embryos reconstituted by transfer of nuclei in Gi-phase 
from 8-cell stage embryos to enucleated metaphase II oocytes were able to 
develop to blastocyst; but none of the embryos reconstituted with nuclei in S-
phase developed even to the 4-cell stage. (27%v 0%). 
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Table 6.10 - Effect of the cell-cycle phase of the nuclear donor cell (8- 
cell stage blastomere) on the development to blastocyst of embryos 
reconstituted by nuclear transfer into a metaphase II cytoplast 
Development (total number) 
Cell-cycle 	Number 	Number of fused 
phase replicates couplets / Total 
2-cell 	Blastocyst 
Gi-phase 2 33/38 30 9 
S-phase 3 58/60 9 0 
* Nuclei from 8-cell stage embryos in Gi or S-phase were obtained as described in 
section 6.2.2.2.3 and transferred to the cytoplast of enucleated oocytes recovered 14 to 
15 hours after hCG. The reconstituted embryos were activated by exposure to the 
strontium activation media and the rate of development in vitro to blastocyst was 
recorded. 
6.3.2.3 - Discussion 
These results, support the idea of a cell-cycle effect rather than an 
embryo stage effect, and confirmed independent reports (Cheong et al., 1993) 
of development to blastocyst after nuclei in Gi-phase at the 8-cell stage were 
used as nuclear donors. The lower development after nuclear transfer achieved 
with nuclei from 8-cell stage than with 4-cell stage embryos may be due to the 
greater technical difficulties involved in the extraction of karyoplast from the 
8-cell stage embryos, which could have slightly increased the duration of the 
nuclear transfer procedure and resulted in nuclei outside of the permissive 
window being transferred. Nevertheless, the possibility that the use of more 
differentiated embryos as nuclear donors in this experiment may have been 
responsible for the lower development observed in this case cannot be ignored. 
6.4 EFFECT OF INTERACTIONS BETWEEN DONOR 
BLASTOMERES AND CYTOPLAST CELL-CYCLE 
PHASE 
The aim of this experiment was to study the effect of the interaction of 
nuclear donor cell-cycle phase with cytoplast cell-cycle phase on the 
development of the embryos produce by nuclear transfer. 
Several ways of maintaining normal ploidy by avoiding abnormal DNA 
replication after nuclear transfer have been established. The objective of this 
study was to compare development in several different situations, in some of 
which it was expected that errors in DNA replication after nuclear transfer will 
be avoided and ploidy of the daughter cells would be normal. 
6.4.1 - Experimental design 
Four-cell stage embryos were used as nuclear donors, and nuclei, as 
defined before, in Gi-phase, early S-phase and late S-G2 phase were obtained 
as described previously (see section 6.2.2.1.3). Since it was not possible to 
detect a clearly separate G2-phase in the nuclear donor embryos, an 
undetermined mixture of nuclei in late S-phase or G2-phase was used. Oocytes 
recovered 14 to 15 hours after hCG were enucleated and used as recipients 
before activation (metaphase 11), six to eight hours after activation ("early S") 
and 12 to 16 hours after activation ("late S-G2"). To avoid cytoplast 
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fragmentation the activated cytoplasts were cultured in lOp.M nocodazole 
pM16 until the end of the nuclear transfer procedure. The reconstituted 
couplets were placed in the same media for one hour to allow cell membrane 
fusion to happen. Afterwards, the reconstituted embryos were cultured in 
pM16 and development to 2-cell and blastocyst was recorded. Two hours after 
nuclear transfer a number of reconstituted embryos were stained with Hoechst 
and examined to assess the proportion of nuclear envelope break-down 
induced in each treatment group. Each and every experimental day activation 
control groups were made, consisting of intact oocytes that were either 
exposed to the activation media (Act co+) to evaluate the quality of the 
activation stimulus or cultured without exposure to the activation media (Act 
co-) to evaluate the activation induced during recovery and handling of the 
oocytes. 
Due to limits in the number of treatments done each experimental day it 
was decided to do one of the following combinations of treatments each day: 
nuclear donors in Gi or S-phase into recipients in metaphase II, nuclear donors 
in Gi or S-phase into recipients in early S-phase, nuclear donors in Gi or S-
phase into recipients in late S-G2 phase, nuclear donors in late S-G2 phase into 
recipients in metaphase II, nuclear donors in late S-G2 phase into recipients in 
early S-phase and nuclear donors in late S-G2 phase into recipients in late S-
G2 phase. 
Statistical analysis: The results were analysed by a split-plot ANOVA with 
days as plots. The between-days treatments were the recipient cell-cycle phase 
and a comparison between the (Gi and S) and late S-G2 cell-cycle phase of the 
nuclear donor. The within-days comparison was done between Gl-and S cell-
cycle phases of the nuclear donor. 
6.4.2 - Results 
Most of the objectives of transferring the nuclei into different 
cytoplasmic environments were achieved. Nuclear envelope break-down and 
premature chromosome condensation was observed in almost all of the nuclei 
transferred into a metaphase II cytoplast (Table 6.11, fig 6.7). However, none 
of the nuclei transferred into a cytoplast activated six to eight hours previously 
underwent premature chromosome condensation (Table 6.11). A proportion 
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(23%) of the nuclei transferred into cytoplast activated 12 to 16 hours before 
underwent premature chromosome condensation (Table 6.11). 
Fusion rate assessed one hour after nuclear transfer by observing the 
embryos under the dissecting microscope was over 85 %. The activation level 
achieved in the experiment was good as indicated by the high proportion of 
oocytes in the control group that developed to the 2-cell (92%) and blastocyst 
(49%) stages (Table 6.11). However, on some of the days a low level of 
activation induced during handling was detected (Table 6.11). 
Development to 2-cell and to blastocyst was influenced by both the 
nuclear donor and the cytoplast cell-cycle stage (p<O.Ol).The pattern of results 
was as would be expected if there was an interaction between these factors. 
However, the large number of treatments when no development to blastocyst 
was observed made statistical treatment of such an interaction impossible. 
When nuclei in GI-phase were used as nuclear donors, a high 
proportion of the embryos reconstituted with cytoplast in metaphase II or 
"early S-phase" developed to blastocyst, but none when cytoplast in "late S-
phase" were used as recipients. Embryos reconstituted with nuclei in early S-
phase developed to blastocyst solely when transferred into cytoplast in "early 
S-phase". Also nuclei in late S-G2 phase only developed to blastocyst when 
transferred into "late S-phase" cytoplast. Together, these observations suggest 
a benefit from synchronization between nuclei and cytoplast for the 
development of the embryo after nuclear transfer. 
When the quality of the blastocysts was assessed, embryos 
reconstituted with Gi-phase nuclei developed to morphologically normal 
looking blastocysts with a, clearly visible 1CM and an average of 58-59 cells. 
The few blastocysts obtained from late S-G2 nuclei group were also of high 
quality. Embryos reconstituted with nuclei in S-phase developed to a mixture 
of high and lower quality blastocyst when assessed in terms of both 
morphology and cell number (Table 6.11). Note the large standard error for 
number of cells. 
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Figure 6.7 - Premature chromosome condensation of nuclei transferred 
into cytoplasts in metaphase H. 
Nucleus from a 4-cell stage blastomere early in Gi-phase. Note individual 
chromosomes. 
Nucleus from a 4-cell stage blastomere in early S-phase. 
Nucleus from a 4-cell stage blastomere in late S -02 phase. 

Table 6.11 Effect of interaction between donor blastomere and recipient 
cytoplast cell-cycle phase 
on development to blastocyst after nuclear transfer 
Cell-cycle phase Number Number 2-cell Blast. PCC Blast. 
replicates reconstituted (%)C (%)d observed cell 
nuclear 	cytoplastb embryos /totale number 
donora 
GI 	Mell 4 60 72 43 18/19 58±2.40 
GI 	6-8h 4 50 93 60 0/17 59±2.33 
Gi 	12-16h 4 56 32 0 2/18 - 
S 	Mel[ 4 55 24 0 21/22 - 
S 	6-8 h 4 46 34 14 0121 50±8.46 
S 	12-16h 4 53 33 0 5/21 - 
1S-G2 	Me  3 60 3 0 22/22 - 
1S-G2 	6-8 h 3 61 0 0 0/20 - 
1S-G2 	12-16h 3 57 39 12 6/17 68±3.36 
Activation Co+ * 19 290 92 49 - 54±1.69 
Activation Co- * 19 277 4 3 - 60±2.56 
a Four-cell stage embryos were used as nuclear donors. Nuclei in GI-phase, early S-phase 
and late S-G2 phase were obtained as described in section 6.2.2.1.3. 
b 	Oocytes recovered 14 to 15 hours alter hCG were enucleated and used as recipients 
before activation (metaphase II), 6 to 8 hours alter activation ("early S-phase") or 12 to 16 
hours alter activation ("late S-phase"). 
C. d Percentage of reconstituted embryos that developed to 2-cell and blastocyst stage 
respectively 
e Two hours after nuclear transfer a number of reconstituted embryos were stained with 
Hoechst and examined to asses the proportion of premature chromosome condensation 
induced in each treatment group. 
* Each and every experimental day activation control groups were made, consisting of intact 
oocytes that were either exposed to the activation media (Activation Co+) to evaluate the 
quality of the activation stimulus or cultured without exposure to the activation media 
(Activation Co-) to evaluate the activation induced during recovery and handling of the 
oocytes. 
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6.4.3 - Discussion 
There were several circumstances in which normal DNA replication 
was expected: Gi-phase donor with metaphase II and all donors with 
cytoplasts in S-phase. There were obvious differences between these groups in 
the proportion of embryos developing to blastocyst showing that factors other 
than the maintenance of ploidy influence development. 
If the cytoplast was at metaphase II a good number of embryos 
reconstituted with nuclei in Gi-phase developed to blastocyst. These results 
confirmed earlier reports in which a superior development to blastocyst was 
achieved with nuclei in Gi-phase when embryos were reconstituted using 
metaphase II cytoplasts as recipients (Collas et a!, 1992b, Cheong et al., 1993). 
However, similar development to blastocyst was observed if such a nucleus 
was transferred to a recipient in early S-phase(43% vs. 60%). This similarity 
was observed despite the fact that in metaphase II cytoplasts almost all nuclei 
underwent nuclear envelope breakdown and chromosome condensation, 
whereas in S-phase cytoplast no such condensation was observed. At least as 
assessed by development to blastocysts the results show that nuclear envelope 
breakdown and chromatin condensation are not required for reprogramming. 
This observation supports the idea of "reprogramming factor(s)" able to 
migrate through the nuclear membrane. This may or may not be the same as 
the "reprogramming mechanisms" which may act during chromosome 
condensation and reformation of the nucleus. 
No development to blastocyst was observed when nuclei in early S-
phase or late S-phase/G2 phases were transferred into metaphase II cytoplasts. 
When such cytoplast were used, none of the embryos reconstituted with a S-
phase nuclei arrived to blastocyst, which was in agreement with the 
observations reported by others (Kono et al., 1992; Cheong et al., 1993). This 
probably reflects damage to chromosomes caused by inappropriate 
chromosome condensation and DNA replication. Accurate interpretation of the 
observations made with nuclei late in S-phase/G2 phase is made impossible by 
the fact that several cell-cycle phases were represented and indistinguishable. 
The absence of development to blastocyst when nuclei late in S-phase/G2 
phase were transferred into metaphase II cytoplast could be due to a majority 
of nuclei in late S-phase in the embryos used as nuclear donors in this group. 
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Also, a number of the nuclei in G2-phase could be unable to direct 
development after nuclear transfer. It must be noted that when embryos were 
reconstituted transferring nuclei from late 2-cell embryos, which were all in 
02-phase, into metaphase II cytoplasts only between 20-25% of them 
developed to blastocysts (Kono et al., 1992; Cheong et al., 1993; see also 
section 5.6). 
The apparent variation between cytoplasts at different points in S-phase 
to support development after nuclear transfer was unexpected. One possible 
interpretation is that quite precise cell-cycle synchrony offers an advantage, but 
the mechanisms of such an effect is not known. 
Differences in chromatin structure may account for some of the results 
in this experiment. Nuclei in 01-phase appear to confer an advantage to the 
embryos produced by nuclear transfer. It may be that the chromatin in those 
nuclei is deprived either of some transcription factors or other ways of 
controlling gene expression due to its partially condensed configuration. In 
normal circumstances, after completion of mitosis those transcription 
controlling factors would find their way to the chromatin in order to maintain 
the cell gene expression. However, when these nuclei are transferred into 
different cytoplasmic conditions, transcription factors characteristic of the 
cytoplasts-donor cell gene expression that remain present in the cytoplast may 
migrate to the chromatin and modulate the expression of genes appropriate for 
this stage. In nuclei at the S-phase however, the chromatin is completely 
decondensed and the transcription factors may have already migrated to the 
nucleus making it more difficult for the host cytoplast to reprogram the 
nucleus. A proportion of nuclei in 02-phase have probably started to prepare 
for mitosis and may have lost some of these transcription factors, becoming 
similar to the 01-phase nuclei. 
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6.5 - EFFECT OF OOCYTE AGE UPON DEVELOPMENT 
AFTER NUCLEAR TRANSFER 
The purpose of this experiment was to discover if oocyte age at the 
time of recovery influenced development. It was anticipated that older oocytes 
would be more liable to activate spontaneously and that this might modify the 
development of embryos after nuclear transfer. 
6.5.1 - Experimental design 
Nuclei in Gi-phase and S-phase from embryos at the 4-cell stage were 
used as donors. Oocytes recovered 14, 15 hours and 17 hours after hCG were 
enucleated and used as recipients 6 to 8 hours after activation. Non-intended or 
spontaneous activation was assessed by the proportion of oocytes in anaphase-
telophase H at the time of enucleation and by the proportion of intact oocytes 
which developed to 2-cell and blastocysts without having been exposed to the 
strontium activation method. 
6.5.2 - Results 
Development to blastocyst of cytoplasts receiving a Gi-phase nucleus 
was not affected by oocyte age. By contrast, development to blastocyst of 
cytoplast receiving an early S-phase nucleus was achieved only with older 
cytoplasts, when some degree of non-intended activation was detected (Table 
6.12). 
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Table 6.12 - Effect of non-intended activation induced during 











cell-cycle 	embryos 	(%)d 
phasec 
(%) 
2-cell (%) Blast (%) 
14 0 0 0 01 26 58 
S 24 0 
15 25 18 14 01 24 63 
S 22 29 
17 39 48 24 Gi 22 60 
S 50 19 
a Oocytes recovered 14, 15 hours and 17 hours after hCG were enucleated and used as 
recipients 6 to 8 hours after activation. 
b Non-intended or spontaneous activation was assessed by the proportion of oocytes 
in anaphase-telophase II at the time of enucleation and by the proportion of intact 
oocytes which developed to 2-cell and blastocysts without having been exposed to the 
strontium activation method. 
C Nuclei in 01-phase and early S-phase from embryos at the 4-cell stage were 
obtained as described in section 6.2.2.1.3 and used as donors. 
d Percentage of reconstituted embryos that developed to blastocyst stage. 
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6.5.3 - Discussion 
The result obtained in this experimen suggested the idea that something 
else, other than loss of MPF activity, may be important to achieve development 
after nuclear transfer with nuclei in S-phase. In this discussion, it will be 
refered to as the "extra factor". However, there is no evidence whatsoever to 
say if this "extra factor" is something related with the "spontaneous" activation 
stimuli or if it has to do with the postovulatory age of the oocytes used as 
recipients. Since older oocytes are easier to activate by handling, it may be 
difficult to separate these two factors. In this case, the spontaneous activation 
may be just a collateral effect of postovulatory ageing. It may be possible that 
the criteria used routinely to monitor the efficiency of the activation stimulus, 
this is MPF inactivation assessed by chromatin changes and cleavage, may not 
be sufficient. In this context, the older oocytes (15 and 17 hp-hCG) could have 
produced a more complete activation answer (MPF inactivation + "extra 
factor") which made the cytoplasts able to better support development of the 
reconstituted embryo. Although is not clear how this happens, it may be due to 
the inactivation/activation of a factor(s) involved in the reprogramming of the 
transferred nucleus that was/were not affected in the younger oocytes (14 hp-
hCG). In this context, recent studies with rabbit embryos consistently found 
that poor development after nuclear transfer was related with a poor activation 
of the reconstituted embryo (Pinto-Correira et al, 1995). 
The key question in this experiment is whether MPF was inactivated by 
the parthenogenic activation method used. If this is true in the three different 
cytoplasts used in the experiment (14, 15 and 17 h p-hCG; see table 6.12), then 
the differences observed on development after nuclear transfer could not be 
explained as due to a cell-cycle phase effect, since all the recipient-cytoplasts 
were activated at the same time prior to nuclear transfer and, therefore, they 
will be more or less at the same point in the S-phase of their cell-cycle. In this 
case, something else will be needed to account for the detected effect. 
Evidence supporting that destruction of MPF activity occurs after 
exposure of oocytes and enucleated oocytes to the strontium media is 
presented in several sections of this thesis. Data in chapter 4 shows the ability 
of the strontium media to induce a very good activation rate on intact oocytes 
assessed as cleavage to 2-cell, which is an indirect but quite strong evidence of 
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MPF inactivation. Also in chapter 4, development to blastocyst achieved by 
oocytes activated by this method showed that the quality of the activation 
achieved is quite good. It may be assumed that the method used is very 
efficient. Nevertheless, it is not clear which is the effect of enucleating the 
oocyte before activation on MPF inactivation. However, observations 
presented in different experiments in which MPF activity on cytoplasts used as 
recipients was evaluated by looking at NEBD after nuclear transfer (see 
experiments 5.5 and 6.4) showed that this activation method induced complete 
destruction of MPF activity in enucleated cytoplasts by the time when nuclear 
transfer was conducted in experiment 6.5 (6 to 8 hours after activation). 
Although NEBD after nuclear transfer was not directly determined in this 
experiment, as it was done in experiment 6.4, the two set of observations 
mentioned above may be considered as a very strong support to the affirmation 
that MPF was completely inactivated in the three different recipients used in 
this experiment and that there were not differences in MPF activity between 
them that would explain the different development to blastocyst observed. 
To conclude, when nuclei in S-phase are transferred into preactivated 
cytoplasts where MPF activity has been loss, it may be beneficial to use 
oocytes slightly aged after ovulation. More experiments will be needed to fully 
understand the effect detected in this experiment and how activation methods 
and protocols used in nuclear transfer experiments affect the role of cytoplasts 
activation on the nuclear-cytoplasm interactions after nuclear transfer and the 
consequences it has on the survival of the reconstituted embryos. 
6.6 IS THERE ANY "REPROGRAMMING FACTOR"? 
The aim of this experiments was to transfer nuclei in the nuclear 
transfer permissive window detected in GI-phase into enucleated zygotes to 
rule out any nuclear donor cell-cycle effect as responsible for the failure to 
develop of embryos reconstituted by nuclear transfer when cytoplast were 
obtained from pronuclear stage embryos and not from metaphase II oocytes. 
In early experiments nuclei in S-phase or at least beyond the nuclear 
transfer permissive window detected in early Gi-phase used here were used as 
nuclear donors for transfer into enucleated zygotes (McGrath and Solter, 1984; 
Robl et al., 1986; Tsunoda et a!, 1987; Kono and Tsunoda, 1988) or 
parthenogenones (Howlett et al 1987). The existence of a "reprogramming" 
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factor(s) present in the cytoplasm of metaphase II oocytes that are able to 
migrate through the nuclear membrane and modify gene expression has been 
suggested in a previous experiment (see section 6.4). These factor(s) are either 
sequestered or inactivated during pronucleus formation (see section 5.1). It is 
the difference in the presence or absence of such factors which accounts for the 
failure of development after nuclear transfer to enucleated zygotes, rather than 
the use of nuclei outside the nuclear transfer permissive window detected in 
early G1 -phase. 
In this final experiment the possibility of a cell-cycle effect rather than 
a "reprogramming" effect as responsible for the failure of embryos produced 
by nuclear transfer of nuclei from 4-cell stage embryos into enucleated zygotes 
was tested. It was anticipated that no development would be observed even 
when nuclei inside the nuclear transfer permissive window were transferred 
into zygotes. By contrast, if the result were due to a nuclear donor cell-cycle 
phase effect, when nuclei inside the nuclear transfer permissive window are 
used, development to blastocyst would be similar to the obtained in 
experiments described previously in this thesis (sections 6.3.1, 6.4 and 6.5) and 
by others (Cheong et al, 1993). 
6.6.1 - Experimental design 
Nuclei in Gi-phase or early S-phase were obtained from 4-cell stage 
embryos and transferred into early (16-20 hours after hCG) or late (24-28 
hours after hCG) enucleated zygotes. The reconstituted embryos were cultured 
in vitro and development to 2-cell and blastocyst was recorded. To assess the 
nuclear transfer procedure auto-nuclear-transfers were conductd in control 
zygotes (auto NT controls). The quality of the embryos used both as nuclear 
donors and cytoplasts donors was assessed by in vitro culturing a group of non 
manipulated embryos (embryos controls). 
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Table 6.13 - Effect of the cell-cycle phase of the nuclear donor cell (4. 
cellstage blastomere) on the development to blastocyst of 
embryos reconstituted by nuclear transfer into cytoplast 
obtained from zygotes * 
Cytoplast 	Nuclear donor 	Number 	% 2-cell 	% Blastocyst 
cell-cycle phase embryos 
Early 1-cell 	G  31 36 3 
S 52 24 0 
Latel -cell 	G  46 23 0 
S 71 53 C) 
Auto-NT control early 26 92 84 
Auto-NT control late 38 92 89 
Nuclear donor embryos control 84 - 97 
Early i-cell embryos control 22 100 87 
Late 1-cell embryos control 52 100 100 
* Nuclei in Gi-phase or early S-phase were obtained from 4-cell stage embryos and 
transferred into early (16-20 hours after hCG) or late (24-28 hours after hCG) 
enucleated zygotes. The reconstituted embryos were cultured in vitro and development 
to 2-cell and blastocyst was recorded. 
To assess the efficiency of the nuclear transfer procedure, auto-nuclear-
transfers were conducted in control zygotes (auto NT control). The quality of the 
embryos used both as nuclear donors and cytoplasts was assessed by n vitro 
culturing a group of non manipulated embryos (embryos control). 
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6.6.2 - Results 
No differences were found in the ability to develop to blastocyst 
between the embryos reconstituted after transfer of nuclei either in early Gi-
phase or S-phase into cytoplasts from enucleated zygotes either early or late in 
the first cell-cycle. Although a proportion of the embryos cleaved to the 2-cell 
stage none developed to morphologically normal blastocyst. Only one of the 
reconstituted embryos developed into a small blastocyst (24 cells) that had 
morphological abnormalities (Table 6.13). By contrast, in the embryos in 
which auto nuclear transfer was done, over 84% of the fused embryos 
developed to blastocyst. Also, the proportion of non manipulated embryos that 
developed to blastocyst showed that the in vitro culture conditions and the 
fertilization rate did not affect these results. 
6.6.3 - Discussion 
The results described in this experiment eliminate a donor cell-cycle 
phase effect as responsible for the lack of development observed after transfer 
of 4-cell nuclei into enucleated zygotes. Also, since the cytoplasts were 
obtained from naturally fertilized zygotes, poor activation can be disregarded 
as causing this developmental failure. Although a direct comparison with Gl-
phase nuclei into metaphase II cytoplast was not done in this experiment, 
development after transfer of 4-cell nuclei in early Gi-phase into cytoplast 
from metaphase II oocytes was consistently obtained during experiments 
previously described in this thesis (sections 6.3.1, 6.4 and 6.5). Therefore, it 
may be concluded that the results reported in this section confirmed the 
absence of a "reprogramming" factor(s) in the cytoplast of the zygote when 
compared with the enucleated oocyte. 
More studies would be need to dilucidate the nature, identity and 
characteristics of this reprogramming factor. 
6.7 DISCUSSION AND CONCLUSIONS. 
The observations presented in this chapter strengthened the idea that 
the low development observed in mouse embryos reconstituted by nuclear 
transfer is due partly to nuclear-cytoplasmic interactions following the 
procedure. Those interactions may affect adversely the viability of 
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reconstituted embryos either due to lethal results (i.e. abnormal DNA 
replication) or to failure to achieve a good reprogramming of the transferred 
nucleus (as when zygotes are used as recipients). A better understanding of the 
molecular mechanisms involved in these nuclear-cytoplasm interactions may 
lead to improvements in the methodology used that would increase the 
efficiency of nuclear transfer procedures. Therefore, the need to further 
understand these interactions in order to find ways to overcome the adverse 
effects of these interactions and to increase their advantageous effects is still 
present. 
The methodology developed during the project allowed to set up an 
experiment in which the effects upon development after nuclear transfer of 
possible errors in ploidy caused by abnormal DNA replication were separated 
from other factors for the first time (see section 6.4). This approach permitted 
to compare treatments in which normal DNA replication was predicted and to 
detect the existence of other factors that could be involved in the outcome of 
nuclear transfer procedures. 
Two main conclusions were made at the end of this chapter: one, that 
cells in Gi-phase and perhaps only in the nuclear transfer "permissive 
window" detected in these experiments, are better nuclear donors than any 
other; and second, the obvious differences in the proportion of embryos 
developing to blastocyst observed between the groups where the combinations 
of cell cycle phases used were expected to maintain normal DNA replication 
suggested that factors other than the maintenance of ploidy influence also 
development after nuclear transfer. It is proposed that some of these factors 
would be related with chromatin configuration of the transferred nucleus and 
cytoplast activation. 
Development to blastocyst was achieved with 4-cell stage nuclei in G 1-
phase, early S-phase and late S-G2 phase, which confirmed that 4-cell nuclei 
remain able to direct development if transferred into the "right" cytoplasmatic 
conditions. Moreover, this study is the first in which blastocyst have been 
obtained after transfer of mouse 4-cell stage nuclei in S-phase into preactivated 
cytoplasts. This observation appears to confirm the idea of the preactivated 
enucleated oocyte as "universal recipient" that has been proposed previously 
(Campbell et al., 1993; see section 1.4). Theoretically, in this "universal 
recipient" the possible anëuploidy resulting from abnormal DNA replication 
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after nuclear transfer was avoided and the reconstituted embryo would 
continue developing. Development to blastocyst of haploid, tetraploid and 
even octoploid embryos has been described (see Henery and Kaufman, 1991; 
Henery and Kaufman, 1992; Winkel and Nuccitelli, 1989). However, the type 
of aneuploidy considered here is related with problems during segregation of 
sister chromatids after nuclear transfer that are lethal for the reconstituted 
embryos. This has been reported in amphibia (DiBenardino and Hoffer, 1970), 
rabbit (Collas et al., 1992a; 1992b) and mouse (Kono et al., 1992; Cheong et 
al., 1993). It has been suggested that abnormal DNA replication caused by the 
choice of cell-cycle phase of nuclear donor and cytoplast may lead to such 
aneuploidy (Barnes et al., 1993; Campbell et al., 1993). 
Cytoplasts both in metaphase II and preactivated either in "early S-
phase" or "late S-phase" did support development to blastocyst. However, only 
in some of the combinations studied did the reconstituted embryos develop to 
blastocyst. This observation further support the idea that the real problem of 
development after nuclear transfer is not a question of something being lost at 
a determined stage, but to the necessity of the "right" combination of nuclear 
donor and cytoplast conditions that, avoiding lethal results, will produce a 
sufficient reprogrammation of the nucleus as a consequence of the nuclear -
cytoplasmic interactions following the procedure. Within the limits of this 
project it was not possible to determine accurately the proportion of embryos 
produced by different treatments which were able to develop to term. It is 
important that these studies are extended to make such comparisons as it is 
possible that some differences in developmental potential will be revealed 
(Pinto-Correia et al., 1993). 
Results presented in sections 6.3.1 and 6.4 suggested that cells with 
nuclei early in Gi-phase, when nuclear envelope has been reformed but the 
chromatin is still partially condensed (Pfeffer et al, 1991) may be the best to be 
used as nuclear donors (see section 6.3.1.3). The nature of this advantage is not 
clear. It is suggested that this effect may be a result of the chromatin 
configuration of the transferred nucleus. The non-completely decondensed 
configuration of the chromatin of nuclei in early Gi-phase would made their 
chromatin more easily to "reprogram" for the cytoplast (see section 6.4.3). 
Development to blastocyst obtained after transfer of 8-cell stage nuclei in Gi-
phase support that these observations were due to a cell-cycle effect rather than 
to an embryo stage effect (see section 6.3.2.3). Nevertheless, to test this 
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hypothesis several experiments in which variations in chromatin configuration 
of the transferred nuclei are determined more precisely and how these changes 
in DNA configuration affect to the various DNA-binding proteins that are 
regulating gene expression is studied in detail will be needed. 
The observed advantage of using nuclei in 01-phase as nuclear donors 
confirmed previous reports in mouse. Development to blastocyst, and to term, 
using as nuclear donors 4-cell, and even 8-cell, stage nuclei in 01-phase has 
been reported recently (Cheong et al., 1993). When nuclei in 01-phase from 
fetal male germ cells were used 62% of the reconstituted embryos developed to 
blastocyst (Tsunoda et al., 1992). Also, development to blastocyst was 
reported after transfer of nuclei from 8-cell stage blastomeres, inner-cell-mass 
cells and primordial male germ cells (Tsunoda et al., 1989; Kono et al., 
1991b.). In those earlier studies the cell-cycle phase of the nuclear donors was 
not determined. However, the very low development to blastocyst reported is 
compatible with nuclei in Gi-phase being used in the embryos that developed 
to blastocyst. 
A preliminary experiment (see section 6.5) suggested that cytoplast 
activation has an important effect on the outcome of nuclear transfer 
procedures. It may be proposed that in addition to MPF inactivation there are 
other factors in the activation response that affect the ability of preactivated 
cytoplast to support development. The nature of such factors is not clear. It 
appears that they would be related with ageing of the oocytes after ovulation. 
Nevertheless, further experiments are needed to fully understand this 
observation. 
Finally, evidence that supports the existence of a "reprogramming" 
factor in the cytoplasm of metaphase II oocytes that is not longer present in the 
cytoplasm of enucleated zygotes has been presented (see sections 6.4, 6.5 and 
6.6). It is suggested that the absence of such factor was responsible for the lack 
of development obtained in previous nuclear transfer experiments with mouse 
embryos (McGrath and Solter, 1984; Robl et al., 1986; Howlett et al., 1987; 
Tsunoda et al, 1987; Kono and Tsunoda, 1988; Smith and Wilmut 1989; 
Cheong and Kanagawa, 1993). This reprogramming factor is able to 
successfully reprogram nuclei in 01-phase even in the absence of chromosome 
condensation (see sections 6.4 and 6.5). In order to further understand how 
these two factors influence reprogramming of the transferred nucleus, more 
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experiments in which the ability to support development after nuclear transfer 
of cytoplast in metaphase II that somehow have been depleted of this 
reprogramming factor is assessed are need. 
CHAPTER 7 
GENERAL DISCUSSION 
The results presented in this thesis showed the important effect of the 
cell-cycle phase, nuclear chromatin configuration and cytoplast activation on 
survival of the embryos reconstituted by nuclear transfer. Also, some evidence 
of the existence of a reprogramming factor in the oocyte cytoplasm is reported 
here. 
The important effect of nuclear cell-cycle phase has been demonstrated. 
It is suggested that this effect is a result of the chromatin configuration of the 
transferred nucleus. As results from section 6.3.1 and 6.4 suggested, it appears 
that cells with nuclei early in 01-phase, when nuclear envelope has been 
reformed but the chromatin is still partially condensed (Pfeffer et al, 199 1) are 
the best to be used as nuclear donors. A consequence of this observation are 
studies on ways of synchronizing nuclear donor cells in this particular period. 
Experiments conducted with this aim in stem cells are explained in appendix 1. 
However, results presented in chapter 3 and appendix 1 suggested that the 
establishment of such synchronization methods may be more difficult than 
thought a priori. Another possibility is the establishment of methods that are 
able to interfere with nuclear swelling after mitosis (i.e. by blocking nuclear 
pores) and may be used to obtain nuclei in this particular period. Nevertheless, 
the existence of stem-cell in mouse allows the use of those cells to further 
investigate these questions. Also, by using stem-cell lines it may be possible to 
clearly separate developmental stage effects from the effects due to cell-cycle 
phase and improve the understanding of what is causing these effects at the 
molecular level. 
When the effect of cytoplast in the outcome of nuclear transfer 
experiments is contemplated three major aspects need careful consideration: 
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the cytoplasts as responsible of the reprogramming of the transferred nucleus, 
the effect of the cytoplast cell-cycle on the nuclear donor cell-cycle phase 
effect and finally, cytoplasts activation. 
Results obtained in this thesis confirmed the evidence available in the 
literature and stressed the need of using metaphase II oocytes as source of 
cytoplasts due to the existence of a reprogramming factor in the cytoplasm of 
these oocytes. More studies are needed to establish the nature, identity and 
characteristics of this reprogramming factor. Likewise, nuclear transfer 
experiments with mouse stem-cells will permit more conclusive studies in this 
phenomenon of reprogramming and may allow a description of the molecular 
mechanism underlying it. 
If it is not possible to obtain cells in Gi-phase as nuclear donors, 
another strategy to improve the chances of development after nuclear transfer 
is to activate the cytoplast before nuclear transfer is conducted in order to 
inactivate MPF and avoid nuclear envelop break-down and premature 
chromosome condensation that will induce DNA re-replication (Campbell et 
al., 1993, 1994). However, a better monitoring of the activation degree 
achieved and its effect on survival of the reconstituted embryo is necessary to 
fully explain some of the observations made in the experiments described in 
this thesis (sections 6.4 and 6.5). The use of more sophisticated activation 
methods such as the employed by Cheong et al (1993) or even the one 
described by Ozil (1990) and Vitullo and Ozil (1992) may result in more 
perfectly activated cytoplasts that would lead to further improvement on 
survival after nuclear transfer (see section 6.5). 
As a conclusion of the results obtained during this thesis it appeared 
that if a nucleus, inside the nuclear donor permissive window detected in early 
Gi-phase, is transferred into cytoplasts obtained by enucleating a oocyte in 
metaphase II, therefore where the reprogramming factor is still present, the 
chances of survival of the reconstituted embryo are very good. Even, it may be 
possible to use this approach to obtain development from more advanced cells. 
Experiments with stem-cells related in appendix 1 were started to investigate 
this question, however due to the lack of time to solve the technical difficulties 
encountered it was decided to interrupt these experiments by the moment. 
Nevertheless, nuclear transfer experiments where stem-cells are used as 
nuclear donors will provide a very powerful tool to get a better understanding 
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of the molecular interactions and mechanism involved in the acquisition of 
differentiation by the cells and how the reversal of this differentiation is 
achieved during the process of reprogramming after nuclear transfer. 
An approach to the question of how reprogramming is achieved at the 
molecular level may be to inject plasmid DNA into the nuclei of embryonic 
blastomeres to determine the interactions of trans -acting factors characteristic 
of the different development stages with cis-acting DNA sequences of genes 
that are important in the early stages of development (see Henery et al., 1995). 
Alternatively, the larger cloning capacity of YAC vectors (about 1-2 Mb) 
would ensure the transfer of all regulatory sequences required for the correct 
expression of a given gene in its new genomic environment. Over the past two 
years several publications have reported the introduction of yeast artificial 
chromosomes (YACs) into the mouse germline using different methods 
(reviewed in Forget, 1993; Montoliu et al., 1994; Lamb and Gearhart, 1995). 
The effect that the cytoskeleton has in the survival after nuclear transfer 
needs to be further investigated. Several publications have reported the 
extrusion of polar-body like structures containing DNA derived from the 
transferred nucleus (Kono et al., 1992; Cheong et al., 1993; see also section 
5.3.1). It is not clear what causes this phenomenon. It may be the result of the 
"mixture" between the mitotic cleavage of the transferred nucleus and polar 
body extrusion mechanism that remain in the cytoplast. Experiments in which 
the role of the cytoplast is studied in detail during the first few hours after 
nuclear transfer may help to clarify this question (Pinto-Correia et al., 1993). 
Nevertheless, it may be useful to correct ploidy of the embryos if nuclei in G2-
phase are used as nuclear donors. 
Although development to term has been achieved with cultured cells 
derived from the 1CM in sheep (Campbell et al., 1995), no development to 
term has been reported after blastocyst developed from stem-cell nuclei were 
transferred into pseudopregnant mouse (Kato and Tsunoda, 1993). The 
differences on the proportion of embryos reconstituted by nuclear transfer that 
developed to blastocyst and to term between mouse and rabbit or ruminant 
embryos remains unsolved. As it has been discussed before (see section 1.3) it 
has been suggested that this difference is due to the variation in the timing 
when the major onset of zygotic transcription occurs in those species (McGrath 
and Solter, 1984; Howlett et al., 1987; Prather and First, 1990; Wilmut and 
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Campbell, 1992). Development to term has been achieved from later stages in 
those species in which the onset of transcription occurs also later (see table 
1.1). The existence of a mouse species (Mus caroli) in which embryonic 
genome onset of transcription happens at the 8-cell stage (Dr John Ansell, 
personal communication, see also West et al, 1991) may provide a good 
experimental approach to investigate these effects by inter-specie nuclear 
transfer. 
One of the questions not contemplated in this thesis is the possibility of 
conditioning the cells used as nuclear donors in order to make those nuclei 
more easily reprogramable. Experiments conducted with amphibian embryos 
showed that exposure of the nuclear donor cells to substances such as spermine 
(Hennen, 1970), protamine or polyarginine (Brothers, 1985) or to lower 
temperatures (Hennen, 1970) resulted in an important improvement on the 
development after nuclear transfer, which suggests that this will be an 
interesting approach to study. Mouse stem-cells cultures will make the use of 
these pre-nuclear transfer treatments relatively easy to perform and evaluate. 
Theoretically, the majority of cells in an adult animal contain all the 
necessary information to direct the development of a new individual. Similarly, 
diploid cultured cells would be able to do the same. Although insurmountable 
biological barriers can not be excluded, it can be wildly speculated that the real 
problem is the absence of adequate methodology which would achieve it. The 
results presented in this thesis have shown that some of the problems that were 
considered such biological barriers in the past were no more than 
methodologically wrong approaches to the problem. The challenge to solve the 
remaining technical and methodological problems and thus found the way that 







The experiments described in this chapter were set up with the 
intention of testing the hypothesis obtained as conclusion of the experiments 
conducted during this project. This hypothesis can be stated as follows. During 
the early Gi-phase of the cell-cycle, when the nuclear envelope has been 
reformed but the chromatin is still partially condensed, a nuclear transfer 
permissive window exist. Although it is not clear how, it can be suggested that 
the special chromatin configuration at that period is responsible for the 
superior capability of these nuclei to conduct development after nuclear 
transfer. The cytoplasts used as recipient must be obtained from an oocyte in 
metaphase II where the reprogramming factor is still present. It appears 
advantageous if this cytoplasts is preactivated before nuclear transfer to avoid 
interferences with DNA replication associated with nuclear envelope break-
down and premature chromosome condensation. Finally, the use of slightly 
older oocytes which can answer with an "extra activation" to unintended 
activation stimuli received during the procedures may increase the chances of 
survival of the reconstituted embryo. It may be possible to use this approach to 
obtain development after nuclear transfer using nuclei from cells more 
differentiated than the embryonic blastomeres utilized in the experiments 
described before. 
Mouse stem-cells provide a source of nuclei that may be used to test 
the hypothesis stated above. Those cells have the advantage of their 
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pluripotency and therefore would be more able to support development after 
nuclear transfer than, for example cultured fibroblasts. Thus, Tsunoda and 
Kato (1993) reported 12-18% of development to blastocyst of embryos 
reconstituted by transfer of stem cells into enucleated metaphase II oocytes. 
However, so far, nobody has reported development to term when mouse stem 
cells were used as nuclear donors. Nevertheless, the existence of almost 
totipotent stem-cell lines in mouse (Nagy et al., 1993) that were able to 
developed to live mice entirely derived from the stem cells after aggregation 
with tetraploid embryos suggested the use of those cells as nuclear donors in 
this investigation. 
Another advantage of using stem-cells as nuclear donors is the 
possibility of separating developmental stage effects from the effects due to 
cell-cycle phase and having a clearer understanding of the importance of these 
last effects on survival after nuclear transfer. Finally, the establishment of a 
routine method to conduct nuclear transfer experiments where stem-cell are 
used as nuclear donors will provide a very powerful tool to get a better 
understanding of the molecular interactions and mechanism involved in the 
acquisition of differentiation by the cells and how the reversal of this 
differentiation is achieved during the process of reprogramming after nuclear 
transfer. 
However, to test the hypothesis stated earlier, it was necessary to obtain 
stem-cells at the adequate early Gi-phase. Therefore, studies on ways of 
synchronizing nuclear donor cells in this particular period were conducted with 
this aim. It was decided to obtain a population of stem-cells in mitosis and map 
their progress into the Gi-phase to assess the time they will need to enter the 
nuclear transfer permissive window. Also, a major technical problem that has 
to be addressed before large scale experiments are conducted is the difficulty 
of fusing stem-cells with the cytoplasts cell membrane (Kato and Tsunoda, 
1993). In another separate series of experiments different approaches to 
overcome this problem were compared. 
A1.2 MATERIAL AND METHODS 
Stem cells. The culture and maintenance of the stem cells was done by 
Mrs Ray Ansell. Briefly, stem-cells of Ri line (a gift from Dr Lesley 
Forrester), at passage n°10 to 12 were used in the experiments described here. 
The cells were cultured in BHK-21 medium (GLASGOW MEM) 
supplemented with 1% sodium pyruvate, 1% non-essential amino-acids, 5% 
foetal calf serum, 5% new born calf serum, 0.2% B mercaptoethanol and 285 p.! 
human LIF. The culture medium was changed every day and the cells were 
passaged every 2 - 3 days. The cells used in these experiments were obtained 
from culture flask on day 1 after passage. 
Obtaining cells in mitosis. Two approaches were used to collect a 
population of stem-cells in mitosis. A medium change was done 2 hours before 
any manipulation of the cells. After this time, a new medium change was done. 
The cells were harvested shaking the flask and removing those cells that had 
detached. In the second approach the cells were incubated for 1 hour with 
1p.g/ml colcemid in complete culture medium prior to shaking and collecting 
them. 
Mapping the cell cycle. The sample of cells in mitosis was plated in 
several culture Petri dishes. Progression through anaphase and telophase and 
completion of mitosis was monitored every 30 minutes. To do so, first a dish 
was fixed in methanol at 4 C for 10 minutes and then was stained either with 
Giemsa for 3 minutes or with Hoechst 33342 for 5 minutes. Nuclear 
morphology of the cells was monitored either by bright field microscopy or by 
examination of Hoechst stained cells under UV microscopy. 
Fusion experiments. Two different populations of stem-cells were 
used as nuclear donors in these experiments. Thirty minutes before nuclear 
transfer the cells were collected by removing them from the culture flask by 
shaking (mitotic cells) or by trypsinisation (interphase cells). Cytoplasts were 
obtained from oocytes in metaphase II recovered 15 to 16 hours after hCG 
injection. A slit was made in the zona pellucida and a flat-end pipette was used 
to enucleate them. The oocytes were stained with Hoechst 33343 to check that 
all were enucleated. Details of these procedures are given in chapter 2. 
In the first experiment, the influence of the cell-cycle phase of both the 
oocyte and the stem-cell on the efficiency of Sendai virus mediated fusion and 
subsequent development of the reconstituted embryo was investigated. Stem-
cells either in mitosis or in interphase were exposed to Sendai virus for 30 
207 
seconds before they were introduced below the zona pellucida of oocytes either 
in metaphase II or 6 to 8 hours after parthenogenetic activation induced by 
strontium. There were 2 replicates and 30 to 50 embryos in each treatment. 
In a second experiment, a different approach was tried where stem-cell 
nuclei were injected into the oocyte cytoplasm with a system similar to the one 
used for intracellular sperm injection procedures. Nuclei from stem cells were 
injected into the cytoplasm of enucleated oocytes. The intracytoplasmatic 
injections were performed by Mr. Bill Ritchie. The cells were drawn into a 
flat-end enucleation pipettes where the cell membrane was lysed. The pipette 
was then pushed into the middle of the oocyte inside an invagination of the 
cellular membrane before starting the injection procedure. Applying gentle 
suction the cytoplasm was drawn inside the pipette until the cellular membrane 
was broken. At this time the contents of the pipette were put back inside the 
oocyte and the pipette was removed. 
A1.3 RESULTS 
A1.3.1 - Obtaining stem-cells early in GI-phase. 
A population rich in mitotic cells was obtained with either of the two 
approaches used to collect the cells. As shown in figures A1.1 and A 1.2, it was 
easy to distinguish between interphase and mitotic cells. However, the main 
problem encountered to accomplish the aim of this experiment was the 
inability to identify cells in the anaphase-telophase period of the mitosis. 
Individual chromosomes were easily seen once the cell membrane was 
broken during the preparation of the specimen (see fig Al. I  b and c). However, 
if the integrity of this membrane was conserved, the chromosomes appeared as 
a chromatin mass where individual chromosomes were indistinguishable. 
Several preparations were observed. However, no cells showing an anaphase-
telophase nuclear morphology were identified. 
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Figure Al.! - Nuclear morphology of the stem-cells stained with 
Gi emsa. 
The sample of cells was fixed in methanol at 4 C for 10 minutes and then was stained 
with Giemsa for 3 minutes. 
Stem-cell in interphase. Note high nucleus/cytoplasm ratio and also the presence of 
several nucleoli in each nucleus. 
and c) Samples of stem cells in mitosis. Individual chromosomes were easily seen 
once the cell membrane was broken during the preparation of the specimen (arrow 
heads). However, if the integrity of this membrane was conserved, the chromosomes 
appeared as a chromatin mass where individual chromosomes were indistinguishable 
(big arrows). In some cases the cellular membrane was broken but the chromosomes 
were still aggregated appearing as an intermediate situation between those described 
before (thin arrow). 
a 










Figure A1.2 - Nuclear morphology of stem-cells after staining with 
Hoechst 33342. 
The sample of cells was fixed in methanol at 4 C for 10 minutes and then was stained 
with Hoechst 33342 for 5 minutes. 
a) Stem-cell nuclei in interphase. 
b) Stem-cell nuclei in mitosis. 

Figure A1.3 - Comparison of nuclear morphology of stem-cells and 2-
cell stage embryos after staining with Hoechst 33342. 
The sample was fixed in methanol at 4 C for 10 minutes and then was stained with 
Hoechst 33342 for 5 minutes. 
a) Stem-cell nucleus in mitosis. Individual chromosomes were not as clearly visible as 
in b. 
b) 2-cell stage blastomere nucleus in mitosis. 

Figure A1.4 - Development to blastocyst of embryos reconstituted with 
stem-cell nuclei. 
Cytoplasts were obtained from oocytes in metaphase H recovered 15 to 16 
hours after hCG injection. A slit was made in the zona pellucida and a flat-end pipette 
was used to enucleate them. The oocytes were stained with Hoechst 33343 to check 
that all were enucleated. Details of these procedures are given in chapter 2. Nuclei 
from stem cells were injected into the cytoplasm of enucleated oocytes. 




A13.2 - Stem-cells to cytoplast fusion. 
In the first experiment, all the embryos fragmented 24 hours after 
manipulation, although in some of the fragments a pronucleus-size nucleus 
was clearly visible suggesting that fusion had occurred. 
In the second experiment, the survival rate of the oocytes after 
intracytoplasmatic injection was affected by the diameter of the injection 
pipette: 67% (19/28) survived when a pipette of 5 to 7 jL.m diameter was used, 
but only 25% (16/63) when the diameter was increased to 10 to 15 1m. After 
24 hours 47 % (7/15) of the surviving embryos in the first group and 23 % 
(3/14) in the second had undergone nuclear swelling and formed a pronucleus-
size nucleus. A proportion (30%) developed to blastocyst (3 blast/10 embryos) 
(see fig. A 1.4). 
A1.4 DISCUSSION 
Due mainly to the lack of time to solve the technical difficulties 
encountered to obtain stem-cells at the required early 01-phase, it was decided 
to stop these experiments. Nevertheless, the observations made in the fusion 
experiment suggested that intracytoplasmatic injection of nuclei may increase 
the efficiency of nuclear transfer procedures when stem-cells are utilized as 
nuclear donors. This nuclear transfer method has been successfully used 
recently with bovine oocytes (Collas and Barnes, 1994). Also, this method 
would be simpler than the complex method used to enhance the fusion rate 
(phytohaemagglutinin plus Sendai virus plus two electrical pulses separated by 
one hour) in the experiment reported by Tsunoda and Kato (1993). 
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APPENDIX 2 
Culture Media and Solutions 
In this appendix are given detailed composition of the diverse media 
(culture, manipulation, activation and others) and of the procedures followed in 
their preparation. Also in this appendix, the details of stock solutions of 
chemical compounds and antibodies used in this project can be found. 
Al.! - Culture media M16, gM16 and pM16. 
Table A2.1 - Composition of M16, gM16 and pM16 
Compound 	MW 	 gflitre (mM) 
M16 	gM16 	pM16 
NaCl 	 58.450 5.533 (94.66) 4.700 (80.40) 4.700 (80.40) 
KC1 	 74.557 0.356 (4.78) idem idem 
CaC12 7 H20 	147.200 0.252 (1.71) idem idem 
KH2PO4 	136.091 0.162 (1.19) idem idem 
M9SO4 7 HO 	246.500 0.293 (1.19) idem idem 
NaHCO3 	84.020 2.101 (25.00) idem idem 
Sodium pyruvate 	110.000 0.036 (0.33) 0.040 (0.36) 0.040 (0.36) 
Glucose 	179.860 1.000 (5.56) 0.500 (2.78) 0.350 (1.95) 
EDTA 	372.200 0 0 0.037 (0.1) 
Sodium lactate 	112.100 4.349 of 60% syrup(23 28) idem idem 
Bovine serum albumin (BSA) 4.000 idem idem 
Penicillin G (K salt) 
(final conc. 100 units/ml) 0.060 idem idem 
Streptomycin sulphate 
(fmal conc. 50tgIml) 0.050 idem idem 
Phenol Red 0.010 idem idem 
Water (predeionized, sterile, glass-distilled) up to 1 litre. 
Osmolarity: M16 = 280; gM16 = 260; pM16 -265 mosmoles. 
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When no otherwise indicated, the compounds used in the preparation of 
those media were of cell culture tested grade and purchased from Sigma 
(Poole, Dorset, UK). The water was obtained from the instalations at the 
Roslin Institute. 
Procedure - Penicillin and streptomycin were weighed out in a small beaker 
and dissolved in water. The same was done with calcium chloride in another. 
The remaining compounds (except BSA and lactate) were weighed out into a 
1-litre volumetric flask, about 500 ml water was added and the compounds 
were allowed to dissolve. Then the lactate syrup, weighed out separately was 
poured to the solution, the antibiotics and the calcium were added and the 
volume was made up to one litre with water. The required volume was 
supplemented with BSA, filter-sterilised into aliquots and stored at 4°C. 
A2.2 - Manipulation media M2. 
Table A2.2. - Composition of M2. 
Compound 	mm 	MW 	gflitre 
NaCl 94.66 58.450 5.533 
KG 4.78 74.557 0.356 
CaC12 7 H20 1.71 147.200 0.252 
KH2PO4 1.19 136.091 0.162 
MgSO4 7 HO 1.19 246.500 0.293 
NaHCO3 4.15 84.020 0.349 
HEPES 20.85 
Sodium lactate 23.28 
Sodium pyruvate 0.33 
Glucose 5.56 
Bovine serum albumin (BSA) 
Penicillin 0 (K salt) final conc. 100 units/ml 
Streptomycin sulphate (final conc. 50jig/mi) 
Phenol Red 
Water (j:,redeionized, sterile, glass-distilled) 
238.300 4.969 







up to 1 litre. 
Osmolarity M2 = 280 mosmoles. 
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A2.3 - Preparation of manipulation and activation media from stocks. 
Table A2.3 - Composition of stock solutions 
Stock Mg free A. 	Component 
	 g/lOOml 














Stock B 	 Component 	 gIlOOml 
(10 x concentration) 	 NaJ{CO3 	 0.349 
Phenol Red 	 0.010 
Stock C 
	
Component 	 gIlOml 
(100 x concentration) 	Sodium pyruvate 	 0.036 
Stock D 	 Component 	 g/lOml 
(100 x concentration) 	CaC12 7 H20 
	
0.252 
Stock E 	 Component 	 g/lOOml 
(10 x concentration) 	 IIEPES 	 4.969 
Phenol Red 0.010 
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Stock Mg 	 Component 	 g/lOmI 
(100 x concentration) 	M9SO4 7 HO 	 0.293 
Stock Sr 	 Component 	 g/lOml 
(100 x concentration) 	SrC12 6 H20 	 0.452 
Storage - At 4°C stocks A Mg-, D, E, Mg and Sr were kept up to 3 months, 
but stocks B and C were change every three weeks. 
Table A2.4 - Procedure to prepare M2 and calcium magnesium free M16 plus 
strontium from stocks. 
Stock M2 Ca Mg free M16 + Sr 
Mg free A 10 	ml 2.50 ml 
B 1.6 ml 2.50 ml 
C 1.0 ml 0.25 ml 
D 1.0 ml 0 	ml 
E 8.4m1 0 ml 
Mg 1.0 ml 0 	ml 
Sr 0 ml as required (see table A2.5) 
Water Up to 100 ml Up to 25 ml 
Table A2.5 - Preparation of calcium magnesium free M16 plus strontium, 
amount of stock Sr required according with the desired final concentration. 
SrmM 5 10 25 50 100 
stock Sr 	0.74 	1.47 	3.67 	7.35 	14.70 
(ml) 
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A2.4 - Phosphate Buffered Saline (PBS). 
Calcium-magnesium free PBS was prepared by dissolving pre-
formulated tablets (Flow Laboratories,Rickmansworth, Hertfordshire, UK) in 
distilled water into 500 ml bottles. PBS was then sterilised by autoclaving and 
stored at room temperature. 
A25 - Acidic Tyrode solution for removing zona pellucida. 
A fresh 100 ml solution was prepared every two months and kept at 
room temperature. The pH was adjusted with Analar HC1. It was sterilized by 
filtration. Its composition in g/100 ml was: 
NaCl 	 0.800 
KC1 0.020 
CaC12 2H20 	 0.024 
MgCL2 6H20 0.010 
Glucose 	 0.100 
Polyvinylpyrrolidone (PVP) 	0.400 
The PVP was added to increase the viscosity and reduce embryo 
stickiness. 
A2.6 - Hank's Balanced Salt solution (HBSS). 
This solution was used as diluyent through the production of Sendai 
virus. For some of the procedures glucose was omitted in its composition, in 
those cases it was denominated Hanh's balanced salt solution without glucose 
(HBSSG-). The whole composition was: 0.14 g/l of CaCl2; 0.40 g/l of KC1; 
0.06 gIl of KH2PO4 ; 0.0977 g/l of MgSO4 ; 8.00 g/l of NaCl; 0.048 g/l 
Na2HPO4; 1.00 g/l of glucose and 0.01 gIl of phenol red. 
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A2.7 - Chemical stocks 
A2.7.1 - Aphidicolin 
Aphidicolin, from Nigrospora sphaerica (C20H3404; Sigma code n 
°A-0781; Poole, Dorset, UK.) was dissolved in dimethyl suiphoxide at 1 mg / 
ml and kept at -20°C. One .Ll aliquots were made in 1.5 ml Eppendorfs tubes 
that were also kept at -20°C. 
A2.7.2 - Anti-bromodeoxyuridine antibody 
Mouse anti-bromodeoxyuridine (anti-BrdU) monoclonal antibody 
conjugated to fluorescein (Boebringer, cat n° 1202, Lewes, East Sussex, UK.) 
was diluted to 50 .tg/ml.in PBS supplemented with 0.1% BSA. Fifty .tl 
aliquots were made and kept at - 20°C. 
A2.7.3 - Bromodeoxyuridine 
Bromodeoxyuridine (BrdU) (5-bromo-2'deoxyuridine 5 '-triphosphate, 
Sigma code N° B-063 1; Poole, Dorset, UK) was disolved in water at 1 mg /ml 
concentration. Aliquots of 100 tM were made and kept at - 20°C. 
A2.7.4 - Colcemid 
Colcemid, a trade mark for demecolcine, (N-deacetyl-N-methyl-
colchicine; Sigma code No. D-6279; Poole, Dorset, UK) was dissolved in 
distilled water at 0.04 mg/ml and kept at 4°C. 
A2.7.5 - Cycloheximide 
Cycloheximide, (3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-
hydroxyethyl] glutarimide; Sigma code n° C-6255; Poole, Dorset, UK.) was 
dissolved in water at 0.5 mg/ml and kept at - 20 °C in 20p.l aliquots. 
A2.7.6 - Cytochalasin B 
Cytochalasin B, from Helminthosporium dematioideum (C29 H37 
N05; Sigma code No. C-6762; Poole, Dorset, UK.) was dissolved in dimethyl 
suiphoxide at 5mg/nil and kept at - 20°C. The stock solution was used several 
times after freezing and thawing without any apparent lost of potency. For 
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every day use, 2tl (lOp.g) aliquots were made and they were thawed and 
utilised only once . One ml of the medium was added to them to achieve a 
working concentration of 10 tg/ml. 
A2.7.7 - Hoechst dye. 
Hoechst no 33342, bisbenzimide (2'-[4-Ethoxyphenyl]-5-[4-methyl-  1-
piperazinyl]-2,5'-bi-lH-benzimidazole; Sigma code no B-2261; Poole, Dorset, 
UK.) was dissolved in distilled water at 20 mg/mi and kept at - 20 °C. The 
stock solution was further diluted to 0.2 mg/ml and from this 4j.tl (0.8 jig) 
aliquots were made and kept at - 20°C. For chromosome staining during 
oocyte enucleation, a working concentration of 0.8 jig/mi was used. 
A2.7.8 - Hyaluronidase 
Hyaluronidase, Type IV-S from bovine testes lyophilized powder 
containing approx. 90% protein ; balance primarily buffer salts. 
(Hyaluronoglucosaminidase; Hyaluronate 4-glycanohydrolase ; Sigma code 
n°H-3884; Poole, Dorset, UK.) was kept at - 20 °C. A stock solution was 
prepared by dissolving 30 mg into 1 ml of distilled water and it was divided in 
10 pJ aliquots that were kept at -20 °C. Before use 1 ml of medium (gM16 or 
M2) was added to reach a working concentration of 300 jig/mi. 
A2.7. 9 - Hydroxyurea 
Hydroxyurea, (CH4N202; Sigma code n°H-8627; Poole, Dorset, UK.) 
was kept at 4°C as desiccated crystalline powder. A stock solution at 19 mg/ml 
of water was made and divided in 20 p1 aliquots that were kept at -20°C. 
A2.7.10 - Lectin 
Lectin FBP from Lotus tetragonolobus purpureus conjugated to 
fluorescein isothiocyanate (Sigma cat no L-5644) was diluted in PBS 
supplemented with 0.1% BSA to a final concentration of 200 jig lectin/ml. 
Aliquots of 200 p1 were made and stored at -20 °C. Before use those aliquots 
were thawed and centrifugated. The clear supernatant was used for labelling. 
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A2.7.11 - Mimosine 
Mimosine, (leucenol; Aldrich code n° M8,761-4; Gillingham, Dorset, 
UK.) was kept as powder at 4 °C. For the stock solution mimosine was 
dissolved in PBS at 0.2 mg/ml (10 mM) and was kept at 4°C for four weeks. 
A2.7.12 - Nocodazole 
Nocodazole, (methyl (5-[2-thienylcarbonyl] - 1H-benzimidazol-2-yl) 
carbamate; Sigma code n° M-2759; Poole, Dorset, UK.) was dissolved in 
dimethyl sulphoxide at 2 mg/ml and kept at - 20 °C. The stock solution was 
used several times after freezing and thawing without any apparent lost of 
potency. In later experiments, 1 .tl aliquots of the stock solution were made 
and they were thawed and used only once. 
A2.7.13 - Trichostatin A. 
Trichostatin A was a generous gift from Doctor M. Yoshida (Dept. of 
Agricultural Chemistry; University of Tokyo). One mg was dissolve in 0.2 ml 
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Transfer of Nuclei From 8-Cell Stage Mouse 
Embryos Following Use of Nocodazole to Control the 
Cell Cycle 
P.J. OTAEGUI, G.T. O'NEILL, K.H.S. CAMPBELL, AND I. WILMUT 
BBSRC Roslin Institute, Roslin, Midlothian, Edinburgh, Scotland 
ABSTRACT 	Mouse 2-, 4-, 8-, and 16-cell em- 
bryos were exposed to nocodazole in M16 culture me-
dium. The effect of different concentrations and exposure 
times on the efficiency of cell cycle synchronization and 
the development of the treated embyros after release from 
the drug was determined. The minimum effective concen-
tration (>95% of arrested nuclei) for 4-, 8-, and 16-cell 
embryos was 5 p.M nocodazole. The effect upon subse-
quent development of mouse embryos depended upon 
both the stage of development of the embryo at treatment 
(P < 0.001) and the length of exposure to nocodazole 
(P < 0.001). Exposure to any concentration of nocodazole 
within the range 2.5-10 p.M for 12 hr caused a reduction in 
the proportion of embryos that formed blastocysts. As the 
period of exposure to 5 [LM nocodazole increased from 12 
to 24 hr, the proportion of embryos developing to the 
blastocyst stage decreased. The lower proportion of emb-
yros developing to the blastocyst stage and to term 
(P < 0.01) suggests that the more advanced stages were 
more susceptible to damage as a result of exposure to 
nocodazole. The rate of development of 4-cell embryos to 
blastocysts was not affected when an exposure time of 9 
hr was used. Together these results show that it is possible 
to use nocodazole to arrest mouse embryonic cells in 
mitosis but that it is not appropriate to culture the embryos 
in the presence of this drug for prolonged periods. Individ-
ual blastomeres completed mitosis at 60-90 min and 
started DNA synthesis at 120-150 min after release from 
nocodazole. Nuclei from blastomeres thus synchronized 
were used to conduct studies on the effect of the cell cycle 
on nuclear transfer. A signficant effect was found. When 
nuclei from 8-cell embryos in Gi or S-phase were used as 
nuclei donors, development to blastocyst was respectively 
27% and none. 	© 1994 Wiley-Liss, Inc. 
Key Words: Mitosis, Synchronization, Mice, BIas-
tomere 
INTRODUCTION 
There is increasing evidence that the cell cycle stage 
of donor blastomeres influences the development of re-
constituted embryos produced by nuclear transfer, al-
though the mechanisms involved are not understood 
(Howlet et al., 1987; Smith and Wilmut, 1988; Tsunoda 
et al., 1989; Collas et al., 1992; Kono et al., 1992; 
0 1994 WILEY-LISS, INC. 
Cheong et al., 1993). A simple method of obtaining pop-
ulations of blastomeres at specific cell cycle stages is 
required for precise investigations of these effects and 
for the establishment of improved practical procedures. 
Cytoskeletal inhibitors are one group of compounds 
that have the potential to arrest the cell cycle at spe-
cific stages. Some of them have been used to study the 
effect of inhibition of microtubule or microfilament 
function upon mouse preimplantation development 
(Siracusa et al., 1980; Surani et al., 1980), but few stud-
ies have examined their use to control the cell cycle. 
Recently, colcemid has been shown to arrest 16-cell 
rabbit embroys reversibly (Collas et al., 1992) and a 
comparative study of the use of nocodazole and colcemid 
to induce synchronous cell division in mouse 2-cell em-
bryos concluded that nocodazole was less detrimental to 
subsequent pre- and postimplantation development 
(Kato and Tsunoda, 1992). 
The aim of this project was to establish a reliable 
procedure for production of embryonic cells in Gi. To 
achieve this, experiments were conducted to determine 
the lowest concentration of nocodazole able to arrest the 
cell cycle in mitosis and the longest period of culture in 
this concentration that was compatible with normal 
development. A method to synchronise 4-cell embryos 
in mitosis was established and upon release, the timing 
of nuclear events during the subsequent development 
through the 8-cell stage was determined. A comparison 
was then made of development following nuclear trans-
fer from cells in Gi or S phase of the 8-cell stage. 
MATERIAL AND METHODS 
Embryos 
Fl mice (C57BL16 x CBA) aged 4-6 weeks were su-
perovulated by an intraperitoneal injection of 5 IU of 
pregnant mare serum gonadotropin (PMSG) (Folligon, 
Intervet, Cambridge) followed 48 hr later by 5 IU of 
human chorionic gonadotropin (hCG) (Chorulon, In-
tervet, Cambridge) and mated with Fl males of the 
same genotype. The mice were killed by cervical dislo-
cation 44 hr after hCG injection (p-hCG) and the 2-cell 
Received February 16, 1994; accepted April 4, 1994. 
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stage embryos recovered from the oviducts before being 
washed twice in M2 medium (Whittingham and Wales, 
1969). Until required for manipulation, the embryos 
were cultured at 37°C in microdrops of modified M16 
(Whittingham, 1971) (NaCl 80.40 mM, sodium pyru-
vate 0.36 mM, glucose 2.78 mM, osmolarity 0.260 
Osml) under liquid paraffin (Merck Ltd., Poole, Dorset, 
UK) in an atmosphere of 5% CO 2 in air. 
Nocodazole 
Nocodazole, (methyl (5-[2-thienylcarbonyll-1H-benz-
imidazol-2-yl)carbamate, Sigma code M-2759; Poole, 
Dorset, UK) was dissolved in dimethyl sulfoxide at 2 
mg/ml and kept at —20°C. The stock solution was used 
several times after freezing and thawing without any 
apparent loss of potency. 
Exposure to Nocodazole 
Three sets of experiments were conducted to (1) de-
termine the minimum concentration of nocodazole re-
quired to arrest and maintain the cell cycle in mitosis, 
(2) determine the maximum period of culture in that 
concentration that was compatible with normal devel-
opment to blastocyst, and (3) study the ability of no-
codazole-treated embryos to develop to term. 
The effects of nocodazole were investigated using em-
bryos at 2-, 4-, 8-, and 16-cell (morula) stages of devel-
opment. Embryos were transferred into medium sup-
plemented with nocodazole, when they were expected to 
be approaching the end of S-phase.(Pratt, 1987) so that 
the exposure to nocodazole before the blastomeres en-
tered mitosis would be minimized. Thus, 2-cell embryos 
were transferred into nocodazole-supplemented media 
at 48 hr after hCG injection (p-hCG); 4-cell at 58. hr 
p-hCG; 8-cell at 72 hr p-hCG, and 16-ce11 at. 84 hr 
p-hCG. 
The ability of each concentration of nocodazole to 
arrest the cell cycle was assessed by staining the em-
bryos with aceto-orcein to determine the proportion of 
cells in mitosis at the end of the exposure. After over-
night fixation in a solution of 25% glacial acetic acid in 
methanol, embryos were washed with absolute metha-
nol, followed by a solution of 45% glacial acetic acid in 
distilled 'water. They were stained with 1% orcein in 
45% acetic acid. 
When the developmental potential of embryos was to 
be determined, they were washed several times in M2 
and modified M16 and cultured at 37°C in microdrops of 
modified M16 under liquid paraffin in an atmosphere of 
5% CO2 in air. Only those embryos that developed to 
expanded blastocyst stage with a visible inner cell mass 
were recorded as blastocysts. 
Experiments were conducted to study the effect of 
nocodazole on development to term. In the first, 2-, 4-, 
8-, and 16-cell embryos were exposed to 5 pM of nocoda-
zole in modified M16 for 12 hr. In the second, 4-cell 
embryos were exposed to 10 pM of nocodazole in modi-
fied M16 for 9 hr. After treatment embryos were 
washed several times in M2 and M16 and cultured. 
Embryos that formed fully expanded blastocysts were 
transferred to the uteri of day 3 pseudopregnant recipi- 
ent females (day of plug = day 1). Embryo transfer 
procedures were conducted using standard techniques 
(Hogan et al., 1986). Anaesthesia was induced by in-
traperitoneal administration of a mixture of midazolam 
(Hypnovel, Roche Products Ltd., Welwyn Garden City, 
UK) and fentanyl-fluanisone (Hypnorm, Janssen Phar-
maceutica, B.V. Tilburg) (Flecknell, 1983; Hethering-
ton, 1987). The recipient females were allowed to give 
birth and the number of offspring was recorded. Control 
transfers were made with blastocysts that had devel-
oped from the 2-cell stage in culture. 
Cell Cycle After Treatment 
In order to know the stage of the cell cycle when cells 
were used as nuclear donors, the time of progress 
through mitosis and nuclear membrane reformation af-
ter treatment with nocodazole was determined by UV 
microscopy. Embryos were stained with Hoechst 33342 
(Sigma code No. B-2261). The onset of DNA synthesis 
was determined by detection of bromodeoxyuridine 
(BrdU) incorporation by the embryo. Immediately after 
release from nocodazole, embryos were incubated in 
M16 supplemented with 100 pM BrdU (5-bromo-
2'deoxyurdine 5'-triphosphat6, Sigma code B-0631). 
After incubation the zona pellucida was removed with 
acid Tyrode's solution (Hogan et al., 1986) and zona free 
embryos were washed in phosphate-buffered saline 
(PBS), transferred to slides and allowed to air dry. 
When dried, a drop of 0.5% agar solution was placed 
over the embryos .and they were air dried again. Once 
dried, the embryos were fixed in methanol for 10 mm, 
washed in PBS, permeabilised in 2% -Triton X-100 for 
10 :min at room temperature; washed in PBS, hydrol-
ysed in 4N HCl for 2 hr at 37°C, and washed twice in 
borate buffer (pH =8.5), and three times in PBS. Excess 
PBS was removed and the embryos were then incu-
bated in an humidified chamber with 7 pl of fluorescein 
conjugate anti-BrdU monoclonal antibody (Boehringer, 
Cat. no. 1202, Lewes, East Sussex, UK), diluted to 50 
ig/m1 in PBS supplemented with 0.1% BSA. After 1-hr 
incubation at room temperature, the slides were 
washed in PBS, excess PBS was removed, the embryos 
were mounted (Dabco Aldrich Ltd, Dorset, UK) and 
examined by epifluorescence using a Nikon micro-
phot-SA. 
Nuclear Transfer 
In a final experiment nuclei from 8-cell embryos at 
different stages of the cell cycle (Gi or 5) were trans-
ferred to the cytoplasm of enucleated oocytes recovered 
14.5 hr after hCG injection using the method described 
by Kono et al. (1992). Synchronized cells were used as 
nuclear donors 75-90 min or >195 min after release 
from nocodazole (Gi and S phases, respectively). The 
reconstituted embryos were activated by exposure for 1 
hr to 25 mg strontium chloride in calcium and magne-
sium free M16, and the rate of development in vitro to 
blastocyst was recorded. 
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TABLE 1. Effect of Concentration of Nocodazole and Embryo Stage on the 
Proportion of Mouse Embryo Cells Arrested in Mitosis 
2-cell 	 4-cell 	 8-cell 	Morula (16-18) 
5 p.M 	38/38 (100)8 40/40 (100) 	144/152 (94) 	337/358 (94) 
2.5 p.M 14/14 (100) 	24/36 (68) 89/112 (79) 59/90 (65) 
aNumber  (%) of nuclei in mitosis at the end of exposure for 12 hr. Recorded after staining with 
aceto-orcein. 
TABLE 2. Effect of Time of Exposure to Nocodazole and Embryo Stage on the 
Proportion of Mouse Embryo Cells Arrested in Mitosis 
Stage 0 hr 12 hr 16 hr 20 hr 24 hr 
2-cell No data 38/38 (100)8 10/10 (100) 39/40 (98) No data 
4-cell No data 48/50 (96) 40/40 (100) 26/33 (78) 18/24 (75) 
8-cell 6/119 (5) 144/153 (94) 78/78 (100) 109/127 (86) No data 
Morula 17/344 (5) 337/358 (94) 72/91 (91) 35/37 (94) 73/82 (89) 
'Number (%) of nuclei in mitosis at the end of exposure to 5p.M Nocodazole. Recorded after 
staining with aceto-orcein. 
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Statistical Analysis of the Data 
The effects of embryo stage, duration of exposure and 
their interaction, and the effect of nocodazole concen-
tration, allowing for differences between days, on the 
proportion of treated embryos developing to the blasto-
cyst stage were examined by a logistic linear model. 
Differences between means were assessed by a Stu-
dent's t-test. Extrabinomial variation was accommo-
dated by the method of McCullagh and Nelder (1989). A 
similar logistic linear model was used to look at the 
effect of stage on the rate of development to term of 
transferred embryos after exposure to nocodazole. 
RESULTS 
• Effect of Concentration of Nocodazóle and 
Length of Exposure on the Ability of Nocodazole 
to Arrest the Cell Cycle in Mitosis 
• In a comparison of 2.5 p.M and 5 p.M nocodazole the 
effect depended on the concentration of the drug and 
the stage of embryo development (Table 1). More than 
94% of the cells were arrested in mitosis when embryos 
at the 2-,.4-, 8-, or 16-cell stages were cultured in the 
presence of 5 p.M nocodazole for 12 hr (Table 1). By 
contrast, 2.5 p.M nocodazole inhibited mitosis in a lower 
proportion of cells in the 4-, 8-, and 16-cell stage em-
bryos. The effect of nocodazole persisted over long peri-
ods, as even after 20-hr exposure to 5 p.M nocodazole, 
most of the nuclei had condensed chromosomes (Ta-
ble2). 
Development to Blastocyst of Embryos Exposed 
to Nocodazole 
Time of first cleavage after release. Once re-
leased from 10 p.M nocodazole, the blastomeres under-
went synchronous cleavage that was completed within 
1.5 hr (Table 3). A small number of embryos degener-
ated. 
Development to blastocyst. Overall 97% ± 0.92 of 
untreated control embryos reached the blastocyst 
stage. Exposure to the amount of DMSO used as solvent 
for nocodazole had no detrimental effect on develop-
ment (untreated control 327/336; DMSO control 49/51; 
X 2 = 0.248, df = 1, P> 0.5). Among treated embryos, 
only data from higher concentrations of nocodazole 
have been considered because embryos at the 4-, 8-, and 
16-cell stages exposed to 0.25 and 0.62 p.M nocodazole 
for 12 hr divided before the end of treatment and, after 
release from the drug, most of the embryos from these 
groups developed to normal blastocyst. 
Exposure to any concentration of nocódazole within 
the range 2.5-10 p.M for 12 hr caused a reduction in the 
proportion of embryos that formed blastocysts (Table 
4). Most of the embryos that failed to reach the blasto-
cyst stage showed a disorganized morphology with bias-
tomeres of irregular size, small fragments of cytoplasm, 
or large• intracellular vacuoles. Within, this range of 
concentrations; no effect of concentration on develop-
ment to blastocyst was found (x 2 = 3.5, df = 3, P> 0.3 
(Table 4). As the period of exposure to 5 p.M nocodazole 
increased from 12 to 24 hr, the proportion of embryos 
developing to the blastocyst stage decreased in a linear 
manner on the logistic scale (x 2 = 160.55, df = 3, 
P< 0.001; Table 4). 
A significant effect of embryo stage on development 
to blastocyst after exposure to nocodazole was found 
(x2 = 36.52, df = 3, P < 0.001 (Table 4). When consid-
ering all stages exposed to 2.5-10 p.M nocodazole for 
12-24 hr, it was possible to divide the embryos into 
three groups: (1) the control group; (2) 2-, 4-, and 8-cell 
stage embryos; and (3) the morula (16-cell) stage. There 
was a significant difference between these three groups 
in the proportion of embryos forming blastocysts 
(P < 0.001) (Table 4). 
By contrast, there was no effect on development to 
blastocyst of 4-cell embryo when they were exposed to 
10 p.M nocodazole for 9 hr (95% nocodazole treated vs. 
98% control, with 12 replicates and 185 and 120 em-
bryos, respectively (x 2 = 2.14, df = 1, P> 0.1). 
Effect on development to term. As there was no 
effect of treatment upon the proportion of recipient that 
became pregnant, only data from embryo transfer pro- 
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TABLE 3. Synchronization of 4-Cell Stage Mouse Embryos in Mitosis With 














0 2 35 146 0d 146 (100) 0 
1 2 34 169 0 103 (63) 66 (37) 
1.5 2 37 296 0 0 296 (100) 
2 1 21 166 0 2 (1) 164 (99) 
11 1 10 82 75 (91) 3 (4) 4 (5) 
12 3 38 309 253 (81) 45 (15) 12 (4) 
13 3 37 337 190 (57) 62 (19) 85 (23) 
14 1 15 163 42 (26) 35 (21) 86 (53) 
15 2 27 326 55 (17) 47 (13) 224 (70) 
17 1 17 238 18 (8) 16 (6) 204 (86) 
*Completion of mitosis and second mitosis after release from nocodazole 
'Hours after release from nocodazole (10 p.M). 
blnterphase  nuclei in the previous stage. 
clnterphase  nuclei in the next stage. 
"Number (%) of nuclei. Determined by staining with Hoechst 33342. 
TABLE 4. Effect of Nocodazole Concentration, Length 
of Exposure to Nocodazole, and Embryo Stage on 
Subsequent Development of Treated Embryos 
to Blastocystt  
No. of No. of 
replicates embryos % Blastocysta 
Concentration' 
2.5 p.M 22 224 70 
5p.M 33 992 74 
7.5 p.M 12 216 80 
10 p.M 14 277 74 
Length of exposure' 
12 hr 81 1,709 74 (1.02) 
16 hr 12 266 47 (-0.13) 
20 hr 18 279 9 (-2.37) 
24 hr 13 162 4 (-3.21) 
Embryo staged 
2 cell** 38 878 57 
4 cel1** 29 359 66 
8 cell** 33 499 50 
Morulat 24 680 21 
tData from a series of experiments. Percentage of develop-
ment to blastocyst in the nonexposed (control) group was 98% 
from 20 replicates with a total of 336 embryos. 
aValues  are batch transformed from the logistic analysis. 
(Values on logistic scale.) 
b(x2 = 3.5,df = 3,P >0.3). 
c(x2 = 160.55, df = 3, P < 0.001). 
= 36.52, df = 3, P < 0.001). 
**. tDifferent superscripts have statistically different 
(P < 0.001) rates of blastocyst formation. 
cedures that resulted in pregnancy were used to assess 
the proportion of transferred embryos that developed to 
term. There was a significant effect of embryo stage on 
development to term following 12-hr exposore to 5 p.M 
nocodazole. There was a significant decrease in sur-
vival as cell number of the embryo as time of treatment 
increased (x2 = 15.20, df = 3, P < 0.01 (Table 5). De-
velopment to term of embryos treated at the 2- and 
4-cell stage was not significantly different from that of 
the control group. However, survival of 8- and 16-cell 
TABLE 5. Effect on Development to Term of 12-hr 
Exposure of Mouse Embryos to 5 p.M Nocodazole at 
Different Stages of Development 
Offspring/embryos 
Pregnancies/transfer (%) 
Group (%) (Pregnancies only) 
Controla 6/14 (43) 27/68 (39)* 
2-cell 7/9 (77) 34/95 (35)* 
4-cell 8/11 (73) 33/122 (27)* ** 
8-cell 4/7 (57) 10/60 (17)** 
Morula 4/13 (31) 7/47 (15)** 
alloflexposed embryos cultured in vitro from 2-cell stage until 
blastocyst stage. 
*. **jjp with different superscripts have a statistically 
significant (x2 = 15.20, df = 3, P <0.01) different rate of de-
velopment to term. 
embryos was significantly lower than that of the con- 
trol group (P < 0.001). 
When the blastocysts that were transferred had de- 
veloped from 4-cell embryos exposed to 10 p.M nocoda-
zole for 9 hr, there was no apparent effect on develop-
ment to term; in 6 pregnant recipients, 29 of 73 
embryos (40%) developed to term. 
Cell cycle after treatment. Cell cycle synchroniza-
tion after release from nocodazole was observed in 
8-cell embryos that developed from 4-cell embryos ex-
posed to 10 [LM nocodazole for 9 hr. Although comple-
tion of mitosis from the 4- to 8-cell stage was synchro-
nous, the embryos had lost that synchrony by the time 
of the next mitosis (Table 3). BrdU incorporation into 
DNA started at 120-150 min after release from nocoda-
zole and was observed in all embryos after 180 mm 
(Table 6). 
Effect of cell cycle stage of the transferred nu- 
cleus. The stage of the cell cycle of the donor blas-
tomere had a very dramatic effect upon the proportion 
of reconstituted embryos that developed to blastocyst 
when nuclei from 8-cell embryos were transferred into 
enucleated oocytes (Table 7). 
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TABLE 6. Synchronization of 4-Cell Stage Mouse 
Embryos in Mitosis With Nocodazole (10 p.M, 9 hr)* 
No. of 
End of incubation No. of No. of embryos +ve 
with BrdU (min)' replicates total embryos (%) 
120 3 24 3(12) 
150 4 33 30 (90) 
180 4 30 30 (100) 
210 4 28 28 (100) 
240 4 30 30 (100) 
270 4 31 31 (100) 
*Initiation  of bromo deoxyuridine (BrdU) incorporation in re-
sulted 8-cell embryos after release from nocodazole. 
a Start of incubation after release from nocodazole. 
DISCUSSION 
These studies demonstrate that it is possible to use 
nocodazole to synchronise embryonic cells in Gi before 
nuclear transfer and that such reconstructed embryos 
are able to develop to blastocyst. The observed differ-
ence between donors in Gi and S-phase confirms ear-
her observations of the importance of donor cell cycle 
stage (Collas et al., 1992; Cheong et al. 1993). The op-
portunity to obtain embryonic cells at specific cell cycle 
stages will facilitate further analyses of these effects. 
Nocodazole was effective in arresting >95% of cells in 
mitosis provided that the concentration of nocodazole 
was-_5 iM (Table 1). The chromosomes were con-
densed and grouped in the centre of the blastomere, 
with no indication of chromosome dispersal. A similar 
situation was described in the hamster when exposed to 
griseofulvine (Adair, 1974). In other studies of the role 
of the cytoskeleton in early development, 10 .M no-
codazole has been used routinely (Maro and Bornens, 
1980; Maro and Pickering, 1984; Johnson and Maro, 
1985; Maro et al., 1986; Johnson et al., 1988; Kato and 
Tsunoda, 1992). 
The effect of nocodazole on the subsequent develop-
ment of mouse embryos depended upon the stage of 
development of the embryo at the time of exposure and 
the duration of exposure to nocodazole. If treatment 
was for >12 hr, development was significantly reduced, 
but the reduction was greatest when later stages of 
development were treated than with 2- or 4-cell em-
bryos. The effect on 8-cell embryos is similar to the 
previous report that, as the treatment period of isolated 
8-cell blastomeres exposed to 10 jiM nocodazole was 
increased beyond 6 hr, they had a reduced ability to 
progress to "miniblastocyst" (Johnson et al., 1988). 
Nocodazole has been used for the synchronization of 
division in mouse 2-cell embryos in a previous study 
(Kato and Tsunoda, 1992). It was observed that follow-
ing culture for 12.5-14.5 hr in the presence of 10 p.M 
nocodazole, there was no significant reduction in the 
proportion of 2-cell embryos that developed to blasto-
cyst or to term. The apparent difference between these 
results and our observations may reflect minor differ-
ences in treatment protocols, such as the use of low-
temperature storage of the embryos prior to treatment  
(Kato and Tsunoda, 1992). In addition, there are re-
ports of variation in the activity of different prepara-
tions of such drugs (Margulis, 1973). Although there 
was a difference in the proportion of treated embryos 
that became blastocysts, when those blastocysts were 
transferred to pseudopregnant mice, a similar propor-
tion developed to term in the two experiments. 
The antimitotic activity of nocodazole is due to its 
interference with the microtubule assembly process by 
binding to tubulin monomers (Hoebeke et al., 1976). By 
doing so, it prevents the assembly of the spindle and 
arrests cells in the metaphase—anaphase boundary, 
prior to chromosomal separation (Johnson et al., 1988). 
The harmful effects of nocodazole may reflect a disrup-
tion of microtubules other than those required for spin-
dle formation. Important changes within the bias-
tomeres are mediated by the microtubules, particularly 
during polarisation of the cells and compaction of the 
morula (Maro et al., 1991). Since exposure to the drug 
had relatively little effect on 2-cell embryos and in-
creasingly harmful effects on embryos at the 4-, 8-, and 
16-cell stages, it seems likely that this reflects, at least 
in part, disruption of differentiation of the blastomeres 
and the organisation of the embryo. 
The proportion of treated 4-cell embryos developing 
to blastocyst was not affected when the exposure time 
was reduced to 9 hr, and they progressed synchronously 
at least until the start of DNA synthesis at the 8-cell 
stage. Mitosis was completed in all embryos in 90 mm 
(Table 3) and incorporation of BrdU was observed in all 
embryos within 180 mm (Table 6). As a minimum pe-
riod of 45-min incubation was required before incorpo-
ration of BrdU during DNA synthesis was detected 
when 8-cell embryos in S-phase were transferred to 
medium containing BrdU (unpublished data) these ob-
servations taken together show that the Gi phase in 
the treated 8-cell mouse embryos was no more than 45 
mm. 
When nuclei from blastomeres thus synchronized 
were used to conduct studies on the effect of cell cycle on 
nuclear transfer, a proportion of nuclei from 8-cell stage 
embryos transferred to enucleated oocytes were able to 
develop to blastocyst if they were in Gi, confirming 
earlier observations in rabbit and mouse (Cohlas et al., 
1992; Cheong et al., 1993). By contrast, when nuclear 
donors were allowed to enter the S-phase few of the 
reconstituted embryos cleaved and none of them devel-
oped to the blastocyst stage. An explanation that has 
been proposed to explain this phenomenon is that nu-
clei in S-phase undergo "pulverization" of the chromo-
somes because of the induction of condensation during 
DNA replication (Colias et al., 1992; Czolowska et al., 
1992; Cheong et al., 1993). Two methods have been 
used to avoid this damage: either having nuclear do-
nors in Gi (Collas et al., 1992; Cheong et al., 1993) or 
recipients in presumptive S-phase (Campbell et al., 
1994) and both approaches increased development fol-
lowing nuclear transfer. 
In this paper, we have shown that the synchroniza-
tion of nuclei in donor embryos with nocodazole is a 
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TABLE 7. Effect of Cell Cycle Stage of Transferred Nuclei (8-Cell Stage Embryo) 
on Development to Blastocyst of Embryos Reconstituted by Nuclear Transfer 
Development 
Cell cycle stage 	Fused/total 	Replicates 	2-cell (% fused) 	Blastocyst (% fused) 
Gi 	 33/38 	2 	 30 (90) 	 9 (27) 
S 58/60 3 9 (15) 0 
simple method to obtain populations of nuclei in Gi 
either for use in improved embryo cloning procedures, 
or to continue studies of nuclear-cytoplasmic interac-
tions in reconstituted embryos. 
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